|
- clinical trials
Clinical trials of are available for the following clinical conditions:
abdominal aortic aneurysm
Vammen, 2001
-
PATI, 2002
-
Wilmink, 2000
-
Mosorin, 2001
-
Lindholt, 1999
-
Powerlink, 0
-
DREAM, 2005
-
OVER, 2009
-
EVAR trial 2, 2005
-
PIVOTAL (Ouriel), 2010
-
EVAR trial 1, 2005
-
OVER, 2009
-
DREAM, 2005
-
EVAR trial 2, 2005
-
EVAR trial 1, 2005
-
PIVOTAL (Ouriel), 2010
-
acute coronary syndrome
A to Z, 2004
-
IMPROVE-IT, 0
-
FLORIDA, 2002
-
PAIS, 2001
-
LAMIL, 1997
-
PROVE IT - TIMI 22, 2004
-
Czech trial,
-
Colivicchi, 2002
-
PTT, 2002
-
RECIFE, 1999
-
MIRACL, 2001
-
JAPAN ACS, 2009
-
ESTABLISH, 2004
-
PACT, 2004
-
L-CAD, 2000
-
LIPS (sub groups), 2002
-
FRISC 2, 1999
-
Ardissino, 1990
-
Freeman, 1992
-
Nicklas, 1989
-
ABOARD, 2009
-
ICTUS, 2007
-
TIMACS, 2009
-
TACTICS-TIMI 18, 2001
-
the Italian Elderly ACS study, 0
-
TIMI 3B (PTCA), 1994
-
TIMI 3B, 1995
-
van der Brand, 1991
-
Gold, 1987
-
OPTIMA, 2009
-
TRUCS, 2000
-
UNASEM, 1992
-
VINO, 2002
-
Topol, 1988
-
VANQWISH, 1998
-
TAUSA, 1994
-
charbonnier, 1992
-
Williams, 1990
-
ISAR-COOL, 2003
-
TIMI 3A, 1993
-
RITA 3, 2002
-
NQWMI (Eisenberg), 2005
-
MATE, 1998
-
VA cooperative, 1987
-
Holdright, 1994
-
CARS, 1997
-
WARIS, 2002
-
DISPERSE-2 (90mg), 2007
-
ESSENCE, 1997
-
HERO, 1997
-
EVET, 2005
-
ATACS (pilot study) (warfarin vs control), 1990
-
ASPECT-2 (coumadin+asp vs asp), 2002
-
APPRAISE-1 (2.5 mg bid), 2009
-
FRISC (long term), 1996
-
Plaza, 1993
-
PENTUA, 2004
-
TIM, 2000
-
ASPECT-2 (coumadin vs aspirin), 2002
-
ACAPULCO,
-
Théroux, 1988
-
Cohen (ATACS pilot) (heparin vs asp), 1990
-
FRAXIS (14 days), 1998
-
ATLAS ACS TIMI 51,
-
ALDUSA-pilot, 0
-
BAT (Bittl), 1995
-
Gurfinkel (UFH+aspririn vs aspirin), 1995
-
Canadian (sulfinpyrazone alone), 1985
-
CURRENT OASIS 7 (clopidogrel), 2010
-
VA-main, 1983
-
Klootwijk, 1999
-
Cohen (ATACS pilot) (heparin+aspirin vs asp), 1990
-
OASIS Pilot (phase 1), 1998
-
LoWASA, 2004
-
PROTECT-TIMI 30, 2006
-
TIMI 11 B (short term), 1998
-
HIT-4, 1999
-
Gurfinkel (LMWH+asp vs UFH+asp), 1995
-
ATACS, 1994
-
APRICOT-2, 2002
-
RESCUE,
-
FRIC (acute phase LMWH vs UFH), 1997
-
Modena, 0
-
OASIS 5, 2006
-
TRILOGY, 0
-
Huyhn, 2001
-
ATACS (pilot study) warfarin vs aspirin, 1990
-
LANCELOT ACS,
-
Florida UA, 0
-
Gurfinkel (LMWH+asp vs asp), 1995
-
TIMI 11 B (long term), 1998
-
B0661004,
-
STAI, 1990
-
HELVETICA (Serruys), 1995
-
Theroux (heparin vs PBO), 1988
-
Theroux (heparin+ASP vs ASP), 1988
-
CURRENT - OASIS 7 (ASA), 2010
-
Canadian (Aspirin + sulfinpyrazone), 1985
-
OASIS pilot, 1997
-
RISC (heparin+aspirin vs ASP), 1990
-
OASIS Pilot (phase 2), 1998
-
Zibaeenezhad, 2004
-
ATLAS ACS-TIMI 46, 2009
-
SYNERGY, 2005
-
TIMI 9B, 1996
-
OASIS, 1997
-
Williams, 1997
-
CHAMP, 2002
-
PLATO, 2009
-
FRAXIS (6days), 1998
-
ARGAMI-2, 1998
-
INTERACT, 2006
-
CURE, 2001
-
OASIS-2 Warfarin Substudy, 2001
-
APPRAISE-1 (10mg od), 2009
-
J-LANCELOT, 2010
-
ATACS (Cohen), 1994
-
ATACS-pilot, 1990
-
FRIC prolonged treatment phase (LWMH vs PBO), 1997
-
FRISC (short term), 1996
-
APPRAISE 2 (CV185-068),
-
Prandoni, 1991
-
OASIS 2, 1999
-
RISC (heparin vs PBO), 1990
-
RISC (ASP+ heparin vs PBO), 1990
-
TRA*CER,
-
RISC, 1990
-
TRIM, 1997
-
Theroux (heparin+aspirin vs PBO), 1988
-
Canadian (Aspirin vs PBO), 1985
-
SEPIA-ACS1 TIMI 42, 2009
-
VA-pilot, 0
-
GUSTO IIB, 1996
-
RESCUE,
-
the Italian Elderly ACS study, 0
-
TACTICS-TIMI 18 elderly (sub group), 2001
-
ATACS (pilot study) (warfarin vs control), 1990
-
APPRAISE-1 (10mg od), 2009
-
Zibaeenezhad, 2004
-
CHAMP, 2002
-
OASIS-2 Warfarin Substudy, 2001
-
OASIS Pilot (phase 1), 1998
-
ATLAS ACS TIMI 51,
-
ATACS, 1994
-
APPRAISE-1 (2.5 mg bid), 2009
-
ASPECT-2 (coumadin vs aspirin), 2002
-
WARIS, 2002
-
ASPECT-2 (coumadin+asp vs asp), 2002
-
OASIS Pilot (phase 2), 1998
-
B0661004,
-
Williams, 1997
-
ATLAS ACS-TIMI 46, 2009
-
ATACS (pilot study) warfarin vs aspirin, 1990
-
LoWASA, 2004
-
APRICOT-2, 2002
-
Huyhn, 2001
-
APPRAISE 2 (CV185-068),
-
CARS, 1997
-
SEPIA-ACS1 TIMI 42, 2009
-
ASPECT-2 (coumadin+asp vs asp), 2002
-
OASIS Pilot (phase 2), 1998
-
ATACS (pilot study) (warfarin vs control), 1990
-
ASPECT-2 (coumadin vs aspirin), 2002
-
Huyhn, 2001
-
ATACS, 1994
-
ATACS (pilot study) warfarin vs aspirin, 1990
-
OASIS-2 Warfarin Substudy, 2001
-
OASIS Pilot (phase 1), 1998
-
PLATO, 2009
-
VA-pilot, 0
-
CURE, 2001
-
Plaza, 1993
-
Théroux, 1988
-
TRA*CER,
-
ALDUSA-pilot, 0
-
DISPERSE-2 (90mg), 2007
-
VA-main, 1983
-
Canadian (Aspirin vs PBO), 1985
-
Modena, 0
-
Florida UA, 0
-
J-LANCELOT, 2010
-
STAI, 1990
-
CURRENT OASIS 7 (clopidogrel), 2010
-
Canadian (Aspirin + sulfinpyrazone), 1985
-
Canadian (sulfinpyrazone alone), 1985
-
TRILOGY, 0
-
ATACS-pilot, 1990
-
Prandoni, 1991
-
CURRENT - OASIS 7 (ASA), 2010
-
RISC, 1990
-
CURRENT OASIS 7 (clopidogrel), 2010
-
CURRENT - OASIS 7 (ASA), 2010
-
TRITON-TIMI 38, 2007
-
INTERACT, 2006
-
Theroux (heparin vs PBO), 1988
-
ESSENCE, 1997
-
RISC (heparin+aspirin vs ASP), 1990
-
FRISC (long term), 1996
-
RESCUE,
-
FRAXIS (14 days), 1998
-
FRIC prolonged treatment phase (LWMH vs PBO), 1997
-
EVET, 2005
-
RISC (heparin vs PBO), 1990
-
TIMI 11 B (short term), 1998
-
Theroux (heparin+aspirin vs PBO), 1988
-
FRIC (acute phase LMWH vs UFH), 1997
-
Holdright, 1994
-
TIMI 11 B (long term), 1998
-
Theroux (heparin+ASP vs ASP), 1988
-
Gurfinkel (LMWH+asp vs UFH+asp), 1995
-
Cohen (ATACS pilot) (heparin vs asp), 1990
-
SYNERGY, 2005
-
Gurfinkel (UFH+aspririn vs aspirin), 1995
-
FRAXIS (6days), 1998
-
Cohen (ATACS pilot) (heparin+aspirin vs asp), 1990
-
ATACS (Cohen), 1994
-
FRISC (short term), 1996
-
RISC (ASP+ heparin vs PBO), 1990
-
Gurfinkel (LMWH+asp vs asp), 1995
-
DRS, 1986
-
HINT (nifedipine vs metoprolol), 1988
-
Göbel (Dutch study), 1995
-
Williams, 1990
-
Topol, 1988
-
Ardissino, 1990
-
Freeman, 1992
-
Nicklas, 1989
-
UNASEM, 1992
-
TIMI 3B, 1995
-
van der Brand, 1991
-
Gold, 1987
-
TIMI 3A, 1993
-
TAUSA, 1994
-
charbonnier, 1992
-
Doucet, 2000
-
Karlberg, 1998
-
MERLIN TIMI 36, 2007
-
SEPIA-ACS1 TIMI 42, 2009
-
APPRAISE-1 (10mg od), 2009
-
ATLAS ACS TIMI 51,
-
APPRAISE-1 (2.5 mg bid), 2009
-
B0661004,
-
ATLAS ACS-TIMI 46, 2009
-
APPRAISE 2 (CV185-068),
-
TRILOGY, 0
-
ATACS-pilot, 1990
-
Prandoni, 1991
-
LANCELOT ACS,
-
RISC, 1990
-
CURRENT - OASIS 7 (ASA), 2010
-
VA-pilot, 0
-
PLATO, 2009
-
CURE, 2001
-
Plaza, 1993
-
Théroux, 1988
-
J-LANCELOT, 2010
-
ALDUSA-pilot, 0
-
TRA*CER,
-
VA-main, 1983
-
DISPERSE-2 (90mg), 2007
-
Canadian (Aspirin vs PBO), 1985
-
Modena, 0
-
Florida UA, 0
-
STAI, 1990
-
ACAPULCO,
-
Canadian (Aspirin + sulfinpyrazone), 1985
-
CURRENT OASIS 7 (clopidogrel), 2010
-
Canadian (sulfinpyrazone alone), 1985
-
ACUITY (biva alone vs hep+aGP2b3a), 2006
-
ACUITY (biva+aGP2b3a vs hep+aGP2b3a), 2006
-
TRITON-TIMI 38, 2007
-
ACUITY (sub groups PCI, bivalirudin +aGP2b3a) importé, 2007
-
ACUITY (sub groups PCI, bivalirudin alone) importé, 2007
-
CURE (PCI sub study), 2001
-
APPRAISE 2 (CV185-068),
-
ATLAS ACS-TIMI 46, 2009
-
ATLAS ACS TIMI 51,
-
APPRAISE-1 (10mg od), 2009
-
B0661004,
-
APPRAISE-1 (2.5 mg bid), 2009
-
Thurston, 1973
-
Dekleva, 2004
-
Rawles, 1976
-
HOT MI pilot, 1997
-
Hot MI, 1997
-
Sharifi, 2004
-
Ukholkina, 2005
-
AMIHOT II , 2000
-
Kerr, 1975
-
Swift, 1992
-
Wilson, 1997
-
AMIHOT, 2007
-
HEMOPURE, 2005
-
CHAMPION-PCI, 2009
-
PLATO, 2009
-
ERASE-MI, 2009
-
DISPERSE-2 (90mg), 2007
-
JUMBO-TIMI 26, 2005
-
CHAMPION-PLATFORM, 2009
-
TRITON-TIMI 38, 2007
-
acute myocardial infarction
ASPECT-2 (coumadin+ASA vs ASA), 2002
-
Sixty Plus reinfarction Study, 1980
-
ATACS pilot, 1990
-
CARS (warafrin 3mg), 1997
-
BIOMACS II, 1999
-
HIT-4, 1999
-
ASSENT Plus, 2003
-
WARIS, 1999
-
HART II, 2001
-
Williams, 1997
-
OSIRIS, 1992
-
LoWASA (copie de 8025), 0
-
OASIS main, 2001
-
WARIS II (warfarin+ASA), 2002
-
EPSIM, 1982
-
APRICOT-2, 2002
-
LoWASA, 2004
-
AMI-SK, 2002
-
TIMI 9B, 1996
-
ASPECT, 1994
-
ASSENT 3 Plus, 2003
-
ARGAMI-2, 1998
-
Baird, 2002
-
Zibaeenezhad, 2004
-
DUCCS, 1994
-
German-Austrian Study Group (oac vs pbo), 1980
-
OASIS pilot, 1998
-
ISIS-2 Pilot, 1987
-
German-Austrian Study Group (oac vs asp), 1980
-
ASPECT-2 (coumadin alone), 2002
-
CARS (warfarin 1mg), 1997
-
CREATE, 2005
-
ATACS main, 1994
-
CHAMP, 2002
-
FRAMI, 1997
-
HERO, 1997
-
ENTIRE-TIMI 2, 2002
-
Horizons, 2008
-
ASSENT 3, 2001
-
MICHELANGELO OASIS-6, 2006
-
WARIS II (warfarin alone), 2002
-
ECSG, 1992
-
OASIS pilot phase 2, 0
-
Huynh, 2001
-
Federman , 1984
-
Mueller , 1980
-
UKCSG , 1983
-
Curtis , 1991
-
Macleod , 1980
-
Snow , 1980
-
Campbell , 1984
-
Ledwich , 1968
-
Roberts , 1984
-
Azancot, 1982
-
ISIS1 Collaborative Group , 1986
-
Peter , 1978
-
TIMI IIB, 1989
-
Heber , 1987
-
Norris , 1978
-
Wilcox , 1980
-
Fuccella , 1968
-
Multicentre , 1966
-
Van de Werf , 1993
-
Dotremont , 1968
-
McMurray , 1991
-
Thompson , 1979
-
Clausen , 1966
-
Lloyd , 1988
-
Singh , 1985
-
Balcon , 1966
-
Johansson , 1980
-
Pitt , 1976
-
Hutton , 1979
-
Norris , 1984
-
Yang , 1987
-
Gupta , 1982
-
Nigam , 1983
-
Von Essen , 1982
-
Evemy , 1978
-
MIAMI Trial Research Group , 1985
-
Tonkin , 1981
-
CPRG , 1981
-
Lombardo , 1979
-
Sloman , 1967
-
Barber , 1976
-
Kahler , 1968
-
Ranganathan , 1988
-
ICSG , 1984
-
Owensby , 1984
-
Yusuf , 1980
-
Gupta , 1984
-
Norris , 1968
-
Waagstein , 1975
-
Mazur , 1984
-
Darasz , 1995
-
Kaul , 1988
-
Sjöland , 1995
-
Baber , 1980
-
Wilcox , 1980
-
APSI, 1990
-
Schwartz (high risk and low risk) , 1992
-
Reynolds , 1972
-
Multicentre international , 1975
-
EIS , 1984
-
LIT Research Group , 1987
-
Basu , 1997
-
Hjalmarson , 1981
-
Wilhelmsson , 1974
-
Aronow , 1997
-
SSSD , 1993
-
Ahlmark , 1974
-
TIARA (Roqué), 1987
-
Norwegian Multicentre Study Group , 1981
-
Hansteen , 1982
-
Manger Cats , 1983
-
BHAT , 1982
-
Julian , 1982
-
Yusuf , 1979
-
Australian and Swedish study, 1983
-
Taylor , 1982
-
Andersen , 1979
-
Salathia , 1985
-
Rehnqvist , 1983
-
PRAGUE (Widimisky), 2000
-
FINESSE (abciximab-facilitated PCI), 2008
-
ADVANCE-MI, 2005
-
ReoPro-BRIDGING (Gyongyosi), 2004
-
REOMOBILE (Arntz), 2003
-
On-Time (van’t Hof), 2004
-
LIMI (Vermeer), 1999
-
ASSENT-4 PCI (Van de Werf), 2006
-
BRAVE (Kastrati), 2004
-
INTAMI (Zeymer), 2005
-
Zorman, 2002
-
TIGER-PA (Lee), 2003
-
PACT (Ross,), 1999
-
SAMI (O’Neill), 1992
-
FINESSE (combination-facilitated PCI), 2008
-
Bellandi, 2006
-
Cutlip, 2003
-
ERAMI (Mesquita Gabriel), 2003
-
GRACIA (Fernandez-Aviles,), 2004
-
PRAGUE-1 (thrombolysis+PTCA), 2000
-
Western Washington Intravenous Trial, 1988
-
TAPS, 1992
-
ISIS III (SK/tPA), 1992
-
PASEO, 2009
-
stent-PAMI (Grines), 1999
-
Roth, 1990
-
PAIMS, 1989
-
HORIZONS-AMI Stent, 2008
-
FRESCO, 1998
-
AIMS, 1988
-
TAMI 5 (t-PA vs uroK), 1991
-
COBALT, 1997
-
senior PAMI, 2005
-
Jaksch, 1998
-
Díaz de la Llera, 2007
-
Centre Illinois, 1993
-
CARESS, 2008
-
MERLIN (Sutton), 2004
-
CAPTIM, 2002
-
STOPAMI 2, 2002
-
PRIMI (vs SK), 1989
-
duteplase 1, 1993
-
Guerci, 1987
-
PROSIT, 2006
-
PRIMI (vs UK), 1989
-
Ellis, 1994
-
MAASTRICHT (Vermeer), 1999
-
GUSTO 2B, 1997
-
STAT, 2001
-
GUSTO tPA-SK Hiv, 1993
-
ASSENT-1, 1999
-
SWIFT, 1991
-
TYPHOON, 2006
-
USIM, 1991
-
TIMI II-A (defered), 0
-
Topol, 1987
-
Gibbons, 1993
-
AIR-PAMI , 2002
-
GISSI I, 1986
-
STAR, 1995
-
EMIP, 1993
-
PSSAAMI (Scheller), 2001
-
RAPID-2, 1996
-
GRACIA-1, 2004
-
STOPAMI 3, 2004
-
Zijlstra, 1997
-
Zijlstra , 1993
-
German Multicenter Trial, 1988
-
RAAMI, 1992
-
TEAHAT, 1990
-
Juwana, 2009
-
PASTA (Saito), 1999
-
Schofer, 1990
-
TIMI-1, 1987
-
ZEST AMI (vs SES), 2009
-
CADILLAC abciximab., 2002
-
Zwolle, 1994
-
DANAMI-2, 2003
-
ISIS-2 (SK), 1988
-
TEAM 2, 1991
-
ASSENT-2, 1999
-
NORDISTEMI, 2009
-
GRAMI (Rodriguez), 1998
-
MULTISTRATEGY, 2008
-
Cherng, 1992
-
CAPITAL AMI, 2005
-
LIMI (Vermeer), 1999
-
APSIM, 1989
-
Mathey, 1985
-
duteplase 2, 1993
-
Van den Brand, 1991
-
Di Lorenzo et al., 2005
-
Castaigne, 1987
-
DANAMI-2, 1997
-
Vermeer, 1999
-
PRAGUE-1, 2000
-
GUSTO tPA Hiv, 1993
-
STOPAMI 1, 2000
-
GUSTO III, 1997
-
inTIME 1, 1998
-
SIAM, 1992
-
SESAMI, 2007
-
ISIS 2 pilot, 1987
-
TAMI-5 (Califf), 1991
-
TAMI 6, 1992
-
Ribichini, 1996
-
DANAMI-2 , 2003
-
ISIS III (SK/APSAC), 1992
-
RAPID 1, 1995
-
TAMI 1 pilot, 1987
-
PASSION, 2006
-
LATE, 1993
-
SIAM III, 2002
-
TIMI 2A, 1988
-
DeWood, 1989
-
Akhras, 1997
-
GISSI II, 1990
-
TIMI 4, 1994
-
MITI, 1993
-
PRISAM (Kawashima), 1999
-
Barbash, 1990
-
White, 1989
-
WEST, 2006
-
CADILLAC (no abciximab), 2002
-
Ribeiro, 1993
-
PRAGUE-2, 2003
-
ASSET, 1988
-
TEAM 3, 1992
-
InTIME-II, 2000
-
TRIANA, 2009
-
Zwolle 5 (Suryapranata), 1998
-
Castaigne , 1989
-
ECSG, 1985
-
DEDICATION, 2008
-
SWISS-SMASH, 1999
-
ISAM, 1986
-
TAMI 6, 1992
-
SESAM, 1997
-
duteplase 3, 1993
-
TOPS, 1992
-
ZEST AMI (vs PES), 2009
-
Mcneill, 1989
-
TRANSFER-AMI, 2008
-
Erbel, 1989
-
AIR-PAMI, 2002
-
C-PORT, 2002
-
INJECT, 1995
-
Bassand, 1991
-
TIMI 2, 1989
-
MISSION, 2008
-
EMERAS (7-12h), 1993
-
SHOCK (Hochman), 1999
-
Barbash, 1990
-
Garcia, 1997
-
PRAGUE-2 , 2003
-
COMPASS, 1998
-
TIMI 10B, 1998
-
ECSG, 1988
-
HAAMU-STENT, 2006
-
EMERAS (all delay), 1993
-
PRAGUE, 2000
-
Belenkie, 1991
-
PAMI, 1993
-
O'Neill, 1986
-
International Study Group, 1990
-
TAMI 5 (t-PA+uroK vs tPA), 1991
-
GREAT, 1994
-
STENTIM-2 (Maillard), 2000
-
KAMIT, 1991
-
CAPITAL AMI, 2005
-
ZWOLLE 6, 2005
-
Grinfeld, 1996
-
Rasmussen, 1986
-
Urek, 1996
-
Dunn, 1985
-
Nameki, 2004
-
Singh, 1990
-
Sandlar, 0
-
Ising, 1990
-
O, 0
-
Chen, 1991
-
Chopra, 1971
-
MAGIC, 2000
-
Kostuk and Beanlands, 0
-
Santoro, 2000
-
Woods, 1992
-
Koster and Dunning, 1985
-
Parikka, 1990
-
Smith, 1986
-
Singh and Kocot, 1976
-
Morton, 1984
-
Shechter, 1991
-
Lie (IV), 1974
-
Feldstedt, 1991
-
Pitt, 1971
-
Bhargava, 1995
-
Bennett, 1970
-
Abraham, 1987
-
Shechter, 1990
-
Wu, 1992
-
DIAMOND MI, 1997
-
Raghu, 1999
-
Thogersen, 1995
-
Lie (IM), 1978
-
Nakashima, 2004
-
Shechter, 1995
-
Wyse, 1988
-
Gyamlani, 2000
-
Darby, 1972
-
Ceremuzynski, 1989
-
Baker, 1971
-
ISIS-4, 1995
-
Zhu, 2002
-
CAST II (early treatment), 1992
-
TAMI 6, 1992
-
TOSCA-2, 2006
-
DECOPI, 2004
-
TOMIIS, 1994
-
LATE, 1993
-
Silva et al, 2005
-
Horie et al, 1998
-
EMERAS (7-12h), 1993
-
OAT, 2006
-
TOAT, 2002
-
RESCUE II, 2000
-
Belenkie, 1992
-
Mounsey, 1995
-
RESCUE, 1994
-
REACT (rescue PCI), 2005
-
STOPAMI 4, 2004
-
REACT (repeat fibrinolysis), 2005
-
MERLIN, 2004
-
Vermeer, 1999
-
Sarullo, 2000
-
SPRINT II, 1993
-
Sirnes, 1984
-
Zannad, 1988
-
Gottlieb, 1988
-
Loogna, 1985
-
Eisenberg, 1985
-
MDPIT, 1988
-
DAVIT II, 1990
-
Bussman, 1984
-
Erbel, 1988
-
Eichler, 1985
-
TRENT (Wilcox), 1986
-
Bradagan, 1986
-
MI study group, 1979
-
Muller, 1984
-
Gibson, 1986
-
DAVIT I, 1984
-
SPRINT I, 1988
-
Danish study, 1984
-
Walker, 1988
-
Jaffe, 1987
-
CRIS, 1996
-
Gordon, 1984
-
Machecourt, 1986
-
Crea, 1985
-
Eichler, 1985
-
TRENT (Wilcox), 1986
-
Gibson, 1986
-
Erbel, 1988
-
Bradagan, 1986
-
Muller, 1984
-
Sirnes, 1984
-
Walker, 1988
-
Machecourt, 1986
-
Bussman, 1984
-
Jaffe, 1987
-
Gordon, 1984
-
Zannad, 1988
-
Loogna, 1985
-
Crea, 1985
-
Gottlieb, 1988
-
Eisenberg, 1985
-
MI study group, 1979
-
DAVIT I, 1984
-
CRIS, 1996
-
DAVIT II, 1990
-
SPRINT I, 1988
-
Danish study, 1984
-
MDPIT, 1988
-
SPRINT II, 1993
-
Nelson, 1983
-
Beaufils, 1988
-
Chiche, 1979
-
ISIS-4, 1995
-
Hockings, 1981
-
Jugdutt, 1988
-
Jaffe, 1983
-
Charvat, 1990
-
Bussman, 1981
-
GISSI-3, 1994
-
Durrer, 1982
-
Jugdutt, 1983
-
Fitzgerald, 1990
-
Lis, 1984
-
Zharov, 1991
-
Flaherty, 1983
-
Hildebrandt, 1992
-
Cohn, 1982
-
ESPRIM, 1994
-
Hargreaves, 1992
-
Sharpe, 1991
-
FAMIS, 1998
-
SMILE, 1995
-
Hargreaves, 1992
-
GISSI 3, 1994
-
Di Pasquale, 1994
-
GLOBAL,
-
Ray, 1993
-
PRACTICAL (captopril), 1994
-
French, 1999
-
ISIS-4, 1995
-
Di Pasquale, 1997
-
Bussmann, 1992
-
Schulman, 1995
-
ECCE, 1997
-
CATS, 1996
-
CCS-1, 1995
-
Galcera, 1993
-
CONSENSUS 2, 1992
-
Wagner, 2002
-
Nabel, 1991
-
GLOBAL,
-
SAVE, 1992
-
ISIS-4, 1995
-
Ray, 1993
-
PRACTICAL (captopril), 1994
-
French, 1999
-
Di Pasquale, 1997
-
Sogaard, 1994
-
Bussmann, 1992
-
AIRE, 1993
-
Schulman, 1995
-
CCS-1, 1995
-
CONSENSUS 2, 1992
-
ECCE, 1997
-
CATS, 1996
-
Galcera, 1993
-
Sharpe, 1988
-
Wagner, 2002
-
TRACE, 1995
-
Nabel, 1991
-
SMILE, 1995
-
GISSI 3, 1994
-
Sharpe, 1991
-
FAMIS, 1998
-
Hargreaves, 1992
-
Mortarino, 1990
-
Di Pasquale, 1994
-
Pfeffer, 1988
-
Mortarino, 1990
-
Pfeffer, 1988
-
SAVE, 1992
-
Sogaard, 1994
-
AIRE, 1993
-
Sharpe, 1988
-
TRACE, 1995
-
PROVE-IT, 2004
-
ATACS pilot, 1990
-
ASPECT-2 (coumadin+ASA vs ASA), 2002
-
CARS (warafrin 3mg), 1997
-
WARIS, 1999
-
Williams, 1997
-
German-Austrian Study Group (oac vs pbo), 1980
-
OASIS main, 2001
-
German-Austrian Study Group (oac vs asp), 1980
-
APRICOT-2, 2002
-
WARIS II (warfarin+ASA), 2002
-
LoWASA, 2004
-
ASPECT, 1994
-
Zibaeenezhad, 2004
-
OASIS pilot, 1998
-
OASIS pilot phase 2, 0
-
ASPECT-2 (coumadin alone), 2002
-
Sixty Plus reinfarction Study, 1980
-
ATACS main, 1994
-
CARS (warfarin 1mg), 1997
-
CHAMP, 2002
-
Horizons, 2008
-
WARIS II (warfarin alone), 2002
-
LoWASA (copie de 8025), 0
-
Huynh, 2001
-
EPSIM, 1982
-
TAMI 6, 1992
-
STOPAMI 1, 2000
-
Garcia, 1997
-
Van den Brand, 1991
-
Di Lorenzo et al., 2005
-
TIMI II-A (defered), 0
-
DANAMI-2 , 2003
-
PAMI, 1993
-
SIAM, 1992
-
SESAMI, 2007
-
GRACIA-1, 2004
-
TIMI 2A, 1988
-
Akhras, 1997
-
Grinfeld, 1996
-
PASSION, 2006
-
ZEST AMI (vs SES), 2009
-
CADILLAC (no abciximab), 2002
-
PRAGUE-2, 2003
-
Juwana, 2009
-
PRISAM (Kawashima), 1999
-
CAPITAL AMI, 2005
-
SWISS-SMASH, 1999
-
AIR-PAMI, 2002
-
NORDISTEMI, 2009
-
Zwolle 5 (Suryapranata), 1998
-
DANAMI-2, 1997
-
Erbel, 1989
-
Barbash, 1990
-
C-PORT, 2002
-
GUSTO 2B, 1997
-
TOPS, 1992
-
ZEST AMI (vs PES), 2009
-
TAMI-5 (Califf), 1991
-
Belenkie, 1991
-
PRAGUE-2 , 2003
-
Gibbons, 1993
-
TIMI 2, 1989
-
MISSION, 2008
-
SIAM III, 2002
-
O'Neill, 1986
-
Zijlstra, 1997
-
ECSG, 1988
-
HAAMU-STENT, 2006
-
WEST, 2006
-
ZWOLLE 6, 2005
-
PRAGUE-1 (thrombolysis+PTCA), 2000
-
DEBATER (SES vs BMS), 2009
-
Zwolle, 1994
-
STENTIM-2 (Maillard), 2000
-
DEDICATION, 2008
-
FRESCO, 1998
-
CAPTIM, 2002
-
TRIANA, 2009
-
stent-PAMI (Grines), 1999
-
TRANSFER-AMI, 2008
-
MERLIN (Sutton), 2004
-
MAASTRICHT (Vermeer), 1999
-
STOPAMI 2, 2002
-
TAMI 1 pilot, 1987
-
Jaksch, 1998
-
Díaz de la Llera, 2007
-
Ellis, 1994
-
Topol, 1987
-
STAT, 2001
-
Ribichini, 1996
-
Guerci, 1987
-
PROSIT, 2006
-
PRAGUE, 2000
-
AIR-PAMI , 2002
-
DeWood, 1989
-
SWIFT, 1991
-
TYPHOON, 2006
-
CAPITAL AMI, 2005
-
STOPAMI 3, 2004
-
Zijlstra , 1993
-
Ribeiro, 1993
-
PSSAAMI (Scheller), 2001
-
HORIZONS-AMI Stent, 2008
-
CADILLAC abciximab., 2002
-
DANAMI-2, 2003
-
PASEO, 2009
-
PASTA (Saito), 1999
-
CARESS, 2008
-
LIMI (Vermeer), 1999
-
PRAGUE-1, 2000
-
senior PAMI, 2005
-
GRAMI (Rodriguez), 1998
-
MULTISTRATEGY, 2008
-
Vermeer, 1999
-
SWISS-SMASH, 1999
-
SHOCK (Hochman), 1999
-
OAT, 2006
-
TOAT, 2002
-
TAMI 6, 1992
-
TOSCA-2, 2006
-
DECOPI, 2004
-
TOMIIS, 1994
-
LATE, 1993
-
Silva et al, 2005
-
Horie et al, 1998
-
EMERAS (7-12h), 1993
-
IMMEDIATE,
-
Glucose-insulin-potassium study II, 2007
-
Krljanac, 2005
-
OASIS 6, 2007
-
Bucciarelli-Ducci , 2006
-
CREATE-ECLA , 2006
-
VALIANT (valsartan+capropril), 2003
-
OPTIMAAL, 2002
-
VALIANT (valsartan alone), 2003
-
STOPAMI 3, 2004
-
STOPAMI 3, 2004
-
DANAMI, 1997
-
DANAMI, 1997
-
Mounsey, 1995
-
RESCUE, 1994
-
STOPAMI 4, 2004
-
REACT (repeat fibrinolysis), 2005
-
MERLIN, 2004
-
REACT (rescue PCI), 2005
-
Vermeer, 1999
-
Sarullo, 2000
-
RESCUE II, 2000
-
Belenkie, 1992
-
TAMI 5 (t-PA+uroK vs tPA), 1991
-
GUSTO tPA-SK Hiv, 1993
-
KAMIT, 1991
-
GISSI I, 1986
-
PAIMS, 1989
-
TAPS, 1992
-
German Multicenter Trial, 1988
-
Centre Illinois, 1993
-
TAMI 5 (t-PA vs uroK), 1991
-
duteplase 1, 1993
-
ISIS-2 (SK), 1988
-
ASSENT-2, 1999
-
PRIMI (vs UK), 1989
-
ASSENT-1, 1999
-
GUSTO tPA Hiv, 1993
-
Mathey, 1985
-
USIM, 1991
-
STAR, 1995
-
GUSTO III, 1997
-
RAPID-2, 1996
-
RAAMI, 1992
-
ISIS III (SK/APSAC), 1992
-
TIMI-1, 1987
-
GISSI II, 1990
-
Cherng, 1992
-
TEAM 2, 1991
-
duteplase 2, 1993
-
ASSET, 1988
-
InTIME-II, 2000
-
APSIM, 1989
-
inTIME 1, 1998
-
ISAM, 1986
-
SESAM, 1997
-
ISIS 2 pilot, 1987
-
RAPID 1, 1995
-
INJECT, 1995
-
LATE, 1993
-
TIMI 4, 1994
-
COMPASS, 1998
-
White, 1989
-
International Study Group, 1990
-
ECSG, 1985
-
TEAM 3, 1992
-
duteplase 3, 1993
-
Western Washington Intravenous Trial, 1988
-
ISIS III (SK/tPA), 1992
-
TAMI 6, 1992
-
Bassand, 1991
-
AIMS, 1988
-
COBALT, 1997
-
EMERAS (7-12h), 1993
-
TIMI 10B, 1998
-
PRIMI (vs SK), 1989
-
EMERAS (all delay), 1993
-
LATE, 1993
-
COMPLY, 2003
-
APEX-AMI, 2007
-
COMMA, 2003
-
APEX-AMI, 2007
-
DUCCS, 1994
-
HART II, 2001
-
Baird, 2002
-
ECSG, 1992
-
MAGIC (cell infusion ), 2004
-
BALANCE, 2009
-
RIGENERA (Leone), 2007
-
Ruan, 2005
-
Valgimigli, 2005
-
Meluzin HD, 2006
-
MAGIC Cell-3-DES (Kang), 2006
-
Li, 2007
-
STEMMI (Ripa), 2006
-
Janssens, 2006
-
Suarez de Lezo (cell), 2007
-
NCT00975234,
-
Suarez de Lezo (G-CSF), 2007
-
REPAIR-AMI (Schachinger), 2006
-
Ellis, 2006
-
BOOSt (Meyer), 2004
-
MAGIC (G-CSF) (Kang), 2004
-
ASTAMi (Lunde), 2006
-
G-CSF-STEMI (Engelmann), 2006
-
MAGIC Cell-3-DES (Kang), 2006
-
TCT-STAMI (Ge), 2006
-
MARVEL,
-
CADUCEUS,
-
Suzuki, 2006
-
Takano, 2007
-
Penicka, 2007
-
MAGIC 1 (Kang), 2007
-
Meluzin LD, 2006
-
FIRSTLINE-AMI (Ince), 2005
-
Karpov, 2005
-
REVIVAL-2 (Zohlnhöfer ), 2006
-
Huang, 2006
-
senior PAMI, 2005
-
TRIANA, 2009
-
senior PAMI, 2005
-
TRIANA, 2009
-
DEAR-MI, 2006
-
Beran, 2002
-
X AMINE ST, 2005
-
NONSTOP, 2004
-
Wang, 2003
-
Noel, 2005
-
PROMISE, 2005
-
Dudek, 2004
-
UpFlow MI, 2007
-
De Luca, 2006
-
DEDICATION, 2008
-
Florence, 2004
-
Export (Chevalier), 2008
-
ASPARAGUS, 2008
-
EXPIRA, 2005
-
EMERALD, 2005
-
PIHRATE, 2004
-
PREMIAR, 2007
-
Kaltoft, 2006
-
Tahk, 2008
-
TAPAS, 2002
-
Napodano, 2003
-
AiMI, 2006
-
Nanasato, 2004
-
Sardella, 2005
-
DIPLOMATE, 2004
-
VAMPIRE, 2004
-
Ochala, 2007
-
REMEDIA, 2005
-
MICADO, 2007
-
RECOVER 2, 2009
-
Thiele, 2005
-
Burkhoff, 2006
-
Seyfarth, 2008
-
MADIT-II, 2002
-
DINAMIT, 2004
-
IRIS, 2009
-
Frankfurt, 1976
-
Johannessen, 1989
-
Huddinge, 1988
-
ISIS-2, 1988
-
ERASE-MI, 2009
-
Dutch-aspirin, 1990
-
Louvain sulphinpyrazone, 1983
-
Wilcox, 1980
-
Jones, 1987
-
French, 1993
-
INNOVATE,
-
Gent-AMI, 1968
-
APRICOT, 1993
-
GRAND, 1987
-
Knudsen-A, 1985
-
Dutch sulphinpyrazone, 1986
-
ISIS-pilot, 1987
-
CLARITY-TIMI 28, 2005
-
Kerr, 1975
-
Swift, 1992
-
Wilson, 1997
-
AMIHOT, 2007
-
HEMOPURE, 2005
-
Thurston, 1973
-
Dekleva, 2004
-
Rawles, 1976
-
HOT MI pilot, 1997
-
Hot MI, 1997
-
Sharifi, 2004
-
Ukholkina, 2005
-
AMIHOT II , 2000
-
aortic stenosis
ASTRONOMER, 2010
-
SEAS, 2008
-
SALTIRE, 2005
-
atrial fibrillation
PATAF (coumadin low dose vs coumadin standard dose), 1999
-
SPINAF (warfarin vs placebo), 1992
-
NASPEAF (triflusal+coumadin medium dose vs triflusal), 2004
-
rivaroxaban japan phase 3,
-
AFASAK (warfarin standard dose vs placebo), 1989
-
NASPEAF (triflusal + coumadin medium dose vs coumadin standard dose), 2004
-
ENGAGE-AF TIMI 48,
-
LASAF(aspirin vs no treatment), 1999
-
ROCKET-AF (NCT00403767), 0
-
phase 2 AZD0837, 0
-
SPAF II (aspirin vs warfarin standard dose, age>75), 1994
-
RE-LY (150mg), 2009
-
phase 2 edoxaban, 0
-
SPAF II (aspirin vs warfarin standard dose, age<75), 1994
-
SPAF (aspirin , warfarin eligible arm), 1991
-
EXPLORE-Xa, 2010
-
AFASAK II (warfarin low dose vs warfarin standard dose), 1998
-
SPORTIF II (ximelagatran vs warfarin standard dose), 2002
-
AFASAK (aspirin vs warfarin standard dose), 1989
-
ARISTOTLE (CV185-030),
-
PATAF (vs coumadin low dose), 1999
-
BAATAF (warfarin vs no treatment), 1990
-
SAFT(warfarin low dose + aspirin vs no treatment), 2003
-
EmbraceAC,
-
SPAF (aspirin,warfarin ineligible arm), 1991
-
SPORTIF V, 2005
-
AMADEUS, 2008
-
phase 2 dabigatran, 0
-
AFASAK (aspirin vs placebo), 1989
-
edoxaban phase 2, 0
-
phase 2 edoxaban, 0
-
AFASAK II (aspirin vs warfarin standard dose), 1998
-
ACTIVE W, 2006
-
OPAL-2,
-
AFASAK II (warfarin low dose+aspirin vs warfarin standard dose), 1998
-
SPORTIF III, 2003
-
CLAAF(aspirin + clopidogrel vs warfarin standard dose), 2004
-
AVERROES (CV185-048),
-
AFASAK II (aspirin vs warfarin low dose), 1998
-
SPAF (warfarin standard dose), 1991
-
NASPEAF (triflusal vs coumadin standard dose)), 2004
-
RE-LY (110mg), 2009
-
CAFA, 1991
-
MWNAF, 1998
-
ACTIVE A, 2009
-
SPAF I (preliminary report) importé, 1990
-
idraparinux BOREALIS-AF, 0
-
Lip (phase 2 AZD0837), 2009
-
PATAF (vs coumadin standard dose), 1999
-
PETRO (150mg), 2007
-
phase 2 YM150, 0
-
SPAF III, 1996
-
BAFTA (aspirin vs warfarin standard dose), 0
-
phase 2 apixaban, 0
-
AFFIRM, 2002
-
RACE, 2002
-
PIAF, 2000
-
STAF, 2003
-
AF-CHF, 2002
-
J-RHYTHM, 0
-
Hot cafe, 2004
-
EURIDIS ADONIS (pooled analysis), 2009
-
PRODIS, 1996
-
Vitolo, 1981
-
SOPAT (quinidine vs sotalol), 2004
-
Nodari, 2010
-
Naccarelli, 1996
-
Stroobandt, 1997
-
Steinbeck (quinidine vs flecainide), 1988
-
AFFIRM Substudy (sotalol vs class I drugs), 2003
-
DAFNE, 2003
-
Kochiadakis b (propafenone vs placebo), 2004
-
Singh, 1991
-
SOPAT (sotalol vs placebo), 2004
-
Benditt, 1999
-
Karlson, 1998
-
SMART, 2002
-
Lloyd (Disopyramide vs placebo), 1984
-
ASAP, 2003
-
Hohnloser, 1995
-
Richiardi, 1992
-
Carunchio (sotalol vs placebo), 1995
-
ADONIS, 2007
-
FAPIS, 1996
-
Plewan, 2001
-
Byrne Quinn, 1979
-
Kochiadakis (amiodarone vs sotalol), 2000
-
PALLAS,
-
DIAMOND, 2001
-
Okishige, 2000
-
Van Gelder, 1989
-
Lloyd (quinidine vs disopyramide), 1984
-
ATHENA, 2009
-
Kuhlkamp, 2000
-
Sodermark, 1975
-
Steinbeck (flecainide vs digoxin), 1988
-
Carunchio (sotalol vs flecianide), 1995
-
Carunchio (flecainide vs placebo), 1995
-
Kochiadakis (amiodarone vs placebo), 2000
-
SOCESP, 1999
-
PAFAC (sotalol vs placebo), 2004
-
Aliot, 1996
-
Juul-Moller, 1990
-
SAFE-T (amiodarone vs placebo), 2005
-
Kochiadakis (sotalol vs placebo), 2000
-
AFFIRM Substudy (amiodarone vs sotalol), 2003
-
GEFACA, 2001
-
RAFT, 2003
-
AFFIRM Substudy (amiodarone vs class I drugs), 2003
-
SAFE-T (amiodarone vs sotalol), 2005
-
Dogan, 2004
-
PAFAC (quinidine vs placebo), 2004
-
Villani, 1992
-
PAFAC (quinidine vs sotalol), 2004
-
DIONISOS, 2007
-
Lloyd (quinidine vs placebo), 1984
-
Steinbeck (quinidine vs digoxin), 1988
-
Lloyd (Disopyramide vs quinidine), 1984
-
Kochiadakis b (sotalol vs propafenome), 2004
-
Channer, 2004
-
Kochiadakis a, 2004
-
SOPAT (quinidine vs placebo), 2004
-
SAFE-T (sotalol vs placebo), 2005
-
Bellandi (propafenone vs placebo), 2001
-
Kalusche, 1994
-
SAFIRE-D, 2000
-
Kochiadakis b (sotalol vs placebo), 2004
-
AFIB, 1997
-
Hillestad, 1971
-
Reimold, 1993
-
Bellandi (sotalol vs placebo), 2001
-
EURIDIS, 2007
-
ERATO, 2008
-
RACE II, 2010
-
CABANA,
-
Forleo, 2009
-
Krittayaphong, 2003
-
MANTRA-PAF,
-
A4 (Jais), 2008
-
Lakkireddy, 2006
-
ThermoCool AF, 2008
-
APAF (Pappone), 2006
-
Wazni , 2005
-
Pappone, 2003
-
Oral, 2006
-
CAFCOAF (Stabile), 2006
-
RESOLVE-AF,
-
Ueng, 2003
-
Ozaydin, 2006
-
Almroth, 2009
-
Brown,
-
GISSI-AF (Disertori), 2009
-
Madrid, 2002
-
Dernellis, 2006
-
Tveit, 2004
-
ACTIVE I, 2009
-
ANTIPAF,
-
Van den Burg, 1995
-
MIRACL (sub-group) (Schwartz), 2004
-
STOP-AF,
-
CAPRAF (Tveit), 2007
-
Chello, 2006
-
CHARM (AF ancillary study), 2005
-
GISSI-3 (AF ancillary study), 2003
-
MIRACL (AF ancillary study), 2001
-
VA HIT (AF ancillary study), 1999
-
Val-HeFT (AF ancillary study), 2003
-
TRACE (AF ancillary study), 1999
-
ARMYDA-3 (AF ancillary study), 2006
-
GISSI HF (subgroup and ancillary study), 2009
-
LIFE (AF ancillary study), 2005
-
SOLVD (AF ancillary study), 2003
-
PROTECT-AF,
-
PLAATO,
-
RE-LY (150mg), 2009
-
SPORTIF III, 2003
-
RE-LY (110mg), 2009
-
SPORTIF V, 2005
-
PETRO (150mg), 2007
-
SPORTIF II (ximelagatran vs warfarin standard dose), 2002
-
phase 2 edoxaban, 0
-
OPAL-2,
-
AVERROES (CV185-048),
-
ENGAGE-AF TIMI 48,
-
phase 2 YM150, 0
-
phase 2 apixaban, 0
-
rivaroxaban japan phase 3,
-
edoxaban phase 2, 0
-
phase 2 edoxaban, 0
-
EXPLORE-Xa, 2010
-
ARISTOTLE (CV185-030),
-
ROCKET-AF (NCT00403767), 0
-
SPORTIF V, 2005
-
phase 2 edoxaban, 0
-
EXPLORE-Xa, 2010
-
ARISTOTLE (CV185-030),
-
ENGAGE-AF TIMI 48,
-
idraparinux BOREALIS-AF, 0
-
phase 2 dabigatran, 0
-
PETRO (150mg), 2007
-
phase 2 edoxaban, 0
-
SPORTIF II (ximelagatran vs warfarin standard dose), 2002
-
OPAL-2,
-
AVERROES (CV185-048),
-
RE-LY (110mg), 2009
-
ROCKET-AF (NCT00403767), 0
-
RE-LY (150mg), 2009
-
Lip (phase 2 AZD0837), 2009
-
SPORTIF III, 2003
-
phase 2 YM150, 0
-
phase 2 apixaban, 0
-
rivaroxaban japan phase 3,
-
AMADEUS, 2008
-
edoxaban phase 2, 0
-
phase 2 AZD0837, 0
-
RE-LY 110mg subgroup, 2010
-
NASPEAF, 2004
-
ESPS II, 1996
-
EAFT, 1993
-
FFAACS , 2001
-
SIFA, 1997
-
UK-TIA(high dose), 1991
-
EAFT, 1993
-
RE-LY 150mg subgroup,
-
EAFT, 1993
-
UK-TIA(low dose), 1991
-
SPINAF, 1992
-
AFFIRM (rate vs rythm control), 2002
-
RACE II, 2010
-
PIAF (rate vs rythm control), 2000
-
RACE (rate vs rythm control), 2002
-
Hot cafe (rate vs rythm control), 2004
-
AF-CHF (rate vs rythm control), 2002
-
STAF (rate vs rythm control), 2003
-
atrioventricular block or sick sinus syndrome
Davis, 3000
-
Oldroyd, 1991
-
CTOPP, 2000
-
Mattioli, 1998
-
Linde-Edelstam, 1992
-
Kristensson, 1985
-
Sulke, 1994
-
Höijer, 2002
-
Saner and Fricker, 3000
-
Deharo, 1996
-
PASE, 1998
-
Capucci, 3000
-
Menozzi, 1990
-
Avery, 1994
-
Lukl, 1994
-
Lau (1), 1994
-
Wharton, 1998
-
Kamalvand, 1997
-
Sulke, 1991
-
Hargreaves, 1995
-
Perrins, 1983
-
Channon, 1994
-
Mitsuoka, 1988
-
Boon, 1987
-
MOST, 2002
-
Lau (2), 1994
-
Yee, 1984
-
Kenny, 1986
-
Sulke, 1992
-
Heldman, 1990
-
Rediker, 1988
-
CABG surgery
Song, 2008
-
Christenson, 1999
-
Chello et al., 2006
-
Patti et al., 2006
-
Guiteras, 1989
-
Leeds-B, 1985
-
Bridge,
-
Brussels, 1987
-
Ekestrom, 1990
-
Wadsworth, 1985
-
Kohn, 1990
-
Liège-I, 1984
-
Knudsen-B, 1983
-
McEnany, 1982
-
Sydney, 1991
-
Czech, 1986
-
GESIC (aspirin+dipyridamol), 1990
-
GESIC (aspirin), 1990
-
German sulotroban, 1989
-
Lorenz, 1984
-
Toronto dipyridamole, 1987
-
Liège-II, 1987
-
Romeo, 1983
-
Brooks, 1985
-
Des Moines, 1980
-
Thaulow, 1987
-
Basel, 1989
-
CASCADE, 2009
-
VA Co-op CABG, 1988
-
Hockings, 1993
-
Pantely, 1979
-
Baur, 1982
-
Mayo-A, 1984
-
Zurich, 1982
-
Seoul,
-
Hausenloy, 2007
-
Ali, 2007
-
Cheung, 2006
-
Meybohm,
-
Gunaydin, 2000
-
Ozkara, 2007
-
Puskas, 2004
-
Matata, 2000
-
Ascione, 2006
-
Tatoulis, 2006
-
Muneretto, 2003
-
Gu, 1998
-
Selvanayagam, 2004
-
Dorman, 2004
-
OCTOPUS, 2000
-
Legare, 2004
-
Vedin, 2006
-
Wandschneider, 2000
-
PRAGUE-4, 2004
-
Alwan, 2004
-
GOPCABE,
-
Velisaris, 2003
-
Zamvar, 2002
-
ROOBY, 2009
-
Sahlman, 2003
-
Covino, 0
-
Michaux, 2006
-
Jares, 2006
-
Parolari, 2003
-
Diegeler, 2000
-
Ascione, 2005
-
Niranjan, 2006
-
Gasz, 2004
-
SMART, 2003
-
Lingaas, 2003
-
Czerny, 2000
-
PROMISS (Uva), 2010
-
BHACAS I, 1999
-
Gerola, 2001
-
Baker, 2001
-
Vural, 1995
-
BBS, 2010
-
Carrier, 2003
-
OCTOPUS II,
-
Syed, 2004
-
Penttila, 2001
-
Motallebzadeh, 2006
-
Kunes, 2007
-
Parolari, 2003
-
Gulielmos, 1999
-
Kobayashi, 2005
-
Paparella, 2006
-
Guler, 2001
-
Al-Ruzzeh, 2006
-
Motallebzadeh, 2004
-
Czerny, 2001
-
BHACAS II, 2002
-
Khan, 2004
-
Lee, 2003
-
Wan, 2004
-
DOORS,
-
Raja, 2003
-
Ontario,
-
Tang, 2002
-
Caputo, 2002
-
PREVENT IV, 2005
-
RAS,
-
Gaudino (radial A), 2005
-
RAPS (Desai), 2004
-
Gaudino (RITA), 2005
-
CARRPO, 2009
-
RSVP, 2008
-
VA CABG, 2010
-
Hayward (Younger), 2008
-
cardiac arrest
ARREST, 1999
-
ALIVE, 2002
-
TROICA, 2008
-
Abu-Laban, 2002
-
TICA, 2004
-
Stiell, 2001
-
Lindner, 1997
-
Wenzel, 2004
-
Li, 1999
-
Lee, 2000
-
SOFA , 2006
-
Leaf, 2005
-
Raitt , 2006
-
PAD (Hallstrom), 2004
-
HAT,
-
Hallstrom + preliminary study,
-
Rea, 2010
-
Svensson, 2010
-
Hallstrom, 2000
-
cardiovascular prevention
Minnesota, 1989
-
Gundersen, 1976
-
Goteborg, 1986
-
Veterans Ad. (Dayton), 1969
-
LRC, 1984
-
AFCAPS/TexCAPS, 1998
-
MRFIT, 1982
-
Ruoff, 1978
-
Cullen, 1974
-
Finnish Mental Hospital (Miettinen), 1985
-
UCS (Dorr), 1978
-
WOSCOPS, 1995
-
Hjermann, 1981
-
FATS Fukosawa (probucol), 2002
-
Ryan, 1974
-
WHO Collaborative, 1986
-
WHO clofibrate, 1978
-
Helsinki (HHS), 1987
-
PROSPER (sub group), 2002
-
ASPEN, 2006
-
PROVE IT TIMI 22 (diabetic sub group), 2006
-
LIPS (sub group), 2002
-
ACCORD lipid (subgroup Eye study), 2010
-
Post CABG (sub group), 1999
-
ACCORD lipid, 2010
-
4S (sub group), 1999
-
SANDS, 2008
-
LIPID (sub group), 1998
-
Harrold, 1969
-
ASCOT (diabetics sub group), 2003
-
TNT (sub group), 2006
-
ALLHAT-LLT (sub group), 2002
-
AFCAPS/TexCAPS (sub group), 1998
-
Hanefeld, 1991
-
CARDS, 2004
-
HHS (sub group), 1987
-
CARE (sub group), 1998
-
SENDCAP, 1998
-
HPS (sub group), 2002
-
FIELD, 2005
-
ALERT (sub group), 2003
-
GISSI P (sub group), 2000
-
Emmerich, 2009
-
Deutsche Diabetes Dialyse Studie (4D), 2005
-
VA-HIT (sub group), 1999
-
WOSCOPS (sub group), 1996
-
DAIS, 2001
-
HPS (subgroup), 2002
-
4S (subgroup), 1997
-
LIPS (subgroup), 2002
-
PLAC I (sub group), 1995
-
CARE (subgroup), 1998
-
PROSPER, 2002
-
JUPITER (sub group), 2009
-
REGRESS (subgroup), 1995
-
LIPID (sub group), 2001
-
CRISP 20mg, 1994
-
FLARE (subgroup), 1999
-
ARBITER-HALTS 6, 2010
-
JUPITER, 2008
-
PROSPER, 2002
-
ZETELD, 2010
-
REGRESS, 1995
-
ALLHAT, 2002
-
PMSG, 1993
-
HPS, 2002
-
ASCOT, 2003
-
CLAS, 1987
-
Gross, 1973
-
SENDCAP, 1998
-
Tuttle, 2008
-
Riegger et al., 1999
-
IDEAL, 2005
-
Singh, 1992
-
SEARCH, 2009
-
CDP niacin, 1975
-
CDP estrogen 5, 1975
-
Ornish, 1990
-
LIPID, 1998
-
Marmorstein, 1962
-
Tardif, 1997
-
PROVE-IT, 2004
-
HARP, 1994
-
HHS (Frick)(secondary prev subgroup), 1993
-
CIS, 1997
-
FLARE, 1999
-
Vascular basis, 2005
-
GREACE, 2002
-
GISSI Prevenzione, 2000
-
Rose, 1965
-
CDP estrogen 2.5, 1975
-
Kallio, 1979
-
CARE, 1996
-
Stamler, 1963
-
STARS (St Thomas, diet), 1992
-
MIRACL, 2001
-
POSCH, 1990
-
STARS (cholestyramine), 1992
-
REVERSAL, 2004
-
Sahni, 1991
-
CLAPT, 1999
-
SAGE, 2007
-
LCAS, 1997
-
LOCAT, 1997
-
TNT, 2005
-
VA drugs (Estrogen or thyroxine), 1968
-
VA drugs, 1968
-
4S, 1994
-
CDP tyroxine, 1975
-
Los Angeles VA (Dayton), 1969
-
VA-HIT, 1999
-
SCRIP, 1994
-
McCaughan, 1981
-
HOT, 1998
-
Thrombosis Prevention trial (Warfarin), 1998
-
Primary Prevention Project, 2001
-
Thrombosis Prevention trial (W plus A), 1998
-
Thrombosis Prevention Trial, 1998
-
Borchgrevink, 1966
-
Lau, 1993
-
Sarkkinen, 1998
-
Belluzzi, 1996
-
Johansen, 1999
-
Rossing, 1996
-
ALPHA OMEGA (EPA DHA), 2010
-
GISSI-P, 1999
-
Nilsen, 2001
-
GISSI HF fatty acid, 2008
-
Eritsland, 1996
-
Mate-Jimenez, 1991
-
Thien, 1993
-
Connor, 1993
-
Lorenz-Meyer, 1996
-
Sirtori, 1998
-
Brox, 2001
-
Lau, 1995
-
Selvais, 1995
-
ALPHA OMEGA (ALA), 2010
-
Bemelmans, 2002
-
Katan, 1997
-
Sacks (HARP), 1995
-
Bairati, 1992
-
Greenfield, 1993
-
Nye, 1990
-
OMEGA, 2009
-
Franzen, 1993
-
Milner, 1989
-
Veale, 1994
-
Dehmer, 1998
-
Malaguarnera, 1999
-
Skoldstam, 1992
-
Almallah, 1998
-
Burr (DART), 1989
-
Leaf, 1994
-
Shimizu, 1995
-
Bonnema, 1995
-
Kaul, 1992
-
Sacks (TOHP 1), 1994
-
Bellamy, 1992
-
Hawthorne, 1992
-
Reis, 1991
-
n3-PUFA-HF,
-
Geusens, 1994
-
Natvig, 1968
-
von Schacky, 1999
-
Dry, 1991
-
Maresta, 2002
-
Terano, 1999
-
Burr (DART 2), 2003
-
Loeschke, 1996
-
Singh, 1997
-
Bellamy, 1992
-
Lau, 1995
-
von Schacky, 1999
-
Johansen, 1999
-
Shimizu, 1995
-
Franzen, 1993
-
Sacks (TOHP 1), 1994
-
Connor, 1993
-
Reis, 1991
-
Brox, 2001
-
Natvig, 1968
-
ALPHA OMEGA (EPA DHA), 2010
-
Bemelmans, 2002
-
Leaf, 1994
-
GISSI HF fatty acid, 2008
-
Kaul, 1992
-
Singh, 1997
-
GISSI-P, 1999
-
Sarkkinen, 1998
-
Dehmer, 1998
-
Rossing, 1996
-
Burr (DART), 1989
-
Nilsen, 2001
-
ALPHA OMEGA (ALA), 2010
-
Bonnema, 1995
-
Maresta, 2002
-
OMEGA, 2009
-
Bairati, 1992
-
Lau, 1993
-
Sirtori, 1998
-
Hawthorne, 1992
-
Selvais, 1995
-
Eritsland, 1996
-
Sacks (HARP), 1995
-
Burr (DART 2), 2003
-
Nye, 1990
-
Borchgrevink, 1966
-
Milner, 1989
-
n3-PUFA-HF,
-
Skoldstam, 1992
-
Lorenz-Meyer, 1996
-
Greenfield, 1993
-
Belluzzi, 1996
-
Terano, 1999
-
Malaguarnera, 1999
-
Katan, 1997
-
Veale, 1994
-
Dry, 1991
-
Thien, 1993
-
Mate-Jimenez, 1991
-
Loeschke, 1996
-
Geusens, 1994
-
Almallah, 1998
-
VA Neurology Section, 1974
-
CAIUS, 1996
-
Castano, 2001
-
VA Neurology Section (estrogen), 1966
-
Begg, 1971
-
BCAPS, 2001
-
Acheson, 1972
-
ACAPS, 1994
-
LEADER, 2002
-
WENBIT (folic ac,B12), 2008
-
CHAOS-2, 2002
-
HOPE-2 (Lonn), 2006
-
NORVIT (vit B6) (Bonaa), 2006
-
CSPPT,
-
WENBIT (vit B6), 2008
-
FOLARDA (Liem), 2004
-
VISP (Toole), 2004
-
NORVIT (folic acid, B12 and vit B6) (Bonaa), 2006
-
NORVIT (folic acid + B12) (Bonaa), 2006
-
SU.FOL.OM3,
-
VITATOPS, 2010
-
GOES (Liem), 2003
-
Mager, 2009
-
WAFACS, 2008
-
SEARCH, 2007
-
FAVORIT,
-
Tepel, 2003
-
HOPE, 2000
-
ATBC vitamin E, 1994
-
SUVIMAX, 2005
-
NSCP (Green) beta carotene, 1999
-
WACS beta-caroten, 2007
-
CARET beta carotene, 1996
-
PHS II vitamin C, 2008
-
MVP, 1997
-
WACS vitamin C, 2007
-
ASAP, 2000
-
AREDS, 2001
-
SECURE, 2001
-
CHAOS, 1996
-
PHS beta carotene, 1996
-
PHS II vitamin E, 2008
-
HPS antioxidant, 2002
-
PHS II beta carotene, 2003
-
Linxian, 1993
-
MASI, 2000
-
PPP, 2001
-
WHS vitamin E, 2005
-
GISSI, 1999
-
WHS beta carotene, 1999
-
ARISE, 2008
-
SCP beta carotene, 1990
-
WACS vitamin E, 2007
-
ATBC beta carotene, 1994
-
POPADAD (antioxydant), 2008
-
HATS, 2001
-
WAVE (Waters), 2002
-
HOT, 1998
-
British Doctor’s Trial, 1988
-
Primary Prevention Project, 2001
-
Physicians Health Study, 1989
-
Thrombosis Prevention trial (Warfarin), 1998
-
Women’s Health Study, 2005
-
Thrombosis Prevention Trial, 1998
-
Thrombosis Prevention trial (W plus A), 1998
-
SALTIRE, 2005
-
Enhance, 2008
-
ASTRONOMER, 2010
-
ALERT, 2003
-
SEAS, 2008
-
PREVEND IT, 2004
-
SHARP, 0
-
Ruoff, 1978
-
Amburgey CF, 0
-
Riegger et al., 1999
-
PACT, 2004
-
Ornish, 1990
-
HPS, 2002
-
VA drugs, 1968
-
Newcastle, 1971
-
Hanefeld, 1991
-
CORONA, 2007
-
Gross, 1973
-
Schumer W, 1963
-
GREACE, 2002
-
PROVE-IT, 2004
-
STARS (St Thomas, diet), 1992
-
SCOR, 1990
-
WHO Collaborative, 1986
-
CDP Clofibrate, 1975
-
HATS, 2001
-
ASPEN, 2006
-
Landmesser, 2005
-
Acheson, 1972
-
Mohler III, 2003
-
CDP estrogen 2.5, 1975
-
PQRST, 1994
-
Más, 1999
-
UCS (Dorr), 1978
-
ARBITER-HALTS 6, 2010
-
SPARCL, 2006
-
Strey, 2005
-
Sahni, 1991
-
LEADER trial, 2000
-
VA Neurology Section (estrogen), 1966
-
ALLHAT, 2002
-
STARS (cholestyramine), 1992
-
4S, 1994
-
TIPS, 2009
-
WHI low fat, 2005
-
Krum, 2007
-
PMSG, 1993
-
CLAS, 1987
-
FATS Fukosawa (probucol), 2002
-
CARDS, 2004
-
SENDCAP, 1998
-
LIPID, 1998
-
SEARCH, 2009
-
Oslo Diet Heart Study (Leren), 1966
-
ASTEROID, 0
-
REGRESS, 1995
-
HARP, 1994
-
MAAS, 1994
-
BCAPS, 2001
-
AVERT, 1999
-
Kallio, 1979
-
BIP, 2000
-
Goteborg, 1986
-
Veterans Ad. (Dayton), 1969
-
LOCAT, 1997
-
A to Z, 2004
-
GISSI-HF rosuvastatine, 2008
-
Ryan, 1974
-
Hutchinson K, 1983
-
ALERT, 2003
-
FIELD, 2005
-
Los Angeles VA (Dayton), 1969
-
BECAIT, 1996
-
Göteborg (Wilhelmsen), 1986
-
CDP niacin, 1975
-
ARBITER 6-HALTS (niacin vs ezetimibe), 2009
-
IMPROVE-IT, 0
-
VA Neurology Section, 1974
-
Castano, 2003
-
VA drugs (Estrogen or thyroxine), 1968
-
PLAC I, 1995
-
Batista, 1996
-
MARS, 1993
-
Hjermann, 1981
-
WHO clofibrate, 1978
-
Oxford Niaspan Study, 2009
-
MEGA, 2006
-
Tousoulis, 2005
-
Harrold, 1969
-
Mondillo, 2003
-
CDP tyroxine, 1975
-
LIPS, 2002
-
McCaughan, 1981
-
Helsinki (HHS), 1987
-
AIM-HIGH,
-
TNT, 2005
-
Node, 2003
-
ACAPS, 1994
-
Davis, 1975
-
Marmorstein, 1962
-
ASCOT, 2003
-
LEADER, 2002
-
CARE, 1996
-
SANDS, 2008
-
Rose, 1965
-
Excel, 1991
-
CIS, 1997
-
POSCH, 1990
-
REVERSAL, 2004
-
FLARE, 1999
-
MIRACL, 2001
-
MRFIT, 1982
-
VA-HIT, 1999
-
CRISP 40mg, 1994
-
MRC Soya, 1968
-
Emmerich, 2009
-
Vascular basis, 2005
-
Tuttle, 2008
-
Gundersen, 1976
-
Aronow , 2003
-
LCAS, 1997
-
CCAIT, 1994
-
Minnesota, 1989
-
KAPS, 1995
-
Black, 1994
-
Scottish, 1971
-
ZETELD, 2010
-
JUPITER, 2008
-
Cullen, 1974
-
St Thomas, 1983
-
Singh, 1992
-
PLAC II, 1995
-
Castano, 2001
-
FATS, 1990
-
Finnish Mental Hospital (Miettinen), 1985
-
Carlson (Stockholm), 1977
-
ARBITER 2, 2009
-
METEOR, 2007
-
Hong, 2005
-
Begg, 1971
-
Blann, 2001
-
CDP estrogen 5, 1975
-
NHLBI (Brensike), 1984
-
Tardif, 1997
-
LRC, 1984
-
HPS 2-Thrive,
-
IDEAL, 2005
-
Laufs, 2004
-
CAIUS, 1996
-
Gans, 1990
-
Stamler, 1963
-
PROSPER, 2002
-
DAIS, 2001
-
WOSCOPS, 1995
-
GISSI Prevenzione, 2000
-
MRC low fat, 1965
-
Weintraub, 1994
-
CRISP 20mg, 1994
-
PQRST, 1994
-
SCRIP, 1994
-
CLAS, 1987
-
CLAPT, 1999
-
AFCAPS/TexCAPS, 1998
-
Minnesota coronary survey (Frantz), 1975
-
Woodhill, 1966
-
SAGE, 2007
-
HPS (sub groups), 2004
-
SPARCL, 2006
-
ETDRS, 1992
-
TIMAD, 1984
-
London diabetes, 1983
-
ACCEPT-D, 0
-
WHS (diabetics sub group), 2005
-
Cocozza, 1995
-
BTRS, 1992
-
Dutch, 1980
-
JPAD, 2008
-
ASCEND (aspirin), 0
-
PHS (diabetics sub group), 1989
-
Nyberg, 1984
-
DAMAD, 1989
-
Birmingham-A, 1979
-
POPADAD aspirin, 2008
-
PPP (diabetics sub group), 2003
-
AAA, 2009
-
CAPRIE, 1996
-
Thrombosis Prevention Trial, 1998
-
TRA 2P -TIMI 50,
-
CHARISMA, 2006
-
HOT, 1998
-
British Doctor’s Trial, 1988
-
JPPP,
-
Women’s Health Study, 2005
-
Primary Prevention Project, 2001
-
Physicians Health Study, 1989
-
POPADAD (antioxydant), 2008
-
HYRIM, 2005
-
ALERT, 2003
-
PMSG, 1993
-
MEGA, 2006
-
KAPS, 1995
-
ASPEN (primary prevention sub group), 2006
-
CARDS, 2004
-
FAST Fukuoka pravastatin, 2002
-
BCAPS, 2001
-
ACAPS, 1994
-
ASPEN, 2006
-
AFCAPS/TexCAPS, 1998
-
HPS (primary prevention sub group), 2003
-
ASCOT, 2003
-
KLIS, 2000
-
Mohler, 2003
-
CAIUS, 1996
-
JUPITER, 2008
-
WOSCOPS, 1995
-
PROSPER (primary prevention subgroup), 2002
-
ALLHAT, 2002
-
PHYLLIS, 2004
-
Walden, 1991
-
Munich B, 1975
-
CAPRIE, 1996
-
Arcan, 1988
-
Hess, 1985
-
Clément, 1989
-
Stiegler, 1984
-
Jones, 1982
-
EMATAP, 1993
-
Coto, 1989
-
TRA 2P -TIMI 50,
-
VA study, 1986
-
Belcaro, 1991
-
Thulesius, 1987
-
Hurlow, 1980
-
Brittenden J, 0
-
Balsano, 1989
-
STIMS, 1990
-
De Crée, 1984
-
Ellis, 1986
-
Holm, 1984
-
Bounameaux, 1985
-
Katsumara, 1982
-
Adriaensen, 1976
-
ADEP, 1993
-
McCollum CN, 0
-
Hess (2), 1985
-
Krause, 1980
-
Brittenden J (2), 0
-
PACK, 1996
-
Munich A, 1975
-
CRAMPS, 2000
-
Cloarec, 1986
-
Schoop, 1983
-
Cameron, 1987
-
Aukland, 1982
-
Verhaeghe, 1981
-
Neirotti, 1994
-
CLIPS, 2007
-
Schoop (2), 1983
-
Fowkes FGR, 0
-
CAPRIE, 1996
-
ASCET,
-
GAMIS, 1980
-
Dewar, 1961
-
Cardiff II, 1979
-
Zion, 1961
-
Wirecki, 1967
-
Atlanta (Sbar), 1967
-
PARIS, 1980
-
TRA 2P -TIMI 50,
-
PARIS, 1980
-
Neumann, 1964
-
Vogel, 1979
-
Kinsella, 1962
-
CDPA, 1976
-
SAPAT, 1992
-
Becker, 1967
-
PARIS-II, 1986
-
JAMIS, 1999
-
Foulds, 1960
-
AMIS, 1980
-
Leiberman, 1964
-
Cardiff I, 1974
-
Igloe, 1970
-
Berglund, 1985
-
PARIS, 1980
-
OXCHECK, 1994
-
Goteborg, 1986
-
Finnish Mental Hospital (Miettinen), 1985
-
Johns Hopkins, 1983
-
Kallio, 1979
-
Family Heart, 1994
-
Los Angeles VA (Dayton), 1969
-
MRC low fat, 1965
-
Tuttle, 2008
-
Finnish Mental Hospital (Turpeinen), 1979
-
Woodhill, 1966
-
Oslo, 1981
-
Minnesota coronary survey (Frantz), 1975
-
MRFIT, 1982
-
Göteborg (Wilhelmsen), 1986
-
MRFIT, 1982
-
Göteborg Study, 1986
-
Minnesota, 1989
-
WHI low fat, 2005
-
Singh, 1992
-
Oslo Diet Heart Study (Leren), 1966
-
WHO Factories, 1982
-
TIPS, 2009
-
Veterans Ad. (Dayton), 1969
-
Meland, 1997
-
Black, 1994
-
Hjermann, 1981
-
HDFP, 1979
-
Ornish, 1990
-
CELL, 1995
-
STARS (St Thomas, diet), 1992
-
Rose, 1965
-
Helsinki Businessmen Study, 1985
-
DART (Burr), 1989
-
MRC Soya, 1968
-
SHARP, 0
-
AURORA, 2009
-
ALERT, 2003
-
Deutsche Diabetes Dialyse Studie (4D), 2005
-
Primary Prevention Project, 2001
-
Physicians Health Study, 1989
-
Women’s Health Study, 2005
-
Thrombosis Prevention Trial, 1998
-
AAA, 2009
-
HOT, 1998
-
British Doctor’s Trial, 1988
-
CLAS, 1987
-
HATS, 2001
-
HPS 2-Thrive,
-
CDP niacin, 1975
-
ARBITER 6-HALTS (niacin vs ezetimibe), 2009
-
Oxford Niaspan Study, 2009
-
VA drugs, 1968
-
ARBITER 2, 2009
-
AIM-HIGH,
-
ACTIVATE, 2006
-
CAPTIVATE, 2009
-
RADIANCE 2, 2007
-
ILLUSTRATE, 2007
-
RADIANCE 1, 2007
-
DEFINE,
-
ILLUMINATE, 2007
-
British Doctor’s Trial, 1988
-
AAA, 2009
-
Women’s Health Study, 2005
-
Physicians Health Study, 1989
-
POPADAD aspirin, 2008
-
HOT, 1998
-
Thrombosis Prevention Trial, 1998
-
JPAD, 2008
-
Primary Prevention Project, 2001
-
TIPS 2,
-
TIPS, 2009
-
UMPIRE,
-
NCT00567307,
-
GAP,
-
NCT00603590,
-
IMPACT,
-
HOPE renal insufficiency subgroup, 2004
-
SPACE, 2000
-
Tepel, 2003
-
AREDS, 2001
-
PHS beta carotene, 1996
-
WHS vitamin E, 2005
-
PHS II beta carotene, 2003
-
PPP, 2001
-
WHS beta carotene, 1999
-
ATBC beta carotene, 1994
-
PHS II vitamin E, 2008
-
Linxian, 1993
-
ATBC vitamin E, 1994
-
CARET beta carotene, 1996
-
SUVIMAX, 2005
-
PHS II vitamin C, 2008
-
WACS beta-caroten, 2007
-
WAVE (Waters), 2002
-
GISSI, 1999
-
HATS, 2001
-
SECURE, 2001
-
WACS vitamin C, 2007
-
HOPE, 2000
-
HPS antioxidant, 2002
-
MVP, 1997
-
HOPE renal insufficiency subgroup, 2004
-
WACS vitamin E, 2007
-
SPACE, 2000
-
CHAOS, 1996
-
ATBC 2nd prev subgroup (b carotene), 1998
-
ATBC 2nd prev subgroup (vitamin E), 1998
-
MEGA (women subgroup) , 2006
-
AFCAPS (women subgroup) , 1998
-
HPS (women subgroup) , 2002
-
ALLHAT (women subgroup) , 2002
-
JUPITER (women subgroup) , 2008
-
ASCOT (women subgroup) , 2003
-
Physicians Health Study, 1989
-
Thrombosis Prevention trial (Warfarin), 1998
-
Women’s Health Study, 2005
-
Thrombosis Prevention Trial, 1998
-
Thrombosis Prevention trial (W plus A), 1998
-
JPPP,
-
HOT, 1998
-
British Doctor’s Trial, 1988
-
Primary Prevention Project, 2001
-
CRESCENDO, 2010
-
RIO europe (20 vs 5 mg), 2005
-
Rio-lipid 20 mg, 2005
-
taranabant phase 3, 0
-
STRADIVARIUS, 2008
-
RIO-North America 20 mg, 2006
-
AUDITOR, 0
-
RIO europe 5mg, 2005
-
RIO europe 20mg, 2005
-
Family Heart, 1994
-
WHO Factories, 1982
-
Meland, 1997
-
Göteborg Study, 1986
-
Helsinki Businessmen Study, 1985
-
OXCHECK, 1994
-
Johns Hopkins, 1983
-
CELL, 1995
-
Oslo, 1981
-
MRFIT, 1982
-
***Wrone, 2004
-
***ASFASR, 2006
-
***HOST, 2007
-
***House, 2010
-
***Righetti, 2006
-
WAVE, 2002
-
WELL-HART (estrogen-progestin), 2003
-
WHISP, 2006
-
WEST, 2001
-
Hall, 1998
-
HERS, 1998
-
WELL-HART (estrogen alone), 2003
-
Schulman (NHLBI) (estrogen-progestogen), 2002
-
PEPI, 1995
-
WISDOM, 2007
-
WHI, 2002
-
HERS II, 2002
-
EPAT, 2001
-
Schulman (NHLBI) (estrogen alone), 2002
-
ERA (estrogen alone ), 2000
-
ERA (estrogen plus medroxyprogesterone), 2000
-
PHASE,
-
ESPRIT, 2002
-
EVTET, 2000
-
EAGAR, 2006
-
WHI, 2002
-
EPAT, 2001
-
EAGAR, 2006
-
WAVE, 2002
-
ERA (estrogen plus medroxyprogesterone), 2000
-
HERS II, 2002
-
HERS, 1998
-
WELL-HART (estrogen alone), 2003
-
WELL-HART (estrogen-progestin), 2003
-
ESPRIT, 2002
-
EVTET, 2000
-
Schulman (NHLBI) (estrogen alone), 2002
-
ERA (estrogen alone ), 2000
-
Schulman (NHLBI) (estrogen-progestogen), 2002
-
WHISP, 2006
-
Hall, 1998
-
carotid stenosis
ACAS, 1995
-
ACST, 1994
-
VA, 1993
-
Kentucky A (Brooks), 2001
-
Leicester (Naylor), 1998
-
CARESS,
-
CREST, 2010
-
ACST-2, 0
-
Kentucky B (Brooks), 2004
-
SPACE, 2000
-
WALLSTENT (Alberts), 2001
-
SPACE 2, 0
-
ICSS, 2010
-
ACT I, 0
-
SAPPHIRE (yadav), 2004
-
EVA-3S (Mas), 2000
-
CAVATAS-CEA, 2001
-
Link, 0
-
Agostoni, 0
-
TESCAS-C (Ling), 2006
-
BACASS (Hoffman), 2006
-
NASCET, 1998
-
VA309, 1991
-
ECST, 1998
-
coronary artery disease
Hancock, 1998
-
ARTS, 2001
-
ELUTES, 2004
-
TRIAS-Low-Risk , 0
-
TAXUS VI, 2005
-
ATLANTIC (Burkhoff), 1999
-
ISAR-DIABETES, 2005
-
BASKET-PROVE, 2008
-
Spaulding pooled analysis Ravel Sirius studies, 2007
-
CASS, 1983
-
RITA, 1993
-
SPIRIT II, 2006
-
Boudriot, 2008
-
Fluck, 2000
-
PEPCAD IV, 0
-
Savage, 1998
-
ALKK, 2003
-
TAXUS II, 2003
-
Kim, 2005
-
FUTURE I, 2004
-
Schofield, 1999
-
Ortolani et al, 2007
-
Zhao, 2006
-
Di Lorenzo et al., 2005
-
MASS II, 2007
-
EAST, 1994
-
GISSOC II, 2010
-
AWESOME, 2001
-
Lotan, 2000
-
ISAR-LEFT-MAIN, 2009
-
Sievert, 1999
-
ZEST AMI (vs PES), 2009
-
C-SIRIUS, 2004
-
FREEDOM, 0
-
DECODE, 2005
-
March, 1999
-
Petronio et al, 2007
-
DANAMI, 2007
-
BARI, 1996
-
EK-12006, 0
-
Thiele, 2009
-
Doucet, 2001
-
VELETI, 0
-
Kochiadakis, 2007
-
SIMA, 2000
-
SCANDSTENT, 2006
-
Salem, 2004
-
PROSIT, 2006
-
ISAR TEST 2 (vs SES), 2009
-
ACME, 1992
-
PERSEUS Workhorse, 2010
-
ZEST (vs PES), 2009
-
ACME 2 (Folland), 1997
-
SPIRIT IV, 2010
-
Buller, 1999
-
FEMH-93005, 0
-
MASS II, 2007
-
ERACI II, 2003
-
DIABETES, 2005
-
Galiñanes, 2004
-
ISAR-SMART 3, 2006
-
BARI 2D, 2009
-
STRATEGY, 2005
-
Leon (low dose), 2005
-
Versaci , 1997
-
ENDEAVOR III, 2006
-
Di Marlo, 2000
-
MIDCAB Versus DES in Proximal LAD Lesions, 0
-
Rodriguez, 1998
-
Cisowski, 0
-
DELIVER, 2004
-
COMBAT, 0
-
PASSION, 2006
-
Aaberge, 2000
-
SIRTAX (Windecker), 2005
-
ISAR-DESIRE (SES vs PTCA), 2005
-
ENDEAVOR II, 2006
-
Texas, 1977
-
ERACI, 1992
-
SYNTAX, 2009
-
Lafont, 2000
-
Nordic Bifurcation Stent Technique Study, 0
-
Erbel, 1998
-
Hambrecht, 2004
-
TAXUS IV, 2004
-
Costar II, 2008
-
FUTURE II, 2006
-
Allen, 1999
-
TAXi, 2005
-
TIME, 2001
-
Stone pooled analysis sirolimus, 2007
-
VA, 1984
-
GABI, 1994
-
FRE-RACE, 0
-
Myoprotect, 2004
-
Weaver, 2000
-
ZoMaxx phase 2, 0
-
Eeckout, 1996
-
ISAR, 2005
-
E-SIRIUS, 2003
-
AMIST (Reeves), 2004
-
SCORE, 2004
-
Munich Study, 0
-
SCORPIUS, 2007
-
Leon (high dose), 2005
-
Han, 2006
-
INSPIRE, 2006
-
MASS, 1995
-
LEADERS, 2008
-
ISAR-TEST-4 (biodegradable polymer), 2009
-
Koning, 2001
-
ISAR-TEST-1, 2006
-
RAVEL, 2002
-
SOS, 2002
-
TYPHOON, 2006
-
Loubani, 2003
-
SORT OUT II, 2008
-
ISAR TEST 2 (vs ZES), 2009
-
Sievers, 1993
-
DEFER-DES, 0
-
STICH (ventricular reconstruction), 2009
-
AVERT, 1995
-
SPIRIT III, 2008
-
Betriu, 1999
-
GENESIS Trial CP-01, 0
-
MASS II, 2007
-
Grip, 2001
-
Pache et al, 2005
-
Stone, 2002
-
Zhang (SES vs PES), 2006
-
LEMANS, 2002
-
ISAR-CABG, 0
-
ISAR TEST 3 (BP), 2009
-
Fischman STRESS, 1994
-
ENDEAVOR IV, 2009
-
Serruys, 2000
-
PRISON III, 2007
-
COURAGE, 2007
-
Diegeler, 2002
-
PATENCY, 2002
-
Korean Randomized Study, 0
-
HAAMU-STENT, 2006
-
Huikeshoven, 2003
-
CORPAL, 2005
-
ISAR-DESIRE (PES vs PTCA), 2005
-
ABSORB, 0
-
Oregon, 1979
-
Toulouse, 1992
-
FOCUS, 0
-
Witkowski, 2000
-
RESEARCH à effacer, 2004
-
Rubartelli, 1998
-
Bech, 2001
-
ASPECT, 2003
-
TRIAS-HR, 2008
-
TAXUS V (all patients), 2005
-
Frazier, 1999
-
ISAR-DESIRE (SES vs PES), 2005
-
VA CARDS, 0
-
Stone pooled analysis TAXUS studies, 2007
-
ECSS (European), 1988
-
Lausanne, 1994
-
DIABEDES IV, 0
-
RESOLUTE, 2010
-
Dangas, 2000
-
ZoMaxx phase 3, 2007
-
Sirnes, 1996
-
Dakik, 1998
-
TAXUS I, 2003
-
Hong, 2005
-
ACTION, 2004
-
REVASCULARIZE, 0
-
MISSION, 2008
-
Gray, 2003
-
BASKET (vs paclitaxel), 2005
-
SWISSI II, 2007
-
CABRI, 1995
-
DES-ISR, 0
-
ARTS 2, 2010
-
Park, 2000
-
Leipzig, 0
-
SIRIUS, 2003
-
CARDia (PCI), 2008
-
SESAMI, 2007
-
van der Sloot, 2004
-
Cervinka, 2006
-
ACIP, 1997
-
MASS, 1995
-
BASKET-SAVAGE, 0
-
Gao,
-
Moer, 2001
-
LEFT-MAIN-2, 0
-
Hoher, 1999
-
ZEST (vs SES), 2009
-
Tomai, 2008
-
OCTOSTENT, 2003
-
PRISON II, 2006
-
Allen, 2000
-
LONG DES II, 2006
-
ZEST AMI (vs SES), 2009
-
RITA 2, 1997
-
SPIRIT I, 2005
-
ISAR TEST 3 (PF), 2009
-
Serruys Benestent, 1994
-
Nordic Bifurcation Study, 0
-
Lincoff (EPISTENT), 1999
-
SORT OUT IV, 0
-
MASS II, 2007
-
Drenth, 2002
-
SES-SMART, 2004
-
PACIFIC, 2000
-
REALITY, 2006
-
Pan, 2007
-
Pasceri, 2003
-
New zealand 1, 1981
-
Serruys Benestent 2, 1998
-
Lipsia-Yukon-DM, 0
-
Kastrati, 2000
-
PROTECT, 0
-
CARDia (PCI), 2008
-
Lipsia-Yukon-DM, 0
-
DES-DIABETES, 2008
-
TAXUS VI (diabetics), 2005
-
TAXUS II (diabetics), 2003
-
ISAR-test (diabetics), 2006
-
ISAR-DIABETES, 2005
-
TAxi (diabetics), 3000
-
Tomai, 2008
-
FREEDOM, 0
-
PEPCAD IV, 0
-
pooled SIRIUS (diabetics), 0
-
TAXUS IV (diabetics), 2005
-
BARI 2D, 2009
-
Ravel (diabetics), 2004
-
REALITY (diabetics), 2006
-
DIABETES, 2005
-
SIRTAX diabetics, 2005
-
Kirtane (pooled Taxus diabetic patients), 2008
-
DIABEDES IV, 0
-
TAXUS V (diabetics), 2005
-
COSTAR II diabetic (sub group), 2008
-
SES-SMARt (diabetics), 2005
-
SIRIUS (diabetics), 2003
-
DECODE, 2005
-
VA CARDS, 0
-
ERACI, 1992
-
EAST, 1994
-
MASS II, 2007
-
OCTOSTENT, 2003
-
Toulouse, 1992
-
GABI, 1994
-
BARI, 1996
-
AWESOME, 2001
-
SOS, 2002
-
ARTS, 2001
-
RITA, 1993
-
CABRI, 1995
-
Myoprotect, 2004
-
CARDia (PCI), 2008
-
ERACI II, 2003
-
SIMA, 2000
-
Diegeler, 2002
-
MASS, 1995
-
AMIST (Reeves), 2004
-
Drenth, 2002
-
Lausanne, 1994
-
Thiele, 2009
-
Hong, 2005
-
Grip, 2001
-
Cisowski, 0
-
RESEARCH à effacer, 2004
-
ISAR-DESIRE (SES vs PTCA), 2005
-
Erglis, 2007
-
COMPARE, 2009
-
C-SIRIUS, 2004
-
HAAMU-STENT, 2006
-
CORPAL, 2005
-
ABSORB, 0
-
FOCUS, 0
-
ZoMaxx phase 3, 2007
-
VA CARDS, 0
-
TRIAS-HR, 2008
-
Thiele, 2009
-
Kochiadakis, 2007
-
TAXUS V (all patients), 2005
-
ISAR-DESIRE (SES vs PES), 2005
-
Stone pooled analysis TAXUS studies, 2007
-
DIABEDES IV, 0
-
Leipzig, 0
-
FREEDOM, 0
-
GENIUS-STEMI, 2009
-
ACTION, 2004
-
MISSION, 2008
-
BASKET (vs paclitaxel), 2005
-
DES-ISR, 0
-
ZEST (vs SES), 2009
-
ISAR TEST 3 (BP), 2009
-
DELIVER, 2004
-
SESAMI, 2007
-
Cervinka, 2006
-
BASKET-SAVAGE, 0
-
LEFT-MAIN-2, 0
-
SORT OUT IV, 0
-
ISAR TEST 2 (vs SES), 2009
-
TAXUS IV, 2004
-
PRISON II, 2006
-
LONG DES II, 2006
-
SPIRIT I, 2005
-
Nordic Bifurcation Study, 0
-
PROTECT, 0
-
ISAR-DESIRE (PES vs PTCA), 2005
-
COMBAT, 0
-
DEBATER (SES vs BMS), 2009
-
E-SIRIUS, 2003
-
SES-SMART, 2004
-
REALITY, 2006
-
Pasceri, 2003
-
Lipsia-Yukon-DM, 0
-
PEPCAD IV, 0
-
BASKET-PROVE, 2008
-
TRIAS-High-Risk à effacer, 0
-
PASEO, 2009
-
RAVEL, 2002
-
TAXUS VI, 2005
-
ISAR-DIABETES, 2005
-
Spaulding pooled analysis Ravel Sirius studies, 2007
-
SPIRIT II, 2006
-
ISAR-LEFT-MAIN, 2009
-
Munich Study, 0
-
Hong, 2005
-
ZEST (vs PES), 2009
-
FUTURE I, 2004
-
Ortolani et al, 2007
-
Di Lorenzo et al., 2005
-
GISSOC II, 2010
-
ZEST AMI (vs PES), 2009
-
DES-DIABETES, 2008
-
PATENCY, 2002
-
DECODE, 2005
-
Petronio et al, 2007
-
EK-12006, 0
-
VELETI, 0
-
FEMH-93005, 0
-
ISAR TEST 2 (vs ZES), 2009
-
ASPECT, 2003
-
SCANDSTENT, 2006
-
PROSIT, 2006
-
PERSEUS Workhorse, 2010
-
SPIRIT IV, 2010
-
MIDCAB Versus DES in Proximal LAD Lesions, 0
-
Pan, 2007
-
Korean Randomized Study, 0
-
RESOLUTE, 2010
-
TAXUS I, 2003
-
DIABETES, 2005
-
ISAR-SMART 3, 2006
-
STRATEGY, 2005
-
ENDEAVOR III, 2006
-
Nordic Bifurcation Stent Technique Study, 0
-
Kim, 2008
-
TRIAS-Low-Risk , 0
-
ISAR-TEST-4 (biodegradable polymer), 2009
-
SIRIUS, 2003
-
PASSION, 2006
-
SIRTAX (Windecker), 2005
-
ENDEAVOR II, 2006
-
SYNTAX, 2009
-
ZoMaxx phase 2, 0
-
REVASCULARIZE, 0
-
Costar II, 2008
-
Gao,
-
Tomai, 2008
-
FUTURE II, 2006
-
TAXi, 2005
-
Stone pooled analysis sirolimus, 2007
-
FRE-RACE, 0
-
ISAR, 2005
-
ISAR TEST 3 (PF), 2009
-
SCORE, 2004
-
SCORPIUS, 2007
-
Han, 2006
-
LEADERS, 2008
-
ISAR-TEST-1, 2006
-
GENESIS Trial CP-01, 0
-
SORT-OUT-3, 2010
-
ELUTES, 2004
-
TYPHOON, 2006
-
SORT OUT II, 2008
-
DEFER-DES, 0
-
SPIRIT III, 2008
-
PRISON III, 2007
-
HORIZONS-AMI Stent, 2008
-
Boudriot, 2008
-
TAXUS II, 2003
-
Pache et al, 2005
-
Zhang (SES vs PES), 2006
-
ISAR-CABG, 0
-
ENDEAVOR IV, 2009
-
Lipsia-Yukon-DM, 0
-
TAXUS VI (diabetics), 2005
-
TAXUS II (diabetics), 2003
-
COSTAR II diabetic (sub group), 2008
-
ISAR-DIABETES, 2005
-
REALITY (diabetics), 2006
-
Tomai, 2008
-
DESSERT, 2008
-
PEPCAD IV, 0
-
pooled SIRIUS (diabetics), 0
-
TAXUS IV (diabetics), 2005
-
DES-DIABETES, 2008
-
Ravel (diabetics), 2004
-
SIRIUS (diabetics), 2003
-
DIABETES, 2005
-
Kim, 2008
-
Kirtane (pooled Taxus diabetic patients), 2008
-
DIABEDES IV, 0
-
TAXUS V (diabetics), 2005
-
SES-SMARt (diabetics), 2005
-
ISAR-test (diabetics), 2006
-
DECODE, 2005
-
TAxi (diabetics), 3000
-
SIRTAX diabetics, 2005
-
MISSION, 2008
-
HAAMU-STENT, 2006
-
DEBATER (SES vs BMS), 2009
-
SORT-OUT-3, 2010
-
DEDICATION, 2008
-
ZEST AMI (vs PES), 2009
-
PROSIT, 2006
-
TYPHOON, 2006
-
GENIUS-STEMI, 2009
-
HORIZONS-AMI Stent, 2008
-
Díaz de la Llera, 2007
-
SORT OUT II, 2008
-
SESAMI, 2007
-
PASSION, 2006
-
PASEO, 2009
-
ZEST AMI (vs SES), 2009
-
MULTISTRATEGY, 2008
-
STRATEGY, 2005
-
SCANDSTENT, 2006
-
TRIAS-HR, 2008
-
CORPAL, 2005
-
TAXUS V (all patients), 2005
-
LONG DES II, 2006
-
PRISON II, 2006
-
SYNTAX, 2009
-
BASKET-SAVAGE, 0
-
VELETI, 0
-
RRISC, 2006
-
SOS, 2008
-
ISAR-CABG, 0
-
TAXUS V ISR, 2006
-
DES-ISR, 0
-
SISR, 2007
-
RIBS-II, 2008
-
FOCUS, 0
-
ISAR-DESIRE (SES vs PES), 2005
-
ISAR-DESIRE-2, 2010
-
CRISTAL, 0
-
SYNTAX (unprotected left main sub group), 2009
-
ISAR-LEFT-MAIN, 2009
-
Erglis, 2007
-
LEFT-MAIN-2, 0
-
Boudriot, 2008
-
Leipzig, 0
-
NORDIC , 2006
-
CACTUS , 2009
-
Pan, 2007
-
Pan, 2004
-
Colombo, 2004
-
Nordic-Baltic Bifurcation Study III, 2009
-
Nordic Bifurcation Study, 0
-
Ferenc, 2008
-
BBC ONE, 2008
-
Nordic Bifurcation Stent Technique Study, 0
-
TAXUS II, 2003
-
SORT OUT II, 2008
-
ENDEAVOR III, 2006
-
TRIAS-High-Risk à effacer, 0
-
C-SIRIUS, 2004
-
SIRTAX (Windecker), 2005
-
LEADERS, 2008
-
ZEST (vs SES), 2009
-
Pache et al, 2005
-
PERSEUS Workhorse, 2010
-
SORT OUT IV, 0
-
ISAR-TEST-4 (biodegradable polymer), 2009
-
ACTION, 2004
-
ABSORB, 0
-
RESEARCH à effacer, 2004
-
BASKET-PROVE, 2008
-
DELIVER, 2004
-
Stone pooled analysis TAXUS studies, 2007
-
ISAR-TEST-1, 2006
-
Munich Study, 0
-
TAXUS IV, 2004
-
Han, 2006
-
ENDEAVOR IV, 2009
-
TRIAS-Low-Risk , 0
-
E-SIRIUS, 2003
-
REALITY, 2006
-
FRE-RACE, 0
-
ISAR, 2005
-
RAVEL, 2002
-
Ortolani et al, 2007
-
DEFER-DES, 0
-
FEMH-93005, 0
-
COMPARE, 2009
-
FUTURE I, 2004
-
pooled SIRIUS (diabetics), 0
-
PROTECT, 0
-
ZEST (vs PES), 2009
-
PATENCY, 2002
-
Spaulding pooled analysis Ravel Sirius studies, 2007
-
ZoMaxx phase 2, 0
-
REVASCULARIZE, 0
-
ASPECT, 2003
-
BASKET (vs paclitaxel), 2005
-
SPIRIT IV, 2010
-
COMBAT, 0
-
Kochiadakis, 2007
-
TAXUS I, 2003
-
Zhang (SES vs PES), 2006
-
SPIRIT II, 2006
-
Costar II, 2008
-
SIRIUS, 2003
-
TAXi, 2005
-
EK-12006, 0
-
GENESIS Trial CP-01, 0
-
RESOLUTE, 2010
-
FUTURE II, 2006
-
SPIRIT I, 2005
-
MIDCAB Versus DES in Proximal LAD Lesions, 0
-
Gao,
-
SCORE, 2004
-
ENDEAVOR II, 2006
-
ZoMaxx phase 3, 2007
-
Wessely, 2008
-
ELUTES, 2004
-
Stone pooled analysis sirolimus, 2007
-
SPIRIT III, 2008
-
Korean Randomized Study, 0
-
SCANDSTENT (subgroup), 2006
-
PRISON II, 2006
-
GISSOC II, 2010
-
PRISON III, 2007
-
SPIRIT III (small vessel subgroup), 2009
-
SES-SMART, 2004
-
ISAR-SMART 3, 2006
-
SIRTAX (small vessels subgroup), 2005
-
Loubani, 2003
-
Stone, 2002
-
Huikeshoven, 2003
-
Frazier, 1999
-
Gray, 2003
-
van der Sloot, 2004
-
Allen, 2000
-
PACIFIC, 2000
-
ATLANTIC (Burkhoff), 1999
-
Schofield, 1999
-
Zhao, 2006
-
March, 1999
-
Salem, 2004
-
Galiñanes, 2004
-
Aaberge, 2000
-
Allen, 1999
-
Leon (low dose), 2005
-
Leon (high dose), 2005
-
Losordo, 2007
-
AGENT 3 and 4 pooled, 0
-
Genzyme SMC00202,
-
AGENT-3, 0
-
Losordo, 2007
-
FIRST, 2002
-
NCT00090714,
-
AGENT-4, 0
-
REVASC, 2006
-
AGENT-1, 2002
-
Seiler,
-
VIVA, 2003
-
AWARE, 0
-
EUROINJECT-ONE, 2005
-
AGENT-2, 2003
-
Kumar,
-
MARIZA, 2004
-
RAN080, 2005
-
CARISA 1000mg, 2004
-
ERICA, 2006
-
Nishimura, 2009
-
Atlanta (Sbar), 1967
-
PARIS, 1980
-
PARIS, 1980
-
Neumann, 1964
-
Vogel, 1979
-
Kinsella, 1962
-
CDPA, 1976
-
SAPAT, 1992
-
Becker, 1967
-
PARIS-II, 1986
-
JAMIS, 1999
-
Foulds, 1960
-
AMIS, 1980
-
Leiberman, 1964
-
Cardiff I, 1974
-
Igloe, 1970
-
Berglund, 1985
-
PARIS, 1980
-
CAPRIE, 1996
-
ASCET,
-
GAMIS, 1980
-
Dewar, 1961
-
Cardiff II, 1979
-
Zion, 1961
-
Wirecki, 1967
-
diabetes
PNFP-001,
-
49653/011 ,
-
49653/080 ,
-
49653/331 ,
-
PNFP-012,
-
EC410,
-
BRL 49653/347 ,
-
49653/162 ,
-
Marre, 2002
-
PNFP-027,
-
AVM100264 ,
-
49653/136 ,
-
APPROACH, 2008
-
PERISCOPE, 2008
-
49653/211 ,
-
49653/128 ,
-
AVA100193 ,
-
49653/094 ,
-
49653/097 ,
-
SB-712753/007 ,
-
EC405,
-
49653/020 ,
-
49653/082 ,
-
49653/137 ,
-
OPI-504,
-
OPI-520,
-
49653/015 ,
-
49653/234 ,
-
Moses, 1999
-
PNFP-026,
-
EC404,
-
BRL 49653C/185 ,
-
49653/145 ,
-
PPAR,
-
PNFP-010,
-
49653/284 ,
-
49653/134 ,
-
ADOPT, 2006
-
PROactive, 2005
-
100684 ,
-
49653/125 ,
-
SB-712753/009 ,
-
OPI-501,
-
49653/024 ,
-
49653/085 ,
-
SB-712753/002 ,
-
GLAI,
-
OPI-506, 0
-
49653/079 ,
-
49653/330 ,
-
TIDE,
-
OPI-502,
-
EC409,
-
BRL 49653/334 ,
-
49653/147 ,
-
Ristic, 2006
-
PNFP-014,
-
712753/008 ,
-
49653/135 ,
-
RECORD, 2009
-
Wang, 2005
-
49653/143 ,
-
49653/127 ,
-
49653/132 ,
-
49653/093 ,
-
49653/095 ,
-
SB-712753/003 ,
-
ABCD, 1998
-
IDNT (irbesartan vs amlodipine), 2001
-
STOP-2 ACEI (diabetic subgroup), 2000
-
NORDIL (diabetic subgroup), 2000
-
HOPE (diabetic subgroup), 2000
-
ALLHAT (amlodipine vs chlor, diabetic subgroup), 2002
-
UKPDS 38, 1998
-
ACCORD blood pressure, 2010
-
FACET, 1997
-
UKPDS 38 10 years, 2008
-
IDNT irbesartan, 2001
-
INSIGHT (diabetic subgroup), 2000
-
IPDM, 2001
-
STOP-2 (ACEI vs CCB) (diabetic subgroup), 2000
-
SHEP (diabetic subgroup), 1996
-
LIFE (diabetic subgroup), 2002
-
MIDAS (diabetic sub group), 1997
-
ABCD (H), 2000
-
IDNT amlodipine, 2001
-
STOP-2 CCB (diabetic subgroup), 2000
-
CAPP (diabetic subgroup), 1999
-
ACCOMPLISH (diabetic subgroup), 2010
-
Syst-Eur (diabetic subgroup), 1999
-
ALLHAT (lisi vs chlor, diabetic subgroup), 2002
-
UKPDS 39, 1998
-
ABCD (N), 2002
-
4S (sub group), 1999
-
LIPID (sub group), 1998
-
VA-HIT (sub group), 1999
-
ASCOT (diabetics sub group), 2003
-
ASPEN, 2006
-
PROVE IT TIMI 22 (diabetic sub group), 2006
-
LIPS (sub group), 2002
-
Post CABG (sub group), 1999
-
CARE (sub group), 1998
-
ACCORD lipid, 2010
-
HPS (sub group), 2002
-
SANDS, 2008
-
TNT (sub group), 2006
-
ALLHAT-LLT (sub group), 2002
-
AFCAPS/TexCAPS (sub group), 1998
-
WOSCOPS (sub group), 1996
-
ACCORD lipid (subgroup Eye study), 2010
-
PROSPER (sub group), 2002
-
HHS (sub group), 1987
-
FIELD, 2005
-
ALERT (sub group), 2003
-
GISSI P (sub group), 2000
-
ASCEND (aspirin), 0
-
TIMAD, 1984
-
London diabetes, 1983
-
WHS (diabetics sub group), 2005
-
Cocozza, 1995
-
POPADAD aspirin, 2008
-
BTRS, 1992
-
Dutch, 1980
-
JPAD, 2008
-
PHS (diabetics sub group), 1989
-
ACCEPT-D, 0
-
Nyberg, 1984
-
DAMAD, 1989
-
Birmingham-A, 1979
-
PPP (diabetics sub group), 2003
-
ETDRS, 1992
-
POPADAD (antioxydant), 2008
-
DIGAMI, 1995
-
Steno 2, 2003
-
ACCORD, 2008
-
UKPDS Metformin10 year, 2008
-
SDIS, 1993
-
Holman , 1983
-
DIGAMI 2, 2005
-
Kumamoto, 1995
-
ADVANCE, 2008
-
VADT, 2008
-
MCSG, 1995
-
Verrillo, 1988
-
UGDP (IVAR), 1996
-
VA CSDM, 1997
-
DCCT (secondary prevention of retinopathy), 1993
-
ACCORD (sub group, Eye study), 2010
-
DCCT (no retinopathy), 1993
-
UKPDS Sulfonyurea–insulin 10 year, 2008
-
Lauritzen (STENO 1), 1991
-
Kumamoto (secondary prev), 2000
-
VA CSDM, 1997
-
ACCORD, 2008
-
UKPDS Metformin10 year, 2008
-
DIGAMI 2, 2005
-
ADVANCE, 2008
-
VADT, 2008
-
Kumamoto (secondary prev), 2000
-
Kumamoto, 1995
-
ACCORD (sub group, Eye study), 2010
-
UKPDS Sulfonyurea–insulin 10 year, 2008
-
Lauritzen (STENO 1), 1991
-
DCCT (no retinopathy), 1993
-
SDIS, 1993
-
Holman , 1983
-
Verrillo, 1988
-
DYNAMIT,
-
DIAD, 2009
-
49653/079 ,
-
49653/330 ,
-
AVA100193 ,
-
PERISCOPE, 2008
-
OPI-506, 0
-
BRL 49653/334 ,
-
49653/147 ,
-
SB-712753/007 ,
-
EC409,
-
712753/008 ,
-
49653/135 ,
-
EC405,
-
49653/127 ,
-
OPI-504,
-
49653/143 ,
-
49653/095 ,
-
PPAR,
-
PNFP-026,
-
49653/093 ,
-
49653/080 ,
-
49653/331 ,
-
ADOPT, 2006
-
PNFP-010,
-
49653/011 ,
-
BRL 49653/347 ,
-
49653/162 ,
-
SB-712753/009 ,
-
PROactive, 2005
-
EC410,
-
AVM100264 ,
-
49653/136 ,
-
SB-712753/002 ,
-
OPI-501,
-
49653/128 ,
-
GLAI,
-
49653/211 ,
-
49653/097 ,
-
TIDE,
-
OPI-502,
-
49653/094 ,
-
49653/082 ,
-
49653/137 ,
-
RECORD, 2009
-
PNFP-014,
-
49653/020 ,
-
49653/015 ,
-
49653/234 ,
-
49653/132 ,
-
Wang, 2005
-
OPI-520,
-
BRL 49653C/185 ,
-
49653/145 ,
-
SB-712753/003 ,
-
EC404,
-
49653/134 ,
-
PNFP-001,
-
49653/284 ,
-
49653/125 ,
-
PNFP-012,
-
100684 ,
-
49653/085 ,
-
APPROACH, 2008
-
PNFP-027,
-
49653/024 ,
-
Li, 1999
-
NAVIGATOR valsartan, 2010
-
Kocak, 2002
-
Eriksson, 2006
-
Tao, 2004
-
James, 2005
-
Tang, 2006
-
STOP-NIDDM (Chiasson), 2002
-
DPS (Lindström), 2003
-
Gambineri, 2004
-
Srinivasan, 2006
-
DREAM rosiglitazone, 2006
-
Keen, 1982
-
Crave, 1995
-
Rodriguez, 2004
-
Fang, 2004
-
Charles, 1998
-
Ng, 2001
-
Pan, 2003
-
NAVIGATOR nateglinide, 2010
-
Lehtovirta, 2001
-
Fan, 2004
-
Wein, 1999
-
Kay, 2001
-
Vitale, 2005
-
US-DDP (lifestyle) (Knowler), 2002
-
Kosaka, 2005
-
Giugliano, 1993
-
Stakos, 2005
-
Voglibose Ph-3, 2009
-
US DDP troglitazone (Knowler), 2005
-
Fleming, 2002
-
Rodriguez-Moctezuma, 2004
-
IDDP (Ramachandran), 2006
-
Charles, 2000
-
Orchard, 2005
-
TRIPOD (Buchanan), 2002
-
Baillargeon, 2004
-
Moghetti, 2000
-
Heymsfield, 2000
-
JDPP (Sakane), 2005
-
Kelly, 2002
-
CANOE, 2010
-
EDIT (Holman), 2003
-
Liao, 2002
-
Hoeger, 2004
-
Sturrock, 2002
-
US-DPP (metformin) (Knowler), 2002
-
Pan, 1997
-
Freemark, 2001
-
Sirtori, 1984
-
DREAM ramipril, 2006
-
Jarret, 1979
-
Choux, 2003
-
Pasquali, 2000
-
XENDOS (Chiasson), 2002
-
Bridger, 2006
-
Morel, 1999
-
ASCEND (aspirin), 0
-
PHS (diabetics sub group), 1989
-
Nyberg, 1984
-
DAMAD, 1989
-
Birmingham-A, 1979
-
POPADAD aspirin, 2008
-
PPP (diabetics sub group), 2003
-
ETDRS, 1992
-
TIMAD, 1984
-
London diabetes, 1983
-
ACCEPT-D, 0
-
WHS (diabetics sub group), 2005
-
Cocozza, 1995
-
BTRS, 1992
-
Dutch, 1980
-
JPAD, 2008
-
PROactive, 2005
-
TIDE,
-
OPI-520,
-
Wang, 2005
-
APPROACH, 2008
-
PERISCOPE, 2008
-
PPAR,
-
OPI-504,
-
PNFP-012,
-
EC410,
-
BRL 49653/347 ,
-
49653/162 ,
-
Horton (vs PBO), 2000
-
PNFP-027,
-
OPI-501,
-
AVM100264 ,
-
49653/136 ,
-
UKPDS (vs SU or INS), 0
-
PERISCOPE, 2008
-
49653/211 ,
-
49653/128 ,
-
AVA100193 ,
-
PPAR,
-
49653/094 ,
-
49653/097 ,
-
SB-712753/007 ,
-
UKPDS (vs glibenclamide), 0
-
49653/020 ,
-
49653/082 ,
-
49653/137 ,
-
Horton (vs Nateglinide), 2000
-
OPI-504,
-
OPI-520,
-
49653/015 ,
-
49653/234 ,
-
Hallsten (vs PBO), 2002
-
PNFP-026,
-
EC404,
-
BRL 49653C/185 ,
-
49653/145 ,
-
UKPDS (v Conven), 0
-
PNFP-010,
-
PNFP-001,
-
49653/284 ,
-
49653/134 ,
-
ADOPT, 2006
-
TIDE,
-
PROactive, 2005
-
100684 ,
-
49653/125 ,
-
SB-712753/009 ,
-
APPROACH, 2008
-
49653/024 ,
-
49653/085 ,
-
SB-712753/002 ,
-
UKPDS (vs insulin), 0
-
GLAI,
-
OPI-506, 0
-
49653/079 ,
-
49653/330 ,
-
Teupe, 1991
-
OPI-502,
-
EC409,
-
BRL 49653/334 ,
-
49653/147 ,
-
DeFronzo (vs glyburide), 1995
-
PNFP-014,
-
EC405,
-
712753/008 ,
-
49653/135 ,
-
RECORD, 2009
-
Wang, 2005
-
49653/143 ,
-
49653/127 ,
-
49653/132 ,
-
HOME, 2009
-
49653/093 ,
-
49653/095 ,
-
SB-712753/003 ,
-
UKPDS (vs chlorpropamide), 0
-
49653/011 ,
-
49653/080 ,
-
49653/331 ,
-
DeFronzo (vs PBO), 1995
-
OPI-520,
-
Wang, 2005
-
APPROACH, 2008
-
PERISCOPE, 2008
-
PPAR,
-
OPI-504,
-
PROactive, 2005
-
TIDE,
-
Josse et al, 2003
-
Hasche et al, 1999
-
Study 541,
-
Campbell et al, 1998
-
Chiasson et al, 1994
-
Bachmann et al, 1998
-
Study 656, 1994
-
Nauck (vs placebo), 2009
-
Madsbad (vs placebo), 2004
-
Seino, 2008
-
Gao, 2009
-
Buse, 2004
-
Heine, 2005
-
Davis, 2007
-
LEAD-1, 0
-
Nauck (vs glimepiride), 2009
-
Feinglos, 2005
-
Kim, 2007
-
Madsbad (vs Glimepiride), 2004
-
Kendall, 2005
-
LEADER,
-
DeFronzo, 2005
-
Barnett, 2007
-
LEAD-4, 0
-
LEAD-5 (vs Glargine), 0
-
Garber, 2009
-
Moretto, 2008
-
Vilsboll, 2008
-
CT Register 8683, 0
-
Zinman, 2007
-
Nauck, 2007
-
LEAD-5 (vs placebo), 0
-
Marre, 2002
-
Moses, 1999
-
Ristic, 2006
-
Goldstein, 2007
-
Pratley, 2006
-
Ristic, 2006
-
Dejager, 2007
-
Ferrannini, 2009
-
Nauck, 2007
-
Garber, 2007
-
Charbonnel, 2006
-
Bolli, 2008
-
Scott* (sit vs pbo), 2007
-
Rosenstock** (vilda vs pio), 2007
-
Hanefeld, 2007
-
Ristic, 2005
-
Marre, 2002
-
Mimori, 2006
-
Goodman, 2009
-
Rosenstock (sit on top pio vs pbo), 2006
-
Rosenstock** (vilda + pio vs pio), 2007
-
Goldstein (sit+met vs met), 2007
-
Bosi, 2007
-
Goldstein (sit vs met), 2007
-
Schweizer, 2007
-
Nonaka, 2008
-
Scherbaum, 2008
-
Moses, 1999
-
Aschner, 2006
-
Pi-Sunyer, 2007
-
Nauck, 2009
-
Scott** (sit vs pbo on top met), 2007
-
DeFronzo, 2009
-
Hermansen, 2007
-
Fonseca, 2007
-
Scott* (sit vs glipi), 2007
-
Ahren, 2004
-
Raz, 2006
-
Rosenstock* (vilda vs rosi), 2007
-
ROADMAP, 2010
-
ORIENT,
-
ADVANCE, 2007
-
Li, 1999
-
NAVIGATOR valsartan, 2010
-
Eriksson, 2006
-
Tao, 2004
-
STOP-NIDDM (Chiasson), 2002
-
DPS (Lindström), 2003
-
DREAM rosiglitazone, 2006
-
Keen, 1982
-
Fang, 2004
-
Pan, 2003
-
NAVIGATOR nateglinide, 2010
-
Fan, 2004
-
Wein, 1999
-
US-DDP (lifestyle) (Knowler), 2002
-
Kosaka, 2005
-
Voglibose Ph-3, 2009
-
US DDP troglitazone (Knowler), 2005
-
IDDP (Ramachandran), 2006
-
TRIPOD (Buchanan), 2002
-
CANOE, 2010
-
Heymsfield, 2000
-
JDPP (Sakane), 2005
-
EDIT (Holman), 2003
-
Liao, 2002
-
US-DPP (metformin) (Knowler), 2002
-
Pan, 1997
-
DREAM ramipril, 2006
-
Jarret, 1979
-
XENDOS (Chiasson), 2002
-
LIFE (diabetic subgroup), 2002
-
RENAAL, 2001
-
ROADMAP, 2010
-
IPDM, 2001
-
ORIENT,
-
IDNT (irbesartan vs amlodipine), 2001
-
ADVANCE, 2007
-
CAPP (diabetic subgroup), 1999
-
HOPE (diabetic subgroup), 2000
-
UKPDS 39, 1998
-
STOP-2 (ACEI vs CCB) (diabetic subgroup), 2000
-
UKPDS 38 10 years, 2008
-
STOP-2 ACEI (diabetic subgroup), 2000
-
RENAAL, 2001
-
UKPDS 38, 1998
-
ROADMAP, 2010
-
LIFE (diabetic subgroup), 2002
-
IDNT irbesartan, 2001
-
IPDM, 2001
-
ADVANCE, 2007
-
ORIENT,
-
ALLHAT (lisi vs chlor, diabetic subgroup), 2002
-
IDNT (irbesartan vs amlodipine), 2001
-
VA CSDM, 1997
-
SDIS, 1993
-
DCCT (secondary prevention of retinopathy), 1993
-
Holman , 1983
-
DCCT (no retinopathy), 1993
-
VADT, 2008
-
DIGAMI, 1995
-
MCSG, 1995
-
Steno 2, 2003
-
Verrillo, 1988
-
ACCORD, 2008
-
UGDP (IVAR), 1996
-
ACCORD (sub group, Eye study), 2010
-
DIGAMI 2, 2005
-
UKPDS Sulfonyurea–insulin 10 year, 2008
-
Kumamoto, 1995
-
Lauritzen (STENO 1), 1991
-
ADVANCE, 2008
-
Kumamoto (secondary prev), 2000
-
ADDITION, 2010
-
UKPDS Metformin10 year, 2008
-
DVT prophylaxis
PENTHIFRA (Eriksson), 2001
-
L8541, 0
-
Cooke, 1977
-
Hamburg, 1976
-
Hume, 1973
-
Gerhart, 1991
-
Eriksson , 1988
-
Xabregas , 1977
-
Lassen, 1989
-
Bergqvist, 1996
-
BISTRO II (225mg bid), 2005
-
CV185-035,
-
Harris-I, 1977
-
Encke-II , 1976
-
Lyon-II, 3000
-
Myrhe, 1969
-
Francis, 1992
-
Torholm, 1991
-
Dechavanne, 1974
-
Leyvraz , 1991
-
RECORD 2, 2008
-
RE-MODEL (150mg), 2007
-
Ericksson, 1997
-
Lyon-I, 1975
-
Danish-A , 1976
-
Samama, 2001
-
Paiement, 1987
-
Turpie, 1986
-
Moskovitz, 1978
-
Dechavanne , 1989
-
Turpie, 2001
-
METHRO III, 2002
-
Morris-B , 1977
-
Colwell, 1999
-
Hume, 1973
-
Welin-Berger, 1982
-
Haas , 1985
-
ODIXa-HIP 10mg, 2006
-
RE-MOBILIZE (220mg), 2008
-
Hull, 2000
-
Platinum (Colwell), 2003
-
Wood , 1973
-
Leclerc, 1996
-
Harris, 1972
-
Abraham-Inpijn , 1975
-
Levine , 1991
-
Svend-Hansen, 1981
-
Kalodiki, 1996
-
Manganelli, 1998
-
PENTATHLON (Turpie), 2002
-
L8635, 0
-
Rocha, 1986
-
Hull, 1993
-
Morris, 1976
-
van Comp, 1998
-
Matzsch , 1988
-
Bergqvist, 1979
-
Yoo, 1997
-
Planes, 1996
-
PENTAMAKS (Bauer), 2001
-
ADVANCE 2 (CV185-047), 2010
-
McKenna-I, 1980
-
Erfurt-B , 1979
-
Gardecki, 3000
-
Hamilton, 1970
-
Hume, 1973
-
Lassen, 1991
-
Dechavanne, 1975
-
Haas , 1987
-
RECORD 3, 2008
-
RE-NOVATE (150mg), 2007
-
REVASC, 1997
-
Massachusetts-II, 1976
-
Danish-B , 1976
-
McBride, 1983
-
Borsgtrom, 1965
-
Bailey, 1991
-
Leclerc, 1991
-
VTCSG, 1975
-
Eriksson , 1989
-
DRIVE, 2008
-
EXPRESS, 2003
-
Mocris-C , 1977
-
Hull, 2000
-
Powers, 1989
-
Bergqvist , 1979
-
Binsack , 1986
-
ODIXa-KNEE, 2005
-
RE-MODEL (220mg), 2007
-
Comp, 2001
-
METHRO I, 2002
-
Zekert-I , 1974
-
Francis, 1997
-
Barber, 1977
-
Lowe , 1981
-
Chiapuzzo , 1988
-
Gallus , 1973
-
Warwick, 1995
-
NPHDO, 1998
-
EPHESUS (Lassen), 2002
-
DRI4757, 0
-
McKenna-II, 1983
-
RD Heparin, 1994
-
Powers, 1989
-
van Geloven, 1977
-
Matzsch , 1991
-
Galasko , 1976
-
Samama, 1997
-
Dahl, 1997
-
PENTHIFRA–PLUS (Eriksson), 2003
-
NCT00320398, 0
-
Sautter, 1983
-
Stockholm-II, 1981
-
Pinto, 1970
-
Barber, 1977
-
DES Group , 1991
-
Lahnborg, 1980
-
Lassen, 1988
-
RECORD 4, 2009
-
RE-MOBILIZE (150mg), 2008
-
Eriksson, 1996
-
Pasteyer, 1977
-
Massachusetts-I , 1981
-
Hume-A, 1977
-
Eskeland, 1966
-
Kaempffe, 1991
-
Jorgensen, 1989
-
Mannucci , 1976
-
Monreal , 1989
-
RECORD 1, 2008
-
Stockholm-I, 1975
-
Powers , 1976
-
Fitzgerald, 2001
-
Lotke, 1997
-
PEP hip-fracture, 2000
-
Hampson, 1974
-
Barre , 1987
-
CV185-010, 2007
-
RE-NOVATE (220mg), 2007
-
Cohen (L8405), 2007
-
METHRO II, 2002
-
Morris-A , 1977
-
Heit, 1997
-
Francis, 1983
-
Morris, 1974
-
Pini , 1989
-
Morris , 1977
-
Sourmelis, 1995
-
Heit, 2000
-
Phase II (Heit), 2001
-
RE-NOVATE 2, 2010
-
Hamulyak, 1994
-
Myrhe, 1969
-
Williams , 1978
-
Planes , 1988
-
Moskovitz, 1978
-
Levine, 1996
-
Lassen, 1998
-
Levine, 1996
-
METHRO III, 2002
-
PENTAMAKS (Bauer), 2001
-
ADVANCE 2 (CV185-047), 2010
-
CV185-010, 2007
-
RE-MOBILIZE (220mg), 2008
-
EXPRESS, 2003
-
Phase II (Heit), 2001
-
RE-MODEL (150mg), 2007
-
L8635, 0
-
RECORD 3, 2008
-
RE-MODEL (220mg), 2007
-
McKenna-I, 1980
-
Leclerc, 1991
-
METHRO I, 2002
-
RE-MOBILIZE (150mg), 2008
-
RECORD 4, 2009
-
ODIXa-KNEE, 2005
-
Planes , 1988
-
RE-NOVATE (220mg), 2007
-
RECORD 1, 2008
-
Eriksson , 1988
-
Samama, 1997
-
Stockholm-II, 1981
-
Torholm, 1991
-
Haas , 1987
-
Cooke, 1977
-
Dechavanne , 1989
-
Stockholm-I, 1975
-
RE-NOVATE 2, 2010
-
Haas , 1985
-
Platinum (Colwell), 2003
-
Eriksson, 1996
-
Levine , 1991
-
RE-NOVATE (150mg), 2007
-
RECORD 2, 2008
-
Matzsch , 1988
-
Kalodiki, 1996
-
ODIXa-HIP 10mg, 2006
-
Lassen, 1991
-
Lassen, 1988
-
Rocha, 1986
-
Eriksson , 1989
-
Harris-I, 1977
-
Binsack , 1986
-
METHRO III, 2002
-
CV185-035,
-
Chiapuzzo , 1988
-
PENTATHLON (Turpie), 2002
-
Ericksson, 1997
-
Matzsch , 1991
-
Warwick, 1995
-
DRIVE, 2008
-
DES Group , 1991
-
Yoo, 1997
-
Hume-A, 1977
-
Turpie, 1986
-
Leyvraz , 1991
-
Sautter, 1983
-
Barre , 1987
-
EXPRESS, 2003
-
NCT00320398, 0
-
Pini , 1989
-
EPHESUS (Lassen), 2002
-
REVASC, 1997
-
PENTHIFRA (Eriksson), 2001
-
Lassen, 1989
-
Sourmelis, 1995
-
PEP hip-fracture, 2000
-
PENTHIFRA–PLUS (Eriksson), 2003
-
Jorgensen, 1989
-
Chicago, 1982
-
Fraisse, 2000
-
Harenberg, 1996
-
Bergmann, 1996
-
Jones , 1987
-
Gardlund, 1996
-
McKenna-II , 1983
-
ARTEMIS (Cohen), 2006
-
Denver-I ,
-
Leizorovicz, 2004
-
Lechler, 1996
-
Dahan, 1986
-
Harenberg, 1990
-
Frankfurt, 1981
-
MAGELLAN,
-
Den Ottolander , 1982
-
Blech, 1981
-
Denver-Il , 1980
-
Mahe, 2005
-
Kleber, 2003
-
Samama, 1999
-
Bergmann and Neuhart, 1996
-
BRiEF,
-
GRAND , 1987
-
Cade, 0
-
Toulouse-Il , 0
-
Lederle, 2006
-
Lahnborg, 1976
-
Australian I, 1975
-
Gordon-Smith, 1972
-
Vinazzer II, 1977
-
Sagar, 1974
-
Pezzuoli , 1989
-
Fricker, 1988
-
Verardi, 1989
-
Gazzaniga (ISG), 1993
-
Torngren, 1978
-
Loew DVT, 1974
-
van Geloven, 1977
-
Erfurt-A, 1979
-
Plante, 1979
-
Vermont, 1975
-
Caloghera, 1984
-
Koller, 1986
-
Heilmann, 1989
-
Kakkar, 1993
-
Gruber, 0
-
MRC, 1972
-
Muiticentre 53,S4, 1984
-
Walker, 1974
-
Kraytman, 1976
-
Onarheim, 1986
-
Salcuni, 1988
-
Borstad, 1992
-
Wu, 1977
-
Carter IA, 1971
-
Gallus, 1973
-
ToÈrngren, 1984
-
Welzel, 1988
-
Schielke, 1991
-
Heilmann, 1997
-
Strand, 1975
-
Athens, 1981
-
Kruse-Blinkenberg, 1980
-
Bergqvist [42],
-
Samama 1, 1988
-
Koppenhagen, 1990
-
McLeod (Canadian), 1995
-
Covey, 1975
-
Australian II, 1976
-
Nicolaides, 1972
-
Zekert VI, 1982
-
Koppenhagen, 1982
-
Valle , 1988
-
Bergqvist, 1988
-
Creperio, 1990
-
Limmer, 1994
-
Torngren, 0
-
Zekert-III, 1977
-
Loew, 1977
-
Zekert V, 1980
-
Abraham-Inpijn, 1979
-
PEP elective arthroplasty, 2000
-
Marchelli, 1983
-
Koller, 1986
-
Baumgartner, 1989
-
Kakkar, 1993
-
Kakkar, 1972
-
Parodi I, 1973
-
Muiticentre, 1984
-
Encke IB, 1976
-
Abernethy, 1974
-
Weiss, 1977
-
Kraytman, 1977
-
Sasahara, 1986
-
Kakkar, 1989
-
Hoffmann and Largiader, 1992
-
Lawrence, 1977
-
Carter IB, 1971
-
Gallus, 1976
-
Kakkar and Murray, 1985
-
Briel, 1988
-
Kaaja, 1992
-
Haas, 1999
-
Roberts, 1975
-
Turpie, 1985
-
Kraytman, 1977
-
Ho [43],
-
Samama 2, 1988
-
Barbui, 1990
-
Gonzalez, 1996
-
Belch, 1980
-
Encke IA, 1976
-
Multiunit, 1974
-
Harjola DVT, 1982
-
Bergqvist, 1980
-
Balas [40],
-
Caen, 1988
-
Hartl, 1990
-
Eurin, 1994
-
Lahnborg, 1975
-
Clagett, 1975
-
Vinazzer, 1980
-
Vinazzer I, 1980
-
Spebar, 1981
-
Ockelford , 1989
-
Ziemski, 1979
-
EFS, 1988
-
Dahan, 1989
-
Godwin, 1993
-
Kiil, 1978
-
Parodi II, 1973
-
Jourdan, 1984
-
Toulouse I, 1979
-
Clarke-Pearson, 1983
-
New York, 1977
-
Kettunen, 1974
-
Voigt, 1986
-
Adolf, 1989
-
Garcea, 1992
-
PEP hip-fracture, 2000
-
Muiticentre, 1984
-
Carter II, 1974
-
Groote Schuur, 1979
-
Bergqvist, 1986
-
Catania, 1988
-
Koppenhagen, 1992
-
Kakkar (IMT), 0
-
Ribaudo, 1975
-
Veth, 1985
-
Marchetti, 1982
-
Schmitz-Huebner, 1984
-
Samama 3, 1988
-
Leizorovicz, 1991
-
ENOXACAN, 1997
-
Taberner, 1978
-
Lasierra, 1982
-
Torngren, 1978
-
Marassi [41],
-
Borstad, 1988
-
Hoffmann and Largiade, 1990
-
Nurmohamed, 1995
-
LeGagneux , 1987
-
Vandendris, 1980
-
Allen, 1978
-
Bejjani, 1983
-
Hedlund, 1979
-
Coe, 1978
-
Kutnowski, 1977
-
Sebeseri, 1975
-
Heilmann, 1997
-
Heilmann, 1989
-
Kaaja, 1992
-
Borstad, 1988
-
Borstad, 1992
-
Briel, 1988
-
Onarheim, 1986
-
Hartl, 1990
-
Adolf, 1989
-
FAME (Rasmussen), 2006
-
Catania, 1988
-
PEGASUS, 2005
-
Bergqvist, 1988
-
McLeod (Canadian), 1995
-
Koller, 1986
-
Koppenhagen, 1992
-
Sasahara, 1986
-
Hoffmann and Largiade, 1990
-
Schmitz-Huebner, 1984
-
Baumgartner, 1989
-
NCT00333021,
-
Salcuni, 1988
-
Lausen, 1998
-
Caen, 1988
-
Gonzalez, 1996
-
EFS, 1988
-
Garcea, 1992
-
Voigt, 1986
-
Koppenhagen, 1990
-
Bergqvist, 1986
-
Verardi, 1989
-
Kakkar, 1989
-
ENOXACAN II (Bergqvist), 2002
-
Welzel, 1988
-
APOLLO (Turpie), 2007
-
Fricker, 1988
-
Kakkar, 1993
-
Koller, 1986
-
Schielke, 1991
-
Nurmohamed, 1996
-
Melon, 1987
-
Cerrato, 1978
-
Agnelli, 1998
-
KANT (7 days), 2008
-
Michot, 2002
-
KANT (14 days), 2008
-
Roth, 1995
-
Wirth, 2001
-
Canata, 2003
-
Wille-Jorgensen, 1991
-
Hui THR, 1996
-
CLOTS, 2009
-
Turpie (GCS vs crtl), 1989
-
*Marescaux, 0
-
*McNally, 0
-
*Scurr, 1977
-
*Wille-Jorgensen, 1989
-
Mellbring, 1986
-
Barnes, 1978
-
Rasmussen (GCS vs UFH), 1998
-
Fredin, 1989
-
Kierkegaard, 1993
-
Wille-Jorgensen, 1985
-
Hui TKR, 1996
-
Muir, 2000
-
Allan, 1983
-
Porteous, 1989
-
*Partsch, 0
-
Holford, 1976
-
*Rasmussen (adj), 1988
-
William, 1996
-
Torngren, 1980
-
*Ohlund, 1983
-
Fasting, 1985
-
*Tsapogas, 1971
-
Turpie (IPD or GCS), 1989
-
Scurr (GCS+IPC vs IPC), 1987
-
Howard, 2004
-
Rosengarten, 1970
-
*Torngren, 1980
-
Williams, 1988
-
*Inada, 1983
-
Turner, 1984
-
*Bucci, 0
-
*Halford, 0
-
*Ishak, 0
-
Hansberry (vs UFH), 1991
-
Cohen (L8405), 2007
-
*Tillberg, 0
-
Camporese, 2008
-
*Bergqvist, 1984
-
Kalodiki (GCS+LMWH vs LMWH), 1996
-
RE-NOVATE (150mg), 2007
-
Hamilton, 1970
-
Hume, 1973
-
RE-NOVATE 2, 2010
-
RE-MODEL (220mg), 2007
-
Borsgtrom, 1965
-
Bailey, 1991
-
CV185-036,
-
Hull, 2000
-
Powers, 1989
-
RECORD 3, 2008
-
Francis, 1997
-
Barber, 1977
-
CV185-010, 2007
-
RD Heparin, 1994
-
Powers, 1989
-
van Geloven, 1977
-
RE-MOBILIZE (150mg), 2008
-
Pinto, 1970
-
Barber, 1977
-
RE-NOVATE (220mg), 2007
-
Eskeland, 1966
-
Kaempffe, 1991
-
CV185-035,
-
Fitzgerald, 2001
-
Lotke, 1997
-
RECORD 4, 2009
-
Heit, 1997
-
Francis, 1983
-
RECORD 1, 2008
-
Hamulyak, 1994
-
Myrhe, 1969
-
ODIXa-HIP 10mg, 2006
-
BISTRO II (225mg bid), 2005
-
Hume, 1973
-
Gerhart, 1991
-
RE-MODEL (150mg), 2007
-
Myrhe, 1969
-
Francis, 1992
-
ADVANCE 2 (CV185-047), 2010
-
RE-MOBILIZE (220mg), 2008
-
Samama, 2001
-
Paiement, 1987
-
ADVANCE-1, 2008
-
Colwell, 1999
-
Hume, 1973
-
RECORD 2, 2008
-
Leclerc, 1996
-
Harris, 1972
-
ODIXa-KNEE, 2005
-
Hull, 1993
-
Morris, 1976
-
van Comp, 1998
-
METHRO II, 2002
-
Phase II (Heit), 2001
-
METHRO III, 2002
-
Platinum (Colwell), 2003
-
EXPRESS, 2003
-
METHRO I, 2002
-
McKenna-II, 1983
-
Dechavanne, 1974
-
Gallus , 1973
-
Sautter, 1983
-
Moskovitz, 1978
-
Galasko , 1976
-
Pasteyer, 1977
-
Welin-Berger, 1982
-
Massachusetts-I , 1981
-
Williams , 1978
-
Powers , 1976
-
Stockholm-I, 1975
-
Gardecki, 3000
-
Morris-A , 1977
-
McBride, 1983
-
Dechavanne, 1975
-
Morris , 1977
-
Cooke, 1977
-
VTCSG, 1975
-
Moskovitz, 1978
-
Harris-I, 1977
-
Bergqvist , 1979
-
Xabregas , 1977
-
Encke-II , 1976
-
Abraham-Inpijn , 1975
-
Danish-A , 1976
-
Lyon-I, 1975
-
Stockholm-II, 1981
-
Morris-B , 1977
-
Hume-A, 1977
-
Lahnborg, 1980
-
Wood , 1973
-
Rocha, 1986
-
Mannucci , 1976
-
Svend-Hansen, 1981
-
McKenna-I, 1980
-
Hampson, 1974
-
Bergqvist, 1979
-
Erfurt-B , 1979
-
Morris, 1974
-
Danish-B , 1976
-
Massachusetts-II, 1976
-
Hamburg, 1976
-
Mocris-C , 1977
-
Lyon-II, 3000
-
Zekert-I , 1974
-
PENTATHLON (Turpie), 2002
-
PENTAMAKS (Bauer), 2001
-
L8541, 0
-
EPHESUS (Lassen), 2002
-
PENTHIFRA–PLUS (Eriksson), 2003
-
L8635, 0
-
Turpie, 2001
-
PENTHIFRA (Eriksson), 2001
-
DRI4757, 0
-
DRIVE, 2008
-
Planes , 1988
-
Levine, 1996
-
Eriksson , 1988
-
Lassen, 1989
-
Torholm, 1991
-
Leyvraz , 1991
-
Turpie, 1986
-
Dechavanne , 1989
-
Haas , 1985
-
FX140, Simonneau G, 2006
-
Levine , 1991
-
Kalodiki, 1996
-
Matzsch , 1988
-
Yoo, 1997
-
Lassen, 1991
-
Haas , 1987
-
Leclerc, 1991
-
Eriksson , 1989
-
Binsack , 1986
-
Chiapuzzo , 1988
-
Warwick, 1995
-
Matzsch , 1991
-
Samama, 1997
-
DES Group , 1991
-
Lassen, 1988
-
Jorgensen, 1989
-
Monreal , 1989
-
Barre , 1987
-
Pini , 1989
-
Sourmelis, 1995
-
Warwick, 1995
-
Chiapuzzo , 1988
-
Samama, 1997
-
Matzsch , 1991
-
Lassen, 1988
-
DES Group , 1991
-
Jorgensen, 1989
-
Monreal , 1989
-
Barre , 1987
-
Sourmelis, 1995
-
Pini , 1989
-
Levine, 1996
-
Planes , 1988
-
Lassen, 1989
-
Eriksson , 1988
-
Torholm, 1991
-
Leyvraz , 1991
-
Turpie, 1986
-
Dechavanne , 1989
-
FX140, Simonneau G, 2006
-
Haas , 1985
-
Kalodiki, 1996
-
Levine , 1991
-
Yoo, 1997
-
Matzsch , 1988
-
Lassen, 1991
-
Haas , 1987
-
Leclerc, 1991
-
Eriksson , 1989
-
Binsack , 1986
-
Ribaudo, 1975
-
Loew, 1977
-
Marchetti, 1982
-
Taberner, 1978
-
Muiticentre, 1984
-
Torngren, 1978
-
Lahnborg, 1976
-
Sagar, 1974
-
Torngren, 1978
-
Plante, 1979
-
Caloghera, 1984
-
Gruber, 0
-
Multiunit, 1974
-
Kraytman, 1976
-
Wu, 1977
-
Vinazzer, 1980
-
Gallus, 1973
-
Strand, 1975
-
Jourdan, 1984
-
Kruse-Blinkenberg, 1980
-
Covey, 1975
-
Muiticentre, 1984
-
Koppenhagen, 1982
-
Torngren, 0
-
Abraham-Inpijn, 1979
-
Marchelli, 1983
-
Kakkar, 1972
-
Abernethy, 1974
-
Kraytman, 1977
-
Lawrence, 1977
-
Gordon-Smith, 1972
-
Gallus, 1976
-
Roberts, 1975
-
van Geloven, 1977
-
Kraytman, 1977
-
Belch, 1980
-
Muiticentre 53,S4, 1984
-
Bergqvist, 1980
-
Lahnborg, 1975
-
Spebar, 1981
-
Ziemski, 1979
-
Kiil, 1978
-
Clarke-Pearson, 1983
-
Kettunen, 1974
-
Kakkar (IMT), 0
-
Nicolaides, 1972
-
Groote Schuur, 1979
-
Bergqvist, 1980
-
Sebeseri, 1975
-
Hampson, 1974
-
Gruber, 0
-
Muiticentre 53,S4, 1984
-
Spebar, 1981
-
Ziemski, 1979
-
Morris, 1974
-
Gallus , 1973
-
Wu, 1977
-
Clarke-Pearson, 1983
-
Kettunen, 1974
-
Williams , 1978
-
Galasko , 1976
-
Strand, 1975
-
Groote Schuur, 1979
-
Lahnborg, 1980
-
Covey, 1975
-
Nicolaides, 1972
-
Marchetti, 1982
-
Mannucci , 1976
-
Torngren, 0
-
Loew, 1977
-
Torngren, 1978
-
Allen, 1978
-
Moskovitz, 1978
-
Kakkar, 1972
-
Muiticentre, 1984
-
Sagar, 1974
-
Bejjani, 1983
-
Welin-Berger, 1982
-
Morris , 1977
-
Lawrence, 1977
-
Plante, 1979
-
Caloghera, 1984
-
Kutnowski, 1977
-
Abraham-Inpijn , 1975
-
Moskovitz, 1978
-
Roberts, 1975
-
Kraytman, 1976
-
Xabregas , 1977
-
Belch, 1980
-
Multiunit, 1974
-
Gallus, 1973
-
Dechavanne, 1974
-
Lahnborg, 1975
-
Vinazzer, 1980
-
Kruse-Blinkenberg, 1980
-
Hedlund, 1979
-
Gallus , 1973
-
Kiil, 1978
-
Jourdan, 1984
-
Koppenhagen, 1982
-
Coe, 1978
-
Bergqvist , 1979
-
Kakkar (IMT), 0
-
Muiticentre, 1984
-
Abraham-Inpijn, 1979
-
Marchelli, 1983
-
Vandendris, 1980
-
Lowe , 1981
-
Svend-Hansen, 1981
-
Ribaudo, 1975
-
Kraytman, 1977
-
Bergqvist, 1979
-
Taberner, 1978
-
Abernethy, 1974
-
Gallus, 1976
-
Dechavanne, 1975
-
Lahnborg, 1976
-
Gordon-Smith, 1972
-
Kraytman, 1977
-
VTCSG, 1975
-
Torngren, 1978
-
van Geloven, 1977
-
Sebeseri, 1975
-
LeGagneux , 1987
-
Vandendris, 1980
-
Allen, 1978
-
Bejjani, 1983
-
Hedlund, 1979
-
Coe, 1978
-
Kutnowski, 1977
-
Onarheim, 1986
-
Salcuni, 1988
-
Borstad, 1992
-
ToÈrngren, 1984
-
Welzel, 1988
-
Schielke, 1991
-
Heilmann, 1997
-
Bergqvist [42],
-
Samama 1, 1988
-
Koppenhagen, 1990
-
McLeod (Canadian), 1995
-
Valle , 1988
-
Bergqvist, 1988
-
Creperio, 1990
-
Limmer, 1994
-
Koller, 1986
-
Baumgartner, 1989
-
Kakkar, 1993
-
Sasahara, 1986
-
Kakkar, 1989
-
Hoffmann and Largiader, 1992
-
Kakkar and Murray, 1985
-
Briel, 1988
-
Kaaja, 1992
-
Haas, 1999
-
Ho [43],
-
Samama 2, 1988
-
Barbui, 1990
-
Gonzalez, 1996
-
Balas [40],
-
Caen, 1988
-
Hartl, 1990
-
Eurin, 1994
-
Ockelford , 1989
-
EFS, 1988
-
Dahan, 1989
-
Godwin, 1993
-
Voigt, 1986
-
Adolf, 1989
-
Garcea, 1992
-
Bergqvist, 1986
-
Catania, 1988
-
Koppenhagen, 1992
-
Schmitz-Huebner, 1984
-
Samama 3, 1988
-
Leizorovicz, 1991
-
ENOXACAN, 1997
-
Marassi [41],
-
Borstad, 1988
-
Hoffmann and Largiade, 1990
-
Nurmohamed, 1995
-
Pezzuoli , 1989
-
Fricker, 1988
-
Verardi, 1989
-
Gazzaniga (ISG), 1993
-
Koller, 1986
-
Heilmann, 1989
-
Kakkar, 1993
-
Fricker, 1988
-
Verardi, 1989
-
Kaaja, 1992
-
Haas, 1999
-
Pezzuoli , 1989
-
Koller, 1986
-
Heilmann, 1989
-
Barbui, 1990
-
Gonzalez, 1996
-
Onarheim, 1986
-
Salcuni, 1988
-
Eurin, 1994
-
Welzel, 1988
-
Godwin, 1993
-
ToÈrngren, 1984
-
Samama 1, 1988
-
Garcea, 1992
-
Bergqvist [42],
-
Bergqvist, 1988
-
Creperio, 1990
-
Koppenhagen, 1992
-
Valle , 1988
-
Koller, 1986
-
Baumgartner, 1989
-
Leizorovicz, 1991
-
ENOXACAN, 1997
-
Sasahara, 1986
-
Kakkar, 1989
-
Hoffmann and Largiade, 1990
-
Nurmohamed, 1995
-
Briel, 1988
-
Gazzaniga (ISG), 1993
-
Kakkar and Murray, 1985
-
Samama 2, 1988
-
Kakkar, 1993
-
Ho [43],
-
Caen, 1988
-
Hartl, 1990
-
Borstad, 1992
-
Balas [40],
-
EFS, 1988
-
Dahan, 1989
-
Schielke, 1991
-
Heilmann, 1997
-
Ockelford , 1989
-
Voigt, 1986
-
Adolf, 1989
-
Koppenhagen, 1990
-
McLeod (Canadian), 1995
-
Catania, 1988
-
Limmer, 1994
-
Bergqvist, 1986
-
Samama 3, 1988
-
Kakkar, 1993
-
Schmitz-Huebner, 1984
-
Borstad, 1988
-
Hoffmann and Largiader, 1992
-
Marassi [41],
-
Cerrato, 1978
-
Agnelli, 1998
-
Nurmohamed, 1996
-
Melon, 1987
-
Melon, 1987
-
Cerrato, 1978
-
Agnelli, 1998
-
Nurmohamed, 1996
-
Borstad, 1992
-
Briel, 1988
-
Heilmann, 1997
-
Heilmann, 1989
-
Kaaja, 1992
-
Borstad, 1988
-
Bergqvist, 1986
-
Verardi, 1989
-
Kakkar, 1989
-
Welzel, 1988
-
Fricker, 1988
-
Kakkar, 1993
-
Koller, 1986
-
Schielke, 1991
-
Onarheim, 1986
-
Hartl, 1990
-
Adolf, 1989
-
Catania, 1988
-
Bergqvist, 1988
-
McLeod (Canadian), 1995
-
Koller, 1986
-
Koppenhagen, 1992
-
Sasahara, 1986
-
Hoffmann and Largiade, 1990
-
Schmitz-Huebner, 1984
-
Baumgartner, 1989
-
Salcuni, 1988
-
Caen, 1988
-
Gonzalez, 1996
-
EFS, 1988
-
Garcea, 1992
-
Voigt, 1986
-
Koppenhagen, 1990
-
APOLLO (Turpie), 2007
-
PEGASUS, 2005
-
NCT00333021,
-
RE-MODEL (150mg), 2007
-
RE-MOBILIZE (220mg), 2008
-
RE-NOVATE 2, 2010
-
RE-NOVATE (150mg), 2007
-
RE-MODEL (220mg), 2007
-
RE-MOBILIZE (150mg), 2008
-
RE-NOVATE (220mg), 2007
-
BISTRO II (225mg bid), 2005
-
CV185-036,
-
RECORD 3, 2008
-
CV185-010, 2007
-
CV185-035,
-
RECORD 4, 2009
-
RECORD 1, 2008
-
ODIXa-HIP 10mg, 2006
-
ADVANCE 2 (CV185-047), 2010
-
ADVANCE-1, 2008
-
RECORD 2, 2008
-
ODIXa-KNEE, 2005
-
ARTEMIS (Cohen), 2006
-
CV185-027,
-
ADVANCE-1, 2008
-
RECORD 2, 2008
-
ODIXa-KNEE, 2005
-
RE-MOBILIZE (150mg), 2008
-
RE-NOVATE (220mg), 2007
-
CV185-036,
-
RECORD 3, 2008
-
CV185-010, 2007
-
ADVANCE 2 (CV185-047), 2010
-
BISTRO II (225mg bid), 2005
-
RE-MODEL (150mg), 2007
-
RE-MOBILIZE (220mg), 2008
-
CV185-035,
-
RECORD 4, 2009
-
RECORD 1, 2008
-
RE-NOVATE 2, 2010
-
ODIXa-HIP 10mg, 2006
-
RE-NOVATE (150mg), 2007
-
RE-MODEL (220mg), 2007
-
RE-MOBILIZE (150mg), 2008
-
RE-MOBILIZE (220mg), 2008
-
ADVANCE 2 (CV185-047), 2010
-
RECORD 3, 2008
-
BISTRO II (225mg bid), 2005
-
RE-MODEL (220mg), 2007
-
RECORD 4, 2009
-
ODIXa-KNEE, 2005
-
RE-MODEL (150mg), 2007
-
ADVANCE-1, 2008
-
CV185-010, 2007
-
RECORD 2, 2008
-
BISTRO II (225mg bid), 2005
-
CV185-035,
-
ODIXa-HIP 10mg, 2006
-
RE-NOVATE (220mg), 2007
-
RE-NOVATE 2, 2010
-
RECORD 1, 2008
-
RE-NOVATE (150mg), 2007
-
PENTAMAKS (Bauer), 2001
-
L8541, 0
-
Sasaki, 2010
-
APOLLO (Turpie), 2007
-
EPHESUS (Lassen), 2002
-
PENTHIFRA–PLUS (Eriksson), 2003
-
L8635, 0
-
NCT00333021,
-
PEGASUS, 2005
-
Turpie, 2001
-
PENTHIFRA (Eriksson), 2001
-
DRI4757, 0
-
NCT00320398, 0
-
PROTECT (fundaparinux),
-
DRIVE, 2008
-
PENTATHLON (Turpie), 2002
-
Butson, 1981
-
Wilson, 1992
-
Turpie, 1989
-
Santori, 1994
-
Stone, 1996
-
Rasmussen (GCS vs UFH), 1998
-
Wille-Jorgensen, 1985
-
Hui TKR, 1996
-
Kosir, 1996
-
Siragusa (H), 1994
-
Kierkegaard, 1993
-
HAAS II, 1990
-
Mellbring, 1986
-
Allan, 1983
-
Porteous, 1989
-
Fisher, 1995
-
Turpie I, 1977
-
paiement, 1987
-
Hull 2 (+asp), 1979
-
Holford, 1976
-
*Rasmussen (adj), 1988
-
Hills, 1972
-
Kosir, 1998
-
Pambianco, 1995
-
Murakami, 2003
-
*Ohlund, 1983
-
CLOTS, 2009
-
Clarke-Pearson II, 1984
-
Blanchard, 1999
-
Wautrecht, 1996
-
Gelfer, 2006
-
Torngren, 1980
-
*Tsapogas, 1971
-
*McNally, 0
-
Bynke, 1987
-
Stannard (vs UFH+asp), 1996
-
Killewich, 1997
-
Fordyce, 1992
-
Warwick, 1998
-
Fasting, 1985
-
Scurr (GCS+IPC vs IPC), 1987
-
Howard, 2004
-
Turple II, 1979
-
Smith (D), 1978
-
McKenna, 1980
-
McKenna (vs aspirin), 1980
-
Turpie (IPD or GCS), 1989
-
*Torngren, 1980
-
Williams, 1988
-
Hull II, 1990
-
Weitz, 1986
-
Rosengarten, 1970
-
Kaempffe, 1991
-
Dickinson, 1998
-
Turner, 1984
-
*Bucci, 0
-
Hull I, 1979
-
Hansberry (vs UFH), 1991
-
Ramos, 1996
-
Kurtoglu, 2004
-
*Ishak, 0
-
Schirai, 1985
-
Coe, 1978
-
Clarke Pearson, 1993
-
Rokito, 1996
-
Elliott, 1999
-
*Tillberg, 0
-
*Partsch, 0
-
Clark, 1974
-
Muir, 2000
-
Soderdahl, 1997
-
Caprini, 1983
-
Norgren, 1998
-
Hansberry (vs UFH), 1991
-
*Bergqvist, 1984
-
William, 1996
-
Bachmann, 1976
-
Scurr, 1981
-
Prasad, 1982
-
Niolaides, 1983
-
Camporese, 2008
-
Wille-Jorgensen, 1991
-
Hui THR, 1996
-
Knudson, 1994
-
Lieberman (A), 1994
-
Kalodiki (GCS+LMWH vs LMWH), 1996
-
HAAS I, 1990
-
Goldhaber, 1995
-
Turpie (GCS vs crtl), 1989
-
*Marescaux, 0
-
Skillman, 1978
-
Chandhoke, 1992
-
Hull (+asp), 1979
-
*Scurr, 1977
-
*Wille-Jorgensen, 1989
-
Blackshear à exclure, 1987
-
Gallus, 1983
-
Coe (vs UFH), 1978
-
Lacut, 2005
-
Ginzburg, 2003
-
Barnes, 1978
-
*Inada, 1983
-
Clarke-Pearson I, 1984
-
Hansberry, 1991
-
Turpie, 1989
-
Warwick à exclure, 2002
-
Mellbring, 1986
-
Fredin, 1989
-
*Halford, 0
-
Lapidus, 2007
-
Jorgensen, 2002
-
FONDACAST,
-
Lapidus, 2007
-
Kujath, 1993
-
PROTECT (fundaparinux),
-
Lassen, 2002
-
Kock, 1995
-
PROTECT (nadroparin),
-
Gallus, 1973
-
Pitt, 1980
-
Emerson, 1973
-
Handley (low dose), 1972
-
Scala, 1990
-
Zawilska, 1989
-
Handley, 1972
-
Warlow, 1973
-
Weiss, 1977
-
Encke IB, 1976
-
Carter IB, 1971
-
Australian I, 1975
-
Turpie, 1985
-
Loew DVT, 1974
-
MRC, 1972
-
Harjola DVT, 1982
-
Vinazzer I, 1980
-
New York, 1977
-
Toulouse I, 1979
-
Carter II, 1974
-
Australian II, 1976
-
Veth, 1985
-
Zekert-III, 1977
-
Parodi I, 1973
-
Lasierra, 1982
-
Vinazzer II, 1977
-
Vermont, 1975
-
Erfurt-A, 1979
-
Walker, 1974
-
Encke IA, 1976
-
Carter IA, 1971
-
Clagett, 1975
-
Parodi II, 1973
-
Athens, 1981
-
PEP hip-fracture, 2000
-
Zekert VI, 1982
-
PEP elective arthroplasty, 2000
-
Zekert V, 1980
-
Erfurt-A, 1979
-
Turpie, 1985
-
Sautter, 1983
-
Encke IA, 1976
-
Harjola DVT, 1982
-
Pasteyer, 1977
-
Clagett, 1975
-
Stockholm-I, 1975
-
Parodi II, 1973
-
New York, 1977
-
Gardecki, 3000
-
PEP hip-fracture, 2000
-
Carter II, 1974
-
McBride, 1983
-
Zekert V, 1980
-
Veth, 1985
-
Cooke, 1977
-
Encke IB, 1976
-
Lasierra, 1982
-
Harris-I, 1977
-
Australian I, 1975
-
Vinazzer II, 1977
-
Lyon-I, 1975
-
Loew DVT, 1974
-
Vermont, 1975
-
Stockholm-II, 1981
-
MRC, 1972
-
Walker, 1974
-
Hume-A, 1977
-
Vinazzer I, 1980
-
Carter IA, 1971
-
Rocha, 1986
-
Toulouse I, 1979
-
Athens, 1981
-
McKenna-I, 1980
-
Australian II, 1976
-
Zekert VI, 1982
-
Massachusetts-II, 1976
-
Zekert-III, 1977
-
PEP elective arthroplasty, 2000
-
Hamburg, 1976
-
Parodi I, 1973
-
Weiss, 1977
-
Lyon-II, 3000
-
Carter IB, 1971
-
McKenna-II, 1983
-
GRAND , 1987
-
Toulouse-Il , 0
-
Chicago, 1982
-
Jones , 1987
-
McKenna-II , 1983
-
Denver-I ,
-
Frankfurt, 1981
-
Den Ottolander , 1982
-
Denver-Il , 1980
-
Gardecki, 3000
-
McBride, 1983
-
Cooke, 1977
-
Harris-I, 1977
-
Lyon-I, 1975
-
Stockholm-II, 1981
-
Hume-A, 1977
-
Rocha, 1986
-
McKenna-I, 1980
-
Massachusetts-II, 1976
-
Hamburg, 1976
-
Lyon-II, 3000
-
McKenna-II, 1983
-
Sautter, 1983
-
Pasteyer, 1977
-
Stockholm-I, 1975
-
Kalodiki (GCS+LMWH vs LMWH), 1996
-
Hui TKR, 1996
-
*Ishak, 0
-
Fredin, 1989
-
Camporese, 2008
-
William, 1996
-
*Wille-Jorgensen, 1989
-
Barnes, 1978
-
Fasting, 1985
-
*Inada, 1983
-
Hui THR, 1996
-
*Ohlund, 1983
-
Holford, 1976
-
*Halford, 0
-
*Scurr, 1977
-
Porteous, 1989
-
*Rasmussen (adj), 1988
-
Wille-Jorgensen, 1985
-
Mellbring, 1986
-
Allan, 1983
-
*Inada, 1983
-
Holford, 1976
-
Williams, 1988
-
*Bucci, 0
-
Scurr (GCS+IPC vs IPC), 1987
-
*Torngren, 1980
-
Rasmussen (GCS vs UFH), 1998
-
Turner, 1984
-
Howard, 2004
-
*Marescaux, 0
-
*Bergqvist, 1984
-
Wille-Jorgensen, 1991
-
Hansberry (vs UFH), 1991
-
Turpie (GCS vs crtl), 1989
-
familial hypercholesterolemia
Enhance, 2008
-
CAPTIVATE, 2009
-
RADIANCE 1, 2007
-
heart failure
DEFINITE, 2004
-
AMIOVIRT, 2003
-
CAT, 2002
-
CCS-1, 0
-
Giles, 1990
-
Uprichard-c, 1994
-
Sharpe, 1984
-
NETWORK (2.5 bid vs 10 bid), 1998
-
CONSENSUS 2, 0
-
Dickstein, 1991
-
Northridge, 1991
-
Cilazapril-Captopril Multi-centre Group, 1995
-
CASSIS (enalapril), 1995
-
SAVE, 0
-
Rucinska-b (enalapril), 1991
-
Dosseger, 1993
-
Cilazapril-Captopril Multi-centre Group (capt vs pbo), 1995
-
Munich MHFT (Kleber), 1992
-
Magnani, 1990
-
Quinapril Heart Failure Trial Investigators, 1993
-
Bussmann, 1987
-
Maass-c, 1991
-
Acanfora, 1997
-
Colfer, 1992
-
Rucinska-c (lisinopril), 1000
-
Maass-a, 1991
-
McGrath, 1985
-
ATLAS, 1999
-
GISSI 3, 0
-
Rucinska-a (enalapril), 1991
-
Uprichard-a, 1994
-
FEST (Erhardt), 1996
-
CASSIS (spirapril), 1995
-
AIRE, 0
-
CONSENSUS, 1987
-
Lechat, 1993
-
Gundersen, 1994
-
Cilazapril-Captopril Multi-centre Group (cila vs capt), 1995
-
SOLVD treatment, 1991
-
Drexler, 1989
-
CMRG, 1983
-
PEP CHF, 2006
-
Captopril Digoxin Multicenter Research Group, 1988
-
Lemarie, 1992
-
beynon, 1997
-
McGany, 1991
-
Gilbert, 1993
-
Gordon, 1991
-
Chrysant, 1985
-
V-HeFT II, 1991
-
ISIS-4, 0
-
Zwehl, 1990
-
Uprichard-b, 1994
-
Hampton, 1998
-
International Study Group (Lewis), 1989
-
TRACE, 1995
-
Enalapril CHF investigators, 1987
-
Riegger, 1990
-
Brown, 1995
-
packer, 1986
-
SOLVD prevention, 1992
-
Cleland, 1985
-
Rieger, 1991
-
Sumukadas, 2007
-
Barabino, 1991
-
SMILE, 1995
-
Nussberger, 1994
-
Magnani, 1986
-
Maass-b, 1991
-
Lough, 1998
-
NETWORK (5 bid vs 10 bid), 1998
-
Lechat, 1991
-
RESOLVD, 2000
-
CAPRICORN, 2001
-
Parker, 1996
-
BEST, 2001
-
Olsen, 1995
-
ANZ-HeFT, 1997
-
Bristow, 1994
-
COMET, 2003
-
Woodley, 1991
-
Engelmeier, 1985
-
CARMEN (carvedilol+enalapril), 2004
-
Colucci, 1996
-
CARMEN (carvedilol alone), 2004
-
Krum, 1995
-
CIBIS II, 1999
-
Eichhorn, 1994
-
MDC (Waagstein), 1993
-
Wisenbaugh, 1993
-
Pollock, 1990
-
SENIORS, 2005
-
Cohn, 1997
-
COPERNICUS, 2002
-
Bristow (MOCHA), 1996
-
MERIT-HF, 1999
-
Metra, 1994
-
CIBIS, 1994
-
Fisher, 1994
-
Hamer, 1989
-
STATCHF, 1995
-
Nicklas, 1991
-
ANDROMEDA, 2008
-
EPAMSA, 1985
-
AMIOVIRT, 2003
-
GESICA, 1994
-
HEAVEN, 2002
-
VALIANT (valsartan+capropril), 2003
-
ELITE, 1997
-
V-HeFT, 1999
-
losartan phase II US, 1996
-
CHARM-Alternative, 2003
-
SPICE, 2000
-
ADEPT, 2001
-
REPLACE, 2001
-
OPTIMAAL, 2002
-
Lang et al., 1997
-
Mazayev et al. (vs lisinopril, 1998
-
ELITE II, 2000
-
Val-HeFT, 2001
-
HEAAL, 2009
-
Crozier et al., 1995
-
STRETCH, 1999
-
VALIDD, 2007
-
ARCH-J, 2003
-
RESOLVD (candesartan alone), 1999
-
Losartan Phase III International, 1996
-
Mazayev et al. (vs placebo), 1998
-
Weber, 1997
-
Hamroff et al., 1999
-
VALIANT (valsartan alone), 2003
-
NCT00090259,
-
Dickstein et al., 1995
-
Tonkon et al., 2000
-
Losartan phase II S, 1996
-
CHARM-Added, 2003
-
RESOLVD association, 1999
-
Losartan Phase III U.S., 1995
-
Mitrovic et al., 2003
-
CHARM-Alternative, 2003
-
SPICE, 2000
-
ELITE II, 2000
-
Mazayev et al. (vs placebo), 1998
-
ARCH-J, 2003
-
Mazayev et al. (vs lisinopril, 1998
-
ELITE, 1997
-
Val-HeFT, 2001
-
REPLACE, 2001
-
Hamroff et al., 1999
-
ADEPT, 2001
-
Tonkon et al., 2000
-
HEAVEN, 2002
-
CHARM-Added, 2003
-
V-HeFT, 1999
-
Lang et al., 1997
-
Dickstein et al., 1995
-
Van den Toren, 1996
-
Abrams, 1993
-
Gaudron, 1996
-
Littler, 1995
-
De Vries, 1996
-
Kassis, 1987
-
Schofer, 1990
-
PRAISE, 1996
-
Udelson, 1996
-
Smith, 1994
-
Gheorghiade, 1991
-
PRAISE II , 2000
-
Liao , 1998
-
Dunselman, 1990
-
VHeFT III, 1997
-
Binkley, 1996
-
Rousseau, 1994
-
Packer, 1991
-
Kassis, 1990
-
DiDi, 1996
-
De Vries, 1995
-
MACH 1, 2000
-
Ghali, 1997
-
Sumukadas, 2007
-
Hutcheon, 2002
-
Barabino, 1991
-
PEP CHF, 2006
-
THE-PRINCE (Kleber), 2003
-
Anderson, 0
-
HELAS (warfarin vs aspirin), 2006
-
Barzizza (warfarin), 1993
-
WATCH (clopidogrel vs aspirin), 0
-
Griffith, 1952
-
WASH (warfarin), 2004
-
Barzizza (A+D), 1993
-
WASH (aspirin), 2004
-
HELAS (warfarin vs placebo), 2006
-
Harvey, 1950
-
Barzizza (ASA), 1993
-
WATCH (warfarin vs aspirin), 2009
-
Myers (copie de 7314), 1982
-
Yee, 2001
-
Myers, 1982
-
Macdonald, 2004
-
Dalhstrom, 1986
-
PROTECT-1,
-
RALES, 1998
-
Burr, 1977
-
UNLOAD,
-
Han, 1994
-
TOPCAT, 0
-
Farquharson, 2000
-
Sievert, 1989
-
Tsutamoto, 2001
-
Nordrehaug, 1992
-
Cicoira, 2004
-
De jong, 1994
-
Agostoni, 2005
-
Cheitlin, 1991
-
Weir,
-
Mauersberger, 1985
-
REMODEL,
-
MacFadyen, 1997
-
Walma, 1997
-
Bednarz, 2000
-
Richardson, 1987
-
Cicoira, 2002
-
Haerer, 1989
-
Mottram, 2004
-
Cowley, 1986
-
EMPHASIS-HF,
-
Boccanelli, 1986
-
PIE II,
-
Barr, 1995
-
Mathur, 1984
-
Ramires, 2000
-
Sherman, 1986
-
EMPHASIS-HF,
-
EPHESUS, 2003
-
Weir,
-
CORONA, 2007
-
DiBianco, 1989
-
Captopril-Digoxin Multicenter Research Group (CDMRG), 1988
-
Proved, 1993
-
Pugh, 1989
-
German and Austrian Xamoterol Study, 1988
-
Lee, 1982
-
DIMT, 1993
-
Fleg, 1982
-
Blackwood, 1990
-
Guyatt, 1988
-
Taggart, 1983
-
Digitalis Investigation Group (DIG), 1997
-
Radiance, 1993
-
Franciosa, 1982
-
NICE (Lewis), 1999
-
Ghose (vs placebo), 1993
-
VHeFT I (hydralazine ISDN), 1986
-
Franciosa , 1978
-
Markham, 1983
-
Chatterjee, 1980
-
Ghose (vs captopril) , 1993
-
V-HeFT II, 1991
-
Magorien , 1984
-
Higginbotham, 1983
-
Colucci, 1980
-
VHeFT I (prazosin), 1986
-
FIRST, 1997
-
Conradson , 1984
-
HF-ACTION, 2008
-
Wielenga et al, 1999
-
Kiilavuori et al, 2000
-
Dubach et al, 1997
-
HEARTS,
-
Willenheimer et al, 1998
-
McKelvie et al, 2002
-
Giannuzzi et al, 1997
-
ExTraMATCH, 2004
-
Zanelli et al, 1997
-
Hambrecht et al, 1995
-
Belardinelli et al, 1999
-
COMPANION (CRT+ICD vs CRT), 2004
-
MADIT-II, 2002
-
RethinQ, 2007
-
AMIOVIRT, 2003
-
PATH-CHF, 2002
-
CONTAK-CD , 2003
-
MUSIT, 1999
-
MIRACLE, 2002
-
MADIT, 1996
-
SCD-HeFT (ICD vs placebo), 2005
-
REVERSE, 2008
-
CAT, 2002
-
RD-CHF, 2003
-
MIRACLE-ICD-I, 2003
-
SCD-HeFT (ICD vs amiodarone), 2005
-
MUSTIC-SR, 2001
-
CABG-patch, 1997
-
CARE-HF, 2005
-
COMPANION (CRT+ICD vs MT), 2004
-
DEFINITE, 2004
-
NCT00887237,
-
MIRACLE-ICD-II, 2004
-
Garrigue, 2002
-
MUSTIC AF, 2002
-
DINAMIT, 2004
-
COMPANION (CRT vs MT), 2004
-
CASH, 2000
-
CIDS, 2000
-
AVID, 1997
-
MADIT, 1996
-
DINAMIT, 2004
-
MADIT-II, 2002
-
OPC-8212 MRG, 1990
-
IRG, 1991
-
EPOCH, 2002
-
EMPOWER,
-
Cowley, 1993
-
ESSENTIAL (I and II), 2009
-
PRIME II, 1997
-
REFLECT II, 1991
-
PICO, 1996
-
Lardoux, 1987
-
ESG, 2000
-
Dies, 1989
-
Cowley, 1994
-
AMTG, 1985
-
VEST, 1998
-
WESG, 1991
-
PMRG, 1992
-
MMTG, 1989
-
FACET, 1993
-
EMTG, 1990
-
EMOTE, 2007
-
Bergler-Klein, 1992
-
VSG, 1993
-
PROMISE, 1991
-
REFLECT, 1993
-
MERIT-HF (elderly subgroup), 1999
-
Carvedilol U.S. Trials (elderly subgroup), 1996
-
CIBIS II (elderly subgroup), 1999
-
SENIORS, 2005
-
COPERNICUS (elderly subgroup), 2001
-
BEST (elderly subgroup), 2001
-
Landmesser, 2005
-
Strey, 2005
-
Yamada, 2007
-
CORONA, 2007
-
GISSI-HF rosuvastatine, 2008
-
Tousoulis, 2005
-
Node, 2003
-
Krum, 2007
-
Wojnicz, 2006
-
Hong, 2005
-
Laufs, 2004
-
Sola, 2006
-
CHARM preserved, 2003
-
VALIDD, 2007
-
I-PRESERVE (McMurray), 2008
-
CHARM preserved, 2003
-
I-PRESERVE (McMurray), 2008
-
PEP CHF, 2006
-
PEP CHF, 2006
-
PIE II,
-
TOPCAT, 0
-
TRACE, 1995
-
Sharpe, 1988
-
EDEN, 1997
-
SAVE, 1992
-
Mortarino, 1990
-
Pfeffer, 1988
-
AIRE, 1993
-
Sogaard, 1994
-
EVEREST Outcome, 2007
-
Udelson, 2008
-
EVEREST Clinical Status , 2007
-
IMPRESS, 2000
-
OVERTURE, 2002
-
STARS-BNP, 2007
-
BASEL,
-
Troughton, 2000
-
RABBIT,
-
van Kraaij,
-
TIME CHF, 2009
-
BATTLESCARRED, 2009
-
PROTECT, 2009
-
PRIMA, 0
-
STARBRITE, 2007
-
Pre-RELAX-AHF, 2009
-
RECOVER,
-
Udelson, 2007
-
EVEREST Clinical Status , 2007
-
EVEREST Outcome, 2007
-
Udelson, 2008
-
Parissis, 2009
-
Ponikowski, 2007
-
Kourea, 2008
-
Parissis, 2008
-
STAMINA-HeFT (Ghali), 2008
-
FAIR-HF (Anker), 2009
-
Palazzuoli, 2006
-
van Veldhuisen, 2007
-
ATMOSPHERE,
-
ACCLAIM, 2008
-
PIE II,
-
ASTRONAUT,
-
Patwala, 2009
-
MADIT CRT, 2009
-
REVERSE, 2008
-
HeartMate II, 2009
-
REMATCH, 2001
-
BEAUTIFUL, 2008
-
SHIFT, 2010
-
PROTECT, 2010
-
heart failure with preserved LVEF
CHARM preserved, 2003
-
TOPCAT, 0
-
I-PRESERVE (McMurray), 2008
-
PEP CHF, 2006
-
hypertension
ANBP2, 2003
-
STOP 2 (vs diurectic or beta-blocker), 1999
-
MRC old (vs diuretics), 1992
-
SHELL, 2003
-
STOP-2 (vs felodipine or isradipine), 1999
-
SYST-EUR, 1997
-
Castel, 1994
-
HYVET, 2008
-
STOP 2 (vs conventional drugs), 1999
-
NICS-EH, 1999
-
MRC old (vs placebo), 1992
-
UKPDS 38, 1998
-
ABCD (H), 2000
-
FACET, 1997
-
IDNT (irbesartan vs amlodipine), 2001
-
STOP-2 ACEI (diabetic subgroup), 2000
-
NORDIL (diabetic subgroup), 2000
-
ACCOMPLISH (diabetic subgroup), 2010
-
RENAAL, 2001
-
ALLHAT (lisi vs chlor, diabetic subgroup), 2002
-
SHEP (diabetic subgroup), 1996
-
ABCD (N), 2002
-
MIDAS (diabetic sub group), 1997
-
UKPDS 38 10 years, 2008
-
IDNT irbesartan, 2001
-
INSIGHT (diabetic subgroup), 2000
-
IPDM, 2001
-
ALLHAT (amlodipine vs chlor, diabetic subgroup), 2002
-
Syst-Eur (diabetic subgroup), 1999
-
ACCORD blood pressure, 2010
-
UKPDS 39, 1998
-
AVOID, 2008
-
ABCD, 1998
-
IDNT amlodipine, 2001
-
STOP-2 CCB (diabetic subgroup), 2000
-
CAPP (diabetic subgroup), 1999
-
STOP-2 (ACEI vs CCB) (diabetic subgroup), 2000
-
HOPE (diabetic subgroup), 2000
-
LIFE (diabetic subgroup), 2002
-
NICS-EH, 1999
-
USPHS, 1977
-
JMIC-B, 2002
-
LIFE, 2002
-
Ruilope, 2010
-
Berglund, 1986
-
VA-I, 1967
-
ANBP2, 2003
-
MRC (diu vs BB), 1985
-
ALLAY, 2009
-
MRC I (vs diuretics), 1985
-
STOP, 1991
-
PATS, 1995
-
STOP-2, 1999
-
ALLHAT (CCB vs ACEI), 2002
-
Oslo (Hegeland), 1980
-
INVEST, 2003
-
UKPDS-HDS, 1998
-
CONVINCE, 2003
-
IDNT (vs placebo), 2001
-
UKPDS, 1998
-
ABCD (H), 1998
-
SHEP, 1991
-
ALLHAT (CCB vs diu), 2002
-
Yurenev, 1992
-
STOP 2 (vs diurectic or beta-blocker), 1999
-
Barraclough, 1973
-
IDNT, 2001
-
IDNT (vs amlodipine), 2001
-
HAPPHY, 1988
-
SYST-EUR, 1997
-
VA II, 1970
-
AASK (vs amlodipine), 2002
-
VALUE, 2004
-
Andersen, 2008
-
IPPPSH, 1985
-
Carter, 1970
-
AASK (vs metoprolol), 2002
-
AASK (vs ramipril), 2002
-
Schmieder (vs HCTZ), 2009
-
MCR 35-64 (diuretics vs pbo), 1985
-
ASCOT-BPLA, 2005
-
CAPPP, 1999
-
INVEST (Pepine), 2003
-
ACCOMPLISH, 2008
-
VA-NHLBI, 1977
-
LIFE, 2002
-
STOP-2 (vs felodipine or isradipine), 1999
-
SHEP-pilot, 1989
-
ELSA, 2002
-
Dutch TIA, 1993
-
NORDIL, 2000
-
Kuramoto, 1981
-
NICOLE, 2001
-
PROPHESS, 2008
-
MRC old (vs placebo), 1992
-
INSIGHT, 2000
-
HDFP, 1979
-
ALLHAT (vs amlodipine), 2002
-
SCOPE, 2003
-
KYOTO HEART Study, 2009
-
Coope, 1986
-
HSCS, 1974
-
ALLHAT (vs chlorthalidone), 2002
-
Castel, 1994
-
AVOID, 2008
-
MRC I (vs placebo), 1985
-
NORDIL, 2000
-
MIDAS, 1996
-
CONVINCE, 2003
-
HYVET, 2008
-
ANBPS (Australian ), 1980
-
ELSA, 2002
-
STOP 2 (vs conventional drugs), 1999
-
ASCOT-BPLA, 2005
-
SHELL, 2003
-
TEST, 1995
-
VHAS, 1998
-
EWPHE, 1985
-
AASK (vs metoprolol), 2002
-
MRC old (vs diuretics), 1992
-
HYVET, 2008
-
Syst-Eur (subgroup ), 1997
-
SHEP-P (subgroup ), 1989
-
HYVET, 2008
-
CASTEL (subgroup ), 1994
-
SHEP (subgroup ), 1991
-
Coope (subgroup ), 1986
-
Syst-China, 1998
-
STOP (subgroup ), 1991
-
EWPHE (subgroup ), 1985
-
AASK (vs ramipril), 2002
-
IDNT, 2001
-
IDNT (vs amlodipine), 2001
-
AASK (vs metoprolol), 2002
-
AASK (vs metoprolol), 2002
-
AVOID, 2008
-
IDNT (vs placebo), 2001
-
AASK (vs amlodipine), 2002
-
HSCS, 1974
-
TEST, 1995
-
PATS, 1995
-
Carter, 1970
-
Dutch TIA, 1993
-
Jikei Heart, 2007
-
ONTARGET/Tel, 2008
-
OPTIMAAL, 2001
-
ONTARGET/Tel+Ram, 2008
-
VALIANT/Val, 2003
-
ELITE, 1997
-
DETAIL, 2004
-
VALIANT/Val+Cap, 2003
-
ELITE-II, 2000
-
Suzuki et al, 2008
-
Takahashi et al, 2006
-
Cice et al, 2003
-
Tepel et al, 2008
-
Zannad et al, 2006
-
Li et al, 2003
-
Nakao et al, 2007
-
Cice et al, 2006
-
AVOID, 2008
-
ALLAY, 2009
-
Andersen, 2008
-
Schmieder (vs HCTZ), 2009
-
AVOID, 2008
-
ABCD (H), 2000
-
Toto, 1995
-
AASK, 2002
-
MDRD, 1994
-
ACCORD blood pressure, 2008
-
REIN-2, 2005
-
HOT, 1994
-
Cardio-Sis, 2009
-
ABCD (N), 2002
-
ABCD (H), 2000
-
ABCD (N), 2002
-
ACCORD blood pressure, 2008
-
Toto, 1995
-
MDRD, 1994
-
Cardio-Sis, 2009
-
HOT, 1994
-
REIN-2, 2005
-
DORADO, 2009
-
DORADO-AC,
-
TROPHY, 2006
-
HOT, 1998
-
HYRIM, 2005
-
ASCOT, 2003
-
impaired fasting glucose
NAVIGATOR valsartan, 2010
-
US-DPP (metformin) (Knowler), 2002
-
DREAM ramipril, 2006
-
NAVIGATOR nateglinide, 2010
-
STOP-NIDDM (Chiasson), 2002
-
DREAM rosiglitazone, 2006
-
CANOE, 2010
-
US-DDP (lifestyle) (Knowler), 2002
-
Voglibose Ph-3, 2009
-
miscellaneous
ONTARGET (association vs ramipril), 2008
-
ORIENT,
-
Ruilope, 2010
-
TRANSCEND, 2008
-
LIFE, 2002
-
IDNT (vs placebo), 2001
-
TROPHY, 2006
-
PROPHESS, 2008
-
IDNT (vs amlodipine), 2001
-
VALUE, 2004
-
ONTARGET (telmisartan alone), 2008
-
ROADMAP, 2010
-
KYOTO HEART Study, 2009
-
ONTARGET (association vs telmisartan), 2008
-
SCOPE, 2003
-
Multiple sclerosis
CLARITY,
-
Bornstein, 1987
-
Wroe, 2005
-
MSCRG,
-
CLARITY (LD),
-
Comi, 2001
-
REGARD,
-
OWIMS,
-
IFNB,
-
Johnson, 1995
-
PRISMS,
-
Knobler, 1993
-
obesity and overweight
Connolly, 1995
-
Bakris, 2002
-
Lucas, 2003
-
Stenlof, 2003
-
Croft, 2002
-
Mendoza Espejo, 1995
-
Kelley, 2002
-
Caterson, 2003
-
Hill, 1999
-
Sjostrom, 1998
-
Halpern, 2003
-
Rosenfalck, 2002
-
BLOSSOM, 2009
-
Deerochanawong,, 2001
-
Naumov, 2002
-
Smith, 2001
-
Darga, 1991
-
Broom, 2002
-
Micic, 1999
-
Tonstad, 2003
-
Jain, 2002
-
Michelson 50wk, 1999
-
Krempf, 2005
-
Pud’homme, 2003
-
Gray, 1992
-
Hollander, 1998
-
Vidgren, 1999
-
Hanefeld, 2002
-
Rossner, 2000
-
SCOUT,
-
Derosa, 2003
-
Reaven, 2001
-
Astrup, 0
-
Goldstein, 1994
-
Broom,, 2001
-
Miles, 2002
-
McMahon , 2000
-
Breum, 1995
-
O’Kane, 1994
-
Lindgarde, 2000
-
Rissanen, 2003
-
Anderson, 2002
-
Marcus, 1990
-
Karhunen, 2000
-
Bray, 2003
-
Hauptman, 2000
-
Shi Yi, 2001
-
Gotfredsen, 2001
-
Rissanen, 2001
-
Astrup (NN8022-1807 ), 2009
-
Davidson, 1999
-
Muls, 2001
-
McMahon, 2002
-
patients at high risk for cardiovascular events
KYOTO HEART Study, 2009
-
ONTARGET (association vs telmisartan), 2008
-
VALUE, 2004
-
Ruilope, 2010
-
TRANSCEND, 2008
-
SCOPE, 2003
-
ONTARGET (telmisartan alone), 2008
-
PROPHESS, 2008
-
LIFE, 2002
-
ONTARGET (association vs ramipril), 2008
-
EUROPA, 2003
-
ONTARGET (association vs ramipril), 2008
-
PEACE, 2004
-
ONTARGET (association vs telmisartan), 2008
-
QUIET, 2001
-
HOPE, 2000
-
CAMELOT (enalapril), 2004
-
ONTARGET (association vs telmisartan), 2008
-
CAMELOT (enalapril), 2004
-
EUROPA, 2003
-
TRANSCEND, 2008
-
ONTARGET (telmisartan alone), 2008
-
PEACE, 2004
-
ONTARGET (association vs ramipril), 2008
-
QUIET, 2001
-
HOPE, 2000
-
TRANSCEND, 2008
-
patients with implantable cardioverter defibrillators
Leaf, 2005
-
Raitt , 2006
-
SOFA , 2006
-
VTACH, 2009
-
SMASH-VT, 2007
-
percutaneous coronary intervention
EPILOG, 1997
-
IMPACT (12h), 1993
-
REPLACE-2, 2003
-
Drozd, 2001
-
ADMIRAL, 2001
-
RESTORE, 1997
-
Mayo-PTCA, 1989
-
Galeote, 2001
-
IMPACT-II (0.5µg), 1997
-
NAPLES (Tavano), 2009
-
Finci, 1989
-
REDUCE, 1996
-
Tamburino, 2002
-
CHAMPION-PCI, 2009
-
TACT, 1990
-
CACHET (without abciximab), 2002
-
Petronio, 2002
-
TRA-PCI, 2009
-
JUMBO-TIMI 26, 2005
-
ACUITY (sub groups, bivalirudin alone), 2007
-
EPISTENT, 1998
-
IMPACT-II (0.75µg), 1994
-
White (ticlopidine), 1991
-
Natarajan (without antiGp2b3a), 2003
-
CADILLAC, 2002
-
Kereiakis, 1996
-
Oriol, 1995
-
Dudek, 2000
-
Natarajan (+ antiGp2b3a), 2003
-
ESPRIT, 2000
-
ATOLL, 2010
-
Taylor (Perth), 1991
-
Rabah, 1999
-
ISAR-2, 2000
-
TRIGGER-PCI,
-
Schwartz (Toronto), 1988
-
Kleiman, 2002
-
Simoons, 1994
-
STREAM,
-
ISAR-REACT 3, 2008
-
ACUITY (Stone) (bivalirudin alone), 2006
-
CAPTURE, 1997
-
ACUITY (sub groups, bivalirudin +aGP2b3a), 2007
-
M-HEART II (sulotroban), 1995
-
Dubek b (+abciximal), 2001
-
EPIC (with infusion), 1994
-
EPIC (without infusion), 1991
-
M-HEART II (aspirin), 1995
-
Dudek b (enox alone), 2000
-
RAPPORT, 1998
-
Harrington, 1995
-
Nye (Dunedin), 1990
-
CRUISE, 2003
-
IMPACT (4h), 1995
-
BRAVE-4,
-
White (aspirin+dipiridamol), 1991
-
BAT (Bittl), 1995
-
Kini, 2001
-
CHAMPION-PLATFORM, 2009
-
STEEPLE, 2006
-
REPLACE-1, 2004
-
ERASER, 1999
-
Topol, 1993
-
HORIZONS-AMI (Stone), 2008
-
ARMYDA, 2004
-
FLARE, 1999
-
ESTATE,
-
Briguori, 2004
-
GAIN, 2001
-
NAPLES II (Briguori), 2009
-
LIPS, 2002
-
PREDICT, 1997
-
ARMYDA-RECAPTURE, 2009
-
Kozuma, 2001
-
CLASSICS, 2000
-
ARTIC adjusted,
-
STARS (vs aspirin), 1998
-
DES-LATE, 2010
-
Foussas, 2000
-
ISAR-SAFE, 0
-
Kamishirado, 2002
-
Ochiai, 1999
-
TOPPS, 2001
-
ARTIC (extended dual antiplatelet), 0
-
Hall, 1996
-
OPTIMIZED,
-
MATTIS, 1998
-
DAPT,
-
FANTASTIC, 1998
-
Sekiya, 1998
-
Park, 1999
-
Piamsomboon, 2001
-
Müller, 2000
-
GRAVITAS,
-
STARS (vs coumadin+asp), 1998
-
CILON-T, 2010
-
ISAR, 1996
-
Kunishima, 1997
-
Yoon, 1999
-
CHAMPION-PCI, 2009
-
STREAM,
-
ATOLL, 2010
-
APEX-AMI, 2007
-
Jorgensen (NICOLE), 2001
-
O’Keefe, 1991
-
Corcos, 1985
-
Unverdorben, 1996
-
Whitworth, 1986
-
Dens (CAPARES), 2000
-
Hoberg, 1994
-
PROVIDENCE,
-
Mann , 1998
-
Li , 2007
-
ACCESS , 1997
-
Lange and von Boetticher, 2006
-
Achenbach , 2005
-
Tian , 2003
-
Moriyama , 2002
-
Monsegu , 2000
-
Vazquez-Rodriguez, 2004
-
BRAFE , 1997
-
RADIAMI , 2007
-
Grinfeld, 1996
-
OUTCLAS , 2005
-
Reddy , 2004
-
TEMPURA , 2003
-
CARAFE , 2001
-
Cooper , 1999
-
Bodi, 2008
-
Mann , 1996
-
FARMI , 2007
-
RADIAL AMI , 2005
-
OCTOPLUS , 2004
-
Gorge and Kirstein, 2001
-
PIHRATE, 2004
-
PREMIAR, 2007
-
Kaltoft, 2006
-
Tahk, 2008
-
Napodano, 2003
-
AiMI, 2006
-
Nanasato, 2004
-
Sardella, 2005
-
DIPLOMATE, 2004
-
VAMPIRE, 2004
-
Ochala, 2007
-
REMEDIA, 2005
-
MICADO, 2007
-
DEAR-MI, 2006
-
Beran, 2002
-
X AMINE ST, 2005
-
NONSTOP, 2004
-
Wang, 2003
-
Noel, 2005
-
PROMISE, 2005
-
TAPAS, 2002
-
Dudek, 2004
-
UpFlow MI, 2007
-
De Luca, 2006
-
DEDICATION, 2008
-
Florence, 2004
-
Export (Chevalier), 2008
-
ASPARAGUS, 2008
-
EXPIRA, 2005
-
EMERALD, 2005
-
PACA, 2009
-
COGENT, 2009
-
OCLA, 2008
-
Nishimura, 2009
-
ACUITY (sub groups, bivalirudin alone), 2007
-
ACUITY (sub groups, bivalirudin +aGP2b3a), 2007
-
STEEPLE, 2006
-
Natarajan (without antiGp2b3a), 2003
-
Dudek, 2000
-
Rabah, 1999
-
Kleiman, 2002
-
ACUITY (Stone) (bivalirudin alone), 2006
-
Topol, 1993
-
REPLACE-2, 2003
-
Dubek b (+abciximal), 2001
-
Dudek b (enox alone), 2000
-
CRUISE, 2003
-
BAT (Bittl), 1995
-
REPLACE-1, 2004
-
NAPLES (Tavano), 2009
-
HORIZONS-AMI (Stone), 2008
-
Natarajan (+ antiGp2b3a), 2003
-
ISAR-REACT 3, 2008
-
Drozd, 2001
-
Galeote, 2001
-
REDUCE, 1996
-
CACHET (without abciximab), 2002
-
ATOLL, 2010
-
ATOLL, 2010
-
peripheral vascular diseases
Cornu C, 0
-
Kellner, 1983
-
Mouren, 1994
-
Fyfe T, 1975
-
Meehan, 1982
-
Adhoute, 1990
-
Thomson, 1990
-
Van der Stricht, 1977
-
Porter, 1982
-
Strandness, 2002
-
Dawson (cilostazol), 2000
-
Fellman N, 1989
-
Dawson (pentoxifylline), 2000
-
Belcaro, 2002
-
Vowden P, 0
-
Wong AL, 1980
-
Beebe, 1999
-
Bisler, 1983
-
Trubestein (naftidrofuryl), 1984
-
Negus, 1987
-
Boccalon, 2001
-
Reilly, 1987
-
Horsch, 1998
-
Shanik GD, 1976
-
Diamantopoulos, 2001
-
Bollinger, 1977
-
Blume, 1996
-
Barnes RW, 1977
-
Elam, 1998
-
LIMB, 2008
-
Ernst, 1992
-
Blume, 1998
-
Mustapha NM, 1984
-
APIC, 1989
-
Cesarone, 2002
-
TRAFFIC, 0
-
Taggart I, 1989
-
Dawson, 1998
-
Bauer, 1984
-
Accetto, 1982
-
Testart, 1994
-
NIQOL germany, 1999
-
NIQOL belgium, 2001
-
Rudofsky, 1989
-
Karnik, 1986
-
Cross FW, 1985
-
Farquhar JW, 0
-
Kriessmann, 1988
-
Peters, 1998
-
Satiani B, 1982
-
Otsuka 21-95-201,
-
Trubestein, 1984
-
Waters, 1980
-
Rudofsky, 1987
-
D'Hooge D, 2001
-
Donaldson, 1984
-
Elam, 1998
-
Fonseca, 1988
-
Meehan SE, 1982
-
Money, 1998
-
De Sanctis, 2002
-
Moody, 1994
-
Greenhalgh RM, 1981
-
Clyne, 1980
-
NCIS, 2001
-
Chacon-Quevedo, 1994
-
Meehan, 1982
-
Calabro, 1993
-
APIC, 1989
-
CLIPS, 2007
-
Schweizer, 2001
-
Simoni, 1993
-
Tesi, 1989
-
Mannarino, 1991
-
De Smit, 1987
-
Palmieri, 1988
-
Cina, 1996
-
Andreozzi, 1993
-
Allegra , 1994
-
Deutschinoff, 1987
-
WAVE, 0
-
Montesi, 1991
-
Serrao, 1991
-
Antonicelli, 1999
-
Fitzgerald DE, 1971
-
Pockley G, 0
-
Holm J, 1973
-
Creasy TS, 1990
-
Larsen OA, 1966
-
Dahllof AG, 1974
-
Gardner, 2001
-
Ericsson B, 1970
-
Stewart A, 0
-
Lear PA, 0
-
Lundgren F, 1989
-
Regensteiner JG, 1996
-
Tisi PV, 1997
-
Hiatt WR, 1990
-
Savage P, 2001
-
Mannarino E, 1989
-
McCloskey B, 0
-
Gelin, 2001
-
Fowler, 2002
-
Taft, 2001
-
Ernest EW, 1987
-
Hiatt WR, 1994
-
Dahllof AG, 1976
-
Mannarino E, 1991
-
Jayatunga AP, 0
-
Castano, 2003
-
Mondillo, 2003
-
Gans, 1990
-
PQRST, 1994
-
Aronow , 2003
-
St Thomas, 1983
-
Blann, 2001
-
HPS (sub group), 2002
-
CLAS, 1987
-
Amburgey CF, 0
-
Schumer W, 1963
-
Mohler III, 2003
-
LEADER trial, 2000
-
Davis, 1975
-
Hutchinson K, 1983
-
Boyd, 1963
-
Hamilton, 1953
-
Westheim, 1975
-
ADMIT, 0
-
POPADAD (antioxydant), 2008
-
Williams , 1962
-
Livingstone, 1958
-
POPADAD (antioxydant), 2008
-
CLIPS, 2007
-
Kusumanto, 2006
-
RAVE (Rajagopalan), 2003
-
TRAFFIC (Lederman), 2002
-
DELTA (Grossman), 2007
-
Makinen, 2002
-
post acute coronary syndromes
REDEEM, 2009
-
ARISE, 2007
-
post myocardial infarction
BIP, 2000
-
REVERSAL, 2004
-
Tuttle, 2008
-
IDEAL, 2005
-
4S, 1994
-
VA-HIT, 1999
-
PACT, 2004
-
Vascular basis, 2005
-
Carlson (Stockholm), 1977
-
LIPID, 1998
-
BECAIT, 1996
-
SAGE, 2007
-
TNT, 2005
-
CARE, 1996
-
OASIS main, 2001
-
German-Austrian Study Group (oac vs asp), 1980
-
APRICOT-2, 2002
-
WARIS II (warfarin+ASA), 2002
-
LoWASA, 2004
-
ASPECT, 1994
-
Zibaeenezhad, 2004
-
OASIS pilot, 1998
-
OASIS pilot phase 2, 0
-
ASPECT-2 (coumadin alone), 2002
-
Sixty Plus reinfarction Study, 1980
-
ATACS main, 1994
-
CARS (warfarin 1mg), 1997
-
CHAMP, 2002
-
Horizons, 2008
-
WARIS II (warfarin alone), 2002
-
LoWASA (copie de 8025), 0
-
Huynh, 2001
-
EPSIM, 1982
-
ATACS pilot, 1990
-
ASPECT-2 (coumadin+ASA vs ASA), 2002
-
CARS (warafrin 3mg), 1997
-
WARIS, 1999
-
Williams, 1997
-
German-Austrian Study Group (oac vs pbo), 1980
-
CAST II (late treatment), 1992
-
BASIS, 1990
-
DIAMOND MI, 1997
-
Navarro-Lopez, 1993
-
BASIS, 1990
-
Julian, 1982
-
CAST I, 1991
-
Hockings, 1987
-
CAMIAT , 1991
-
ALIVE, 2004
-
CAST II (early treatment), 1992
-
Rodriguez, 1992
-
Ceremuzynski, 1992
-
CRIS, 1996
-
DAVIT II, 1990
-
SPRINT I, 1988
-
Danish study, 1984
-
MDPIT, 1988
-
SPRINT II, 1993
-
MI study group, 1979
-
DAVIT I, 1984
-
JAMIS, 1999
-
AMIS, 1980
-
Cardiff I, 1974
-
PARIS, 1980
-
CAPRIE, 1996
-
GAMIS, 1980
-
Cardiff II, 1979
-
PARIS, 1980
-
PARIS, 1980
-
Vogel, 1979
-
CDPA, 1976
-
PARIS-II, 1986
-
OMEGA, 2009
-
REDEEM, 2009
-
ARISE, 2007
-
CAPRIE, 1996
-
GAMIS, 1980
-
Cardiff II, 1979
-
PARIS, 1980
-
PARIS, 1980
-
Vogel, 1979
-
CDPA, 1976
-
PARIS-II, 1986
-
JAMIS, 1999
-
AMIS, 1980
-
Cardiff I, 1974
-
PARIS, 1980
-
post stroke
HPS (sub groups), 2004
-
SPARCL, 2006
-
PROFESS, 2008
-
Danish low-dose, 1986
-
DCS, 1980
-
SALT , 1991
-
Swedish study , 1987
-
ESPS 2 , 1996
-
AICLA, 1981
-
Reuther , 1976
-
UK-TIA low dose , 1988
-
Lindblad , 1991
-
AITA, 1975
-
UK-TIA high dose , 1988
-
Canadian study (CCSG), 1978
-
Thygesen, 1964
-
McDevitt, 1959
-
Enger, 1965
-
VA Study, 1961
-
Nat-Coop, 1962
-
Howard, 1963
-
Baker, 1964
-
Wallace, 1964
-
SWAT, 1998
-
LHSPS, 1999
-
Bradshaw, 1975
-
VISP (Toole), 2004
-
VITATOPS, 2010
-
RESPECT PFO,
-
PC-Trial,
-
CLOSE,
-
REDUCE,
-
CLOSURE I, 2010
-
CryptoCard,
-
postthrombotic syndrome
Aschwanden, 2008
-
Ginsberg, 2001
-
Partsch, 2004
-
Prandoni, 2004
-
Brandjes, 1997
-
prevention of sudden death
COMPANION (CRT+ICD vs MT), 2004
-
DEFINITE, 2004
-
MIRACLE-ICD-II, 2004
-
MUSTIC AF, 2002
-
Garrigue, 2002
-
COMPANION (CRT vs MT), 2004
-
DINAMIT, 2004
-
COMPANION (CRT+ICD vs CRT), 2004
-
MADIT-II, 2002
-
AMIOVIRT, 2003
-
CONTAK-CD , 2003
-
PATH-CHF, 2002
-
MIRACLE, 2002
-
MUSIT, 1999
-
MADIT, 1996
-
SCD-HeFT (ICD vs placebo), 2005
-
CAT, 2002
-
MIRACLE-ICD-I, 2003
-
RD-CHF, 2003
-
MUSTIC-SR, 2001
-
SCD-HeFT (ICD vs amiodarone), 2005
-
CARE-HF, 2005
-
CABG-patch, 1997
-
Dutch trial, 1995
-
AVID, 1997
-
CASH, 2000
-
CIDS, 2000
-
MIRACLE, 2002
-
MUSIT, 1999
-
MADIT, 1996
-
SCD-HeFT (ICD vs placebo), 2005
-
CAT, 2002
-
MIRACLE-ICD-I, 2003
-
RD-CHF, 2003
-
MUSTIC-SR, 2001
-
SCD-HeFT (ICD vs amiodarone), 2005
-
CARE-HF, 2005
-
CABG-patch, 1997
-
COMPANION (CRT+ICD vs MT), 2004
-
DEFINITE, 2004
-
MIRACLE-ICD-II, 2004
-
NCT00887237,
-
MUSTIC AF, 2002
-
Garrigue, 2002
-
COMPANION (CRT vs MT), 2004
-
DINAMIT, 2004
-
COMPANION (CRT+ICD vs CRT), 2004
-
MADIT-II, 2002
-
AMIOVIRT, 2003
-
RethinQ, 2007
-
CONTAK-CD , 2003
-
PATH-CHF, 2002
-
MADIT, 1996
-
pulmonary embolism
European multicentre study, 1991
-
BARRIT, 1960
-
Certoparin-Study Group sub group, 1998
-
THESEE, 1997
-
Kuijer, 1995
-
ACTSG (Hull) sub-group, 1992
-
VanGogh PE, 2007
-
Merli sub group, 2001
-
Campbell, 1998
-
Meyer, 1995
-
Prandoni sub-group, 1992
-
MATISSE PE, 2003
-
Einstein-PE Evaluation,
-
PREPIC, 1998
-
COLOMBUS sub group, 1997
-
Thery, 1992
-
Jerjes-Sanchez, 1995
-
UPET, 1973
-
Levine, 1990
-
Konstantinides, 2002
-
Tibbutt, 1974
-
PAIMS 2, 1992
-
Marini, 1988
-
Tebbe, 2009
-
Ly, 1978
-
Goldhaber, 1993
-
PIOPED, 1990
-
pulmonary hypertension
AIR (Olschewski), 2002
-
FREEDOM-C2,
-
Langleben, 2002
-
ARIES (Galie=, 2008
-
Barst, 1996
-
STRIDE-2 (Barst), 2006
-
SERAPH (Wilkins), 2005
-
BREATH-2 (Humbert), 2004
-
BREATHE-1 (Rubin), 2002
-
Simmoneau, 2002
-
EARLY (Galie), 2008
-
Badesch, 2000
-
STEP (McLaughlin), 2006
-
Singh, 2006
-
STRIDE-1 (Barst), 2004
-
Barst, 2003
-
ALPHABET (Galie), 2002
-
PACES (Simonneau), 2008
-
Channick, 2001
-
COMBI (Hoeper), 2006
-
Rubin, 1990
-
BREATH-5 (Galie), 2006
-
SUPER-1 (Galie), 2005
-
Sastry, 2004
-
restenosis after PCI
SVG-WRIST, 2002
-
Schühlen, 2001
-
ECRIS, 2003
-
SCRIPPS, 1997
-
INHIBIT, 2002
-
WRIST, 2001
-
Long-WRIST, 2003
-
PREVENT, 2000
-
START, 2000
-
GAMMA-ONE, 2001
-
SPARE, 2004
-
stable angina
Sirnes, 1996
-
ERACI II, 2003
-
TAXUS I, 2003
-
Huikeshoven, 2003
-
PRISON II, 2006
-
LEMANS, 2002
-
Han, 2006
-
ARTS 2, 2010
-
Pasceri, 2003
-
CABRI, 1995
-
Lipsia-Yukon-DM, 0
-
Park, 2000
-
PROTECT, 0
-
SIRIUS, 2003
-
Frazier, 1999
-
SES-SMART, 2004
-
VA CARDS, 0
-
LONG DES II, 2006
-
Thiele, 2009
-
Spaulding pooled analysis Ravel Sirius studies, 2007
-
MASS, 1995
-
SPIRIT II, 2006
-
Moer, 2001
-
PEPCAD IV, 0
-
Hoher, 1999
-
Cisowski, 0
-
Tomai, 2008
-
Costar II, 2008
-
FUTURE II, 2006
-
Gray, 2003
-
REALITY, 2006
-
Oregon, 1979
-
RITA 2, 1997
-
GISSOC II, 2010
-
Serruys Benestent, 1994
-
ISAR-LEFT-MAIN, 2009
-
Lincoff (EPISTENT), 1999
-
Hambrecht, 2004
-
MASS II, 2007
-
AMIST (Reeves), 2004
-
SCORE, 2004
-
van der Sloot, 2004
-
ISAR-DIABETES, 2005
-
ECSS (European), 1988
-
EK-12006, 0
-
Serruys Benestent 2, 1998
-
VELETI, 0
-
Kastrati, 2000
-
ISAR, 2005
-
Hancock, 1998
-
SOS, 2002
-
ELUTES, 2004
-
Allen, 2000
-
Ortolani et al, 2007
-
SWISSI II, 2007
-
PERSEUS Workhorse, 2010
-
RITA, 1993
-
SPIRIT IV, 2010
-
Fluck, 2000
-
FEMH-93005, 0
-
Savage, 1998
-
Grip, 2001
-
TAXUS II, 2003
-
PACIFIC, 2000
-
SCANDSTENT, 2006
-
ACIP, 1997
-
BASKET (vs paclitaxel), 2005
-
AWESOME, 2001
-
STRATEGY, 2005
-
EAST, 1994
-
ENDEAVOR III, 2006
-
Lotan, 2000
-
MIDCAB Versus DES in Proximal LAD Lesions, 0
-
Sievert, 1999
-
Diegeler, 2002
-
C-SIRIUS, 2004
-
ATLANTIC (Burkhoff), 1999
-
DIABETES, 2005
-
Kim, 2008
-
Cervinka, 2006
-
ISAR-TEST-4 (biodegradable polymer), 2009
-
ENDEAVOR II, 2006
-
BARI, 1996
-
SYNTAX, 2009
-
Doucet, 2001
-
Nordic Bifurcation Stent Technique Study, 0
-
Kochiadakis, 2007
-
Schofield, 1999
-
TAXUS V (all patients), 2005
-
Zhao, 2006
-
ISAR-SMART 3, 2006
-
New zealand 1, 1981
-
Stone pooled analysis sirolimus, 2007
-
RESOLUTE, 2010
-
ACME, 1992
-
FRE-RACE, 0
-
ACME 2 (Folland), 1997
-
ZoMaxx phase 2, 0
-
Buller, 1999
-
Bech, 2001
-
MASS II, 2007
-
Hong, 2005
-
ACTION, 2004
-
March, 1999
-
SIRTAX (Windecker), 2005
-
CASS, 1983
-
LEADERS, 2008
-
Versaci , 1997
-
ISAR-TEST-1, 2006
-
Di Marlo, 2000
-
Dakik, 1998
-
Rodriguez, 1998
-
CARDia (PCI), 2008
-
DELIVER, 2004
-
Salem, 2004
-
TAXi, 2005
-
MASS II, 2007
-
DEFER-DES, 0
-
ERACI, 1992
-
SPIRIT III, 2008
-
Lafont, 2000
-
GENESIS Trial CP-01, 0
-
Erbel, 1998
-
OCTOSTENT, 2003
-
TAXUS IV, 2004
-
Galiñanes, 2004
-
DECODE, 2005
-
DANAMI, 2007
-
Di Lorenzo et al., 2005
-
Myoprotect, 2004
-
ISAR-CABG, 0
-
GABI, 1994
-
ENDEAVOR IV, 2009
-
Weaver, 2000
-
PRISON III, 2007
-
Eeckout, 1996
-
Drenth, 2002
-
E-SIRIUS, 2003
-
Aaberge, 2000
-
Pache et al, 2005
-
BARI 2D, 2009
-
Petronio et al, 2007
-
COMPARE, 2009
-
ABSORB, 0
-
MASS, 1995
-
FOCUS, 0
-
Koning, 2001
-
RESEARCH à effacer, 2004
-
RAVEL, 2002
-
Allen, 1999
-
TAXUS VI, 2005
-
TIME, 2001
-
Zhang (SES vs PES), 2006
-
STICH (ventricular reconstruction), 2009
-
Stone pooled analysis TAXUS studies, 2007
-
Boudriot, 2008
-
Sievers, 1993
-
DIABEDES IV, 0
-
AVERT, 1995
-
ZoMaxx phase 3, 2007
-
Betriu, 1999
-
ARTS, 2001
-
MASS II, 2007
-
Kim, 2005
-
FUTURE I, 2004
-
Leon (high dose), 2005
-
CORPAL, 2005
-
Texas, 1977
-
DES-ISR, 0
-
Fischman STRESS, 1994
-
Leipzig, 0
-
Serruys, 2000
-
ALKK, 2003
-
COURAGE, 2007
-
FREEDOM, 0
-
PATENCY, 2002
-
Loubani, 2003
-
ISAR-DESIRE (SES vs PES), 2005
-
VA, 1984
-
BASKET-SAVAGE, 0
-
Toulouse, 1992
-
LEFT-MAIN-2, 0
-
Witkowski, 2000
-
ZEST (vs SES), 2009
-
Rubartelli, 1998
-
SIMA, 2000
-
ASPECT, 2003
-
Stone, 2002
-
SCORPIUS, 2007
-
INSPIRE, 2006
-
SPIRIT I, 2005
-
Lausanne, 1994
-
Nordic Bifurcation Study, 0
-
Dangas, 2000
-
SORT OUT IV, 0
-
MASS, 1995
-
ACME, 1992
-
LEMANS, 2002
-
SIMA, 2000
-
Diegeler, 2002
-
Lausanne, 1994
-
Sievers, 1993
-
Thiele, 2009
-
AMIST (Reeves), 2004
-
Drenth, 2002
-
ALKK, 2003
-
MASS, 1995
-
Hong, 2005
-
Grip, 2001
-
Cisowski, 0
-
GABI, 1994
-
Myoprotect, 2004
-
BARI, 1996
-
CARDia (PCI), 2008
-
ARTS, 2001
-
Dakik, 1998
-
ACME 2 (Folland), 1997
-
RITA, 1993
-
CABRI, 1995
-
MASS II, 2007
-
ERACI II, 2003
-
Hambrecht, 2004
-
AVERT, 1995
-
ERACI, 1992
-
EAST, 1994
-
AWESOME, 2001
-
RITA 2, 1997
-
SOS, 2002
-
Bech, 2001
-
MASS II, 2007
-
Toulouse, 1992
-
VA CARDS, 0
-
CARDia (PCI), 2008
-
Kim, 2008
-
FREEDOM, 0
-
BARI 2D, 2009
-
DESSERT, 2008
-
Dewar, 1961
-
Zion, 1961
-
Wirecki, 1967
-
Atlanta (Sbar), 1967
-
ASCET,
-
Neumann, 1964
-
Kinsella, 1962
-
SAPAT, 1992
-
Becker, 1967
-
Foulds, 1960
-
Leiberman, 1964
-
Igloe, 1970
-
Berglund, 1985
-
Murphy, 2003
-
CLARICOR, 2006
-
ANTIBIO, 2003
-
CLARIFY, 2001
-
WIZARD, 2003
-
AZACS, 2003
-
Leowattana et al, 2001
-
ACES, 2005
-
Gupta et al, 1997
-
PROVE-IT, 2005
-
STAMINA (Azithromycin), 2002
-
ROXIS, 1999
-
ACADEMIC, 1999
-
BEAUTIFUL, 0
-
BEAUTIFUL, 2008
-
CL3-023 (15mg), 0
-
Borer (CL2-009) 10mg, 2003
-
ASSOCIATE (Tardif), 2009
-
Ruzyllo (CL3-023) 15mg, 2007
-
CL3-023 (20mg), 0
-
Borer (CL2-009) 20mg, 2003
-
CL3-018 15mg, 3000
-
INITIATIVE (CL3-017, Tardif) 20mg, 2005
-
Ruzyllo (CL3-023) 20mg, 2007
-
INITIATIVE (CL3-017, Tardif) 15mg, 2005
-
CL3-018 10mg, 3000
-
BEAUTIFUL, 2008
-
Borer (CL2-009) 5mg, 2003
-
ERICA, 2006
-
MARIZA, 2004
-
RAN080, 2005
-
CARISA 1000mg, 2004
-
Lanza, 2005
-
ESBY, 1998
-
Eddicks, 2007
-
SPIRIT, 2006
-
de Jongste , 1994
-
stent
STARS (vs coumadin+asp), 1998
-
CILON-T, 2010
-
ISAR, 1996
-
Kunishima, 1997
-
Yoon, 1999
-
Kozuma, 2001
-
CLASSICS, 2000
-
ARTIC adjusted,
-
STARS (vs aspirin), 1998
-
DES-LATE, 2010
-
Foussas, 2000
-
ISAR-SAFE, 0
-
Kamishirado, 2002
-
Ochiai, 1999
-
TOPPS, 2001
-
ARTIC (extended dual antiplatelet), 0
-
Hall, 1996
-
OPTIMIZED,
-
MATTIS, 1998
-
DAPT,
-
FANTASTIC, 1998
-
Sekiya, 1998
-
Park, 1999
-
Piamsomboon, 2001
-
Müller, 2000
-
GRAVITAS,
-
superficial thrombophlebitis
Holzgreve, 1989
-
STENOX (enoxaparin 1.5mg/hg), 2003
-
Belcaro (LMWH vs low dose hep), 1999
-
Titon (nadroparin 0.6ml vs naproxen), 1994
-
Nocker (exhirud), 1991
-
Archer, 1977
-
Nusser, 1991
-
Belcaro (prophylactic UFH vs no), 1999
-
Marshall, 2001
-
Gorski (LMWH vs hep spraygel), 2005
-
Kuhlwein, 1985
-
De Sanctis, 2001
-
Incandela, 2001
-
Belcaro (coumadin vs low dose hep), 1999
-
Ferrari, 1992
-
Vesalio, 2005
-
Andreozzi (desmin SC vs 100), 1996
-
Belcaro, 1989
-
Pinto, 1992
-
Belcaro (hep vs no hep), 1989
-
Andreozzi (200 vs 100), 1996
-
Messa, 1997
-
STENOX (enox fixed dose vs NSAIDS), 2003
-
Lozano, 2003
-
STENOX (tenoxicam vs PBO), 2003
-
Katzenschlager, 2003
-
Belcaro (ligation vs low dose hep), 1999
-
Gorski, 2005
-
Titon (nadroparin 61.5 IU anti-Xa/kg vs naproxen), 1994
-
CALISTO, 2010
-
Belcaro, 1990
-
Stenox (enoxaparin 40mg), 2003
-
Belcaro (hep vs defibrotide), 1990
-
Anonymous, 1970
-
Nocker (diclofenac), 1991
-
STENOX (prophylactic LMWH vs NSAIDs), 2003
-
Marchiori, 2002
-
Katzenschlager (LMWH vs hep spraygel), 2003
-
Koshkin, 2001
-
Belcaro (complete stripping vs low dose hep), 1999
-
throracic aortic aneuvrism
INSTEAD, 2009
-
venous thrombosis
Turpie, 1990
-
Schweizer tPA, 1998
-
Goldhaber (tPA alone), 1990
-
Arneson, 1978
-
Schweizer (local urokinase), 2000
-
Verhaeghe (low dose), 1989
-
Verhaeghe (high dose), 1989
-
Schweizer (local tPA), 2000
-
Kiil, 1981
-
Common, 1976
-
Schweizer (systemic SK), 2000
-
Kakkar (streptokinase), 1969
-
Goldhaber (tPA+heparin), 1990
-
Tsapogas, 1973
-
Schulman, 1986
-
Elsharawy, 2002
-
Schweizer (systemic urokinase), 2000
-
Kakkar (arvin), 1969
-
Schweizer (urokinase), 1998
-
Einstein-DVT Dose-Ranging Study, 2008
-
Lopaciuk et al , 1992
-
Boccalon, 2000
-
Hull, 1986
-
Deitcher, 2003
-
Bratt et al, 1990
-
Pinede, 2001
-
Krahenbuhl, 1979
-
Lopez-Beret, 2001
-
CV185-057,
-
Bratt et al , 1985
-
Schulman, 1995
-
Ott importé, 1998
-
RE-COVER, 2009
-
Partsch, 1996
-
Schulman, 1997
-
Gonzalez-Fajardo, 1999
-
Romera, 2009
-
Charbonnier, 1998
-
Levine, 1996
-
Pini, 1990
-
Botticelli DVT, 2008
-
Hull et al , 1992
-
Chong, 2005
-
Doyle, 1987
-
Kakkar, 2003
-
Collaborative European Multicentre, 1991
-
Agnelli, 2003
-
Bentley, 1980
-
Meyer, 2002
-
MATISSE PE, 2003
-
Holm et al , 1986
-
Kearon, 1999
-
Nielsen importé, 1994
-
VanGogh PE, 2007
-
Siegbahn, 1989
-
MATISSE, 2004
-
Lopaciuk, 1999
-
Einstein-DVT Evaluation, 2010
-
Holmström, 1992
-
Ramacciotti, 2004
-
Pini, 1994
-
González-Fajardo, 2008
-
Simonneau et al , 1993
-
Daskalopoulos, 2005
-
Walker, 1987
-
Lee, 2003
-
Prandoni et al , 1992
-
Kearon, 2004
-
Andersson, 1982
-
Hull, 2002
-
Faivre et al , 1988
-
Agnelli, 2001
-
Fiessinger , 2005
-
CV185-056,
-
Levine, 1995
-
THRIVE I, 0
-
Veiga, 2000
-
Einstein-PE Evaluation,
-
Merli, 2001
-
Merli (once daily vs UFH), 2001
-
Das, 1996
-
VanGogh DVT, 2007
-
Lindmarker et al , 1993
-
Koopman, 1996
-
Lopaciuk, 3000
-
Lopez Beret, 2001
-
Deitcher, 2006
-
Meyer, 2002
-
Hull, 2006
-
Wells (subgroup), 2005
-
Schulman (subgroup), 2003
-
Lee, 2003
-
Cesarone, 2003
-
PREPIC, 1998
-
THRIVE III , 0
-
Faivre et al , 1988
-
Koopman, 1996
-
Romera, 2009
-
Boccalon, 2000
-
Kakkar, 2003
-
Merli, 2001
-
Meyer, 2002
-
Lindmarker et al , 1993
-
Lopaciuk, 1999
-
Lopaciuk et al , 1992
-
Pini, 1994
-
Bratt et al, 1990
-
Levine, 1996
-
Bratt et al , 1985
-
Chong, 2005
-
Lee, 2003
-
Partsch, 1996
-
Hull, 2002
-
Charbonnier, 1998
-
Veiga, 2000
-
Hull et al , 1992
-
Das, 1996
-
Collaborative European Multicentre, 1991
-
Ramacciotti, 2004
-
Holm et al , 1986
-
Daskalopoulos, 2005
-
González-Fajardo, 2008
-
Siegbahn, 1989
-
Deitcher, 2003
-
Holmström, 1992
-
Lopez-Beret, 2001
-
Simonneau et al , 1993
-
Gonzalez-Fajardo, 1999
-
Prandoni et al , 1992
-
Merli (once daily vs UFH), 2001
-
Kakkar, 2003
-
Levine, 1995
-
Bentley, 1980
-
Meyer, 2002
-
Merli, 2001
-
Merli (once daily vs UFH), 2001
-
Lopaciuk, 1999
-
Lindmarker et al , 1993
-
Koopman, 1996
-
Lopaciuk et al , 1992
-
Boccalon, 2000
-
Pini, 1994
-
Bratt et al, 1990
-
Pinede, 2001
-
Walker, 1987
-
Lee, 2003
-
Bratt et al , 1985
-
Schulman, 1995
-
Andersson, 1982
-
Hull, 2002
-
Partsch, 1996
-
Schulman, 1997
-
Veiga, 2000
-
Charbonnier, 1998
-
Levine, 1996
-
Hull et al , 1992
-
Chong, 2005
-
Das, 1996
-
Collaborative European Multicentre, 1991
-
Agnelli, 2003
-
Lopaciuk, 3000
-
González-Fajardo, 2008
-
Holm et al , 1986
-
Kearon, 1999
-
Hull, 1986
-
Deitcher, 2003
-
Siegbahn, 1989
-
Krahenbuhl, 1979
-
Lopez-Beret, 2001
-
Holmström, 1992
-
Ramacciotti, 2004
-
Simonneau et al , 1993
-
Daskalopoulos, 2005
-
Gonzalez-Fajardo, 1999
-
Prandoni et al , 1992
-
Kearon, 2004
-
Pini, 1990
-
Romera, 2009
-
Faivre et al , 1988
-
Agnelli, 2001
-
Doyle, 1987
-
Lopaciuk, 3000
-
Hull, 1986
-
Krahenbuhl, 1979
-
Pini, 1990
-
Doyle, 1987
-
Bentley, 1980
-
Walker, 1987
-
Andersson, 1982
-
RE-COVER, 2009
-
Einstein-PE Evaluation,
-
Einstein-DVT Dose-Ranging Study, 2008
-
EINSTEIN-extension, 2009
-
Botticelli DVT, 2008
-
CV185-057,
-
CV185-056,
-
Einstein-DVT Evaluation, 2010
-
ventricular tachycardia in patients with structural heart disease
SMASH-VT, 2007
-
VTACH, 2009
-
browse_trt4
|
|